Identification of the Mechanisms of mRNA Regulation by PUF Proteins. by Blewett, Nathan Hans
Identification of the Mechanisms of mRNA Regulation by PUF Proteins 
by 
Nathan Hans Blewett 
 
A dissertation submitted in partial fulfillment  
of the requirements for the degree of 
Doctor of Philosophy 
(Cellular and Molecular Biology) 








Associate Professor Aaron C. Goldstrohm, Chair 
Professor David R. Engelke 
Professor Ray C. Trievel 
Professor Michael D. Uhler 



































I would like to first thank my mentor, Aaron Goldstrohm.  It’s clear that he is dedicated 
to providing the most effective, thorough, and thoughtful leadership possible.  I have been 
challenged to perform at a very high-standard, to construct defined testable hypothesis and argue 
my position strongly.  Aaron also promotes a positive atmosphere for professional development, 
and the discussions that we have had were valuable.  He is always willing to argue about a 
hypothesis, or experimental interpretation; provided a strong logical foundation.  It has been an 
honor to be the first graduate student in his lab, I have learned much about what I’m capable of 
from his perseverance, and commitment to good science. 
 
I would also like to acknowledge the members of the Goldstrohm Lab, there are an 
innumerable number of valuable discussions we’ve had, both scientifically, and regarding life.  
There is a lot of pressure to perform in the present funding climate, and I was blessed to work 
with a group of people who are supportive of each other.  I have learned many things from each 
member of the Goldstrohm lab, and count myself lucky to work with such a crew. 
 
Finally, I would like to thank the CMB program, especially: Jessica Schwartz, Bob 
Fuller, and Cathy Mitchell.  Their efforts to help graduate students succeed are remarkable, and I 









List of Figures 
Chapter One: Introduction 
Chapter Two: A quantitative assay for measuring 
mRNA decapping by splinted ligation reverse 
transcription polymerase chain reaction: qSL-RT-PCR:  
2.1  INTRODUCTION  
2.2  RESULTS  
2.3  DISCUSSION   
2.4  MATERIALS AND METHODS  
Chapter Three: An eIF4E-binding protein promotes 
mRNA decapping and is required for PUF repression. 
3.1  INTRODUCTION  
3.2  RESULTS  
3.3  DISCUSSION   
3.4  MATERIALS AND METHODS 



























Chapter Four: Mechanisms of mRNA Regulation by D. 
melanogaster Pumilio. 
4.1  INTRODUCTION    
4.2  RESULTS  
4.3  DISCUSSION   
4.4  MATERIALS AND METHODS 
 
Chapter Five: Concluding Thoughts and Future 




         
               
  
  
    


























List of Figures 
  
1.1 Well-translated mRNAs are bound by the 
eIF-4F complex and undergo multiple 
rounds of translation initiation. 
1.2  Post-transcriptional repression involves 
inhibition of translation and/or activation 
of mRNA decay. 
2.1 The 5′ mRNA decay pathway 
2.2 The qSL-RT-PCR assay specifically 
detects decapped mRNA 
2.3 The qSL--RT-PCR assay has a broad, 
linear dynamic range for sensitive 
detection of decapped RPL41A RNA 
2.4 The in vivo decapping rate of RPL41A 
mRNA 
2.5 Comparison of mRNA half-life, decay, 
and decapping reaction rates 
3.1 EAP1 is required for Puf5p mediated 












30   













3.2 Eap1p does not inhibit poly-ribosome 
association of a Puf5p regulated mRNA 
3.3 Eap1p fractionates with poly-ribosomes 
3.4 Eap1p accelerates mRNA degradation 
3.5 Eap1p promotes decapping of HO mRNA 
3.6 Eap1p associates with Puf5p and Dhh1p 
3.7 Eap1p associates with HO mRNA, 
dependent on Puf5p 
3.8 Model of post-transcriptional regulation 
of HO mRNA by PUFs and Eap1p  
S2.1 Northern blot detection of wild type and 
mutant LacZ-HO reporter mRNAs 
S2.2 Dissociation of poly-ribosomes causes 
HO mRNA to shift to the top of the 
gradient  
S2.3 Deletion of DHH1 gene causes 
accumulation of deadenylated, decapped 
HO mRNA   
4.1 PUM RBD and Mutant RBDs Each 
Reduce Reporter Levels  
4.2 The PUM RBD Binds the 3X PBE and 


























4.3 The PUM RBD Accelerates the Rate of 
Deadenylation 
4.4 CCR4/POP2 are Important for PUM 
RBD-Mediated Deadenylation         
4.5 Deadenylation and Decapping Contribute  
to PUM RBD Mediated mRNA 
Degradation   
4.6 Pabp is Required for RBD-mediated 
Acceleration of Deadenylation, and 





























 Temporal, spatial, and cell-type specific expression of subsets of genes is crucial for 
many biological processes including: body-axis patterning, synaptic plasticity, and stem cell 
maintenance.  Control of gene expression is exerted at multiple levels, beginning with the 
transcription of a nascent protein-encoding mRNA from DNA, by RNA polymerase II.  
Transcription of mRNAs is a highly regulated process that functions in concert with downstream 
post-transcriptional mRNA regulatory processes; this results in nuanced and layered control over 
the timing and level of protein expression from a particular mRNA (Lackner, Beilharz et al. 
2007).  This work will focus on post-transcriptional mechanisms of mRNA control.  
 
Early mRNA processing events: 
 All eukaryotic mRNAs are capped at the 5′ end by a methylated guanosine residue, and 
most mRNAs, aside from histone mRNAs, are appended at the 3’ end with a poly-adenosine, or, 
poly(A) tail that can range from approximately 80 adenosines in S. cerevisiae, to 200 + 
adenosines in mammalian mRNAs (Shatkin and Manley 2000).  These features function 
synergistically to promote the stability, as well as translation of an mRNA (Preiss and Hentze 
1998). The 5′ cap and 3′ poly(A) tail are added co-transcriptionally (Coppola, Field et al. 1983) 
in the nucleus, and any introns are spliced out to produce a functional mRNA capable of being 
translated into a protein. Only after a pre-mRNA has successfully undergone these events will 
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 The processed mature mRNA is transported from the nucleus into the cytoplasm 
(Palayoor, Schumm et al. 1981; Schroder, Bachmann et al. 1987; Eckner, Ellmeier et al. 1991), 
where mRNA decay and translational machinery both are able to engage the mRNA and exert 
positive or negative regulation.  After nuclear export the 5′ mRNA cap is bound by the cap-
binding protein eIF-4E, which is conserved in all eukaryotes (Sonenberg, Morgan et al. 1978; 
Sonenberg, Rupprecht et al. 1979; Altmann, Edery et al. 1985; Altmann, Muller et al. 1989).  It 
is thought that cap-bound eIF-4E interacts with eIF-4A, which is bound to the scaffold protein 
eIF-4G; this complex is termed eIF-4F (Edery, Humbelin et al. 1983; Grifo, Tahara et al. 1983; 
Pestova, Shatsky et al. 1996).  Poly(A) Binding Protein (Pabp) associates with the poly(A) tail 
and contacts eIF-4G (Tarun and Sachs 1996; Tarun, Wells et al. 1997; Kessler and Sachs 1998) 
to cause circularization of a translationally competent mRNA (Ladhoff, Uerlings et al. 1981; 
Grifo, Tahara et al. 1983; Wells, Hillner et al. 1998).   
 
 The 40s ribosomal subunit is recruited to cap-bound eIF-4F complex, along with 
eIF2/GTP/Met-tRNAi (Hoerz and McCarty 1969; Both, Furuichi et al. 1975; Muthukrishnan, 
Both et al. 1975; Nasrin, Ahmad et al. 1986; Jivotovskaya, Valasek et al. 2006); the ternary 
complex composed of 40s subunit eIF2/GTP/Met-tRNAi forms the 43s pre-initiation complex 
(Anderson and Shafritz 1971; Levin, Kyner et al. 1973).  The 43s ribosome then scans along the 
mRNA until reaching a start codon (Kozak and Shatkin 1978; Kozak 1980; Kozak 1980), when 
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Figure 1.1 Well-translated mRNAs are bound by the eIF-4F complex 
and undergo multiple rounds of translation initiation. 
 
The eIF-4F complex is composed of 5′ cap-bound eIF-4E which directly interacts with eIF-4G bound to the 
RNA helicase eIF-4A.  Formation of eIF-4F strengthens the interaction between eIF-4E and the cap, and recruits 
the small ribosomal subunit to direct translation initiation.  Poly(A) Binding Protein (Pabp) binds to the poly(A) 
tail and interacts with eIF-4G, causing circularization of the mRNA, and protecting the 5′ and 3′ ends of the 
mRNA from mRNA degradation. 
the anti-codon of Met-tRNAi docks with the start codon in the ribosomal P-site (Clark, Dube et 
al. 1968; Marcus, Weeks et al. 1970; Sprinzl, Wagner et al. 1976; Lake 1977; Wurmbach and 
Nierhaus 1979).  The 60s subunit joins the 40s subunit bound to a start codon, forming an 80s 
monosome (Kappen, Suzuki et al. 1973; Siekierka, Manne et al. 1983).  Translation initiation 
then involves GTP hydrolysis by eIF-2, which results in the ejection of several initiation factors, 
(Lockwood, Sarkar et al. 1972; Merrick 1979; Peterson, Merrick et al. 1979; Peterson, Safer et 





 Physical association of eIF-4E with eIF-4A, eIF-4G and PABP is thought to increase the 
affinity of eIF-4E for the 5′ cap and lead to more efficient recruitment of ribosomes to the bound 
mRNA (Haghighat and Sonenberg 1997; Ptushkina, von der Haar et al. 1998; Kahvejian, Svitkin 
et al. 2005).  Small ribosomal subunit recruitment, followed by scanning, and translation 
initiation occurs multiple times in succession for a single well-translated mRNA (Goodman and 
Rich 1963; Penman, Scherrer et al. 1963; Gross, Moerke et al. 2003).  Initiation is the rate-
limiting step for translation (Gualerzi, Risuleo et al. 1977; Bergmann and Lodish 1979), for 
poorly translated mRNAs initiation is often impaired, leading to a decrease in ribosome 
occupancy, and a reduction in protein output.  During cellular differentiation, response to 
environmental stimuli, and progression through the cell-cycle, the production of certain proteins 
must be turned off to enable transition from one growth state to another.  To accomplish this 
certain mRNAs must be transitioned from a circularized, stable and highly translated condition to 
an untranslatable state.   
 
mRNA Decay: 
 All mRNAs will be targeted for destruction eventually, but individual mRNA half-lives 
range over several orders of magnitude (Herrick, Parker et al. 1990; Raghavan, Ogilvie et al. 
2002; Sharova, Sharov et al. 2009).  Degradation of mRNAs is a tightly regulated process that 
involves the coordinated action of mRNA decay enzymes, as well as proteins involved in their 
recruitment and catalytic activation.  Decay of mRNAs typically initiates with removal of the 
poly(A) tail (Brewer and Ross 1988; Shyu, Belasco et al. 1991; Decker and Parker 1993) by 
deadenylase enzymes, which are a family of exo-ribonucleases that attack mRNAs from the 3′-5′ 
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direction (Tucker, Valencia-Sanchez et al. 2001; Tucker, Staples et al. 2002; Uchida, Hoshino et 
al. 2004).  
  
 Shortening of the poly(A) tail acts as a signal that results in nucleation of a complex 
containing the mRNA decapping enzyme, as well as associated activators of decapping, leading 
to the subsequent removal of the 5′ cap (Muhlrad, Decker et al. 1994; Chowdhury, 
Mukhopadhyay et al. 2007; Chowdhury and Tharun 2009).  The 5′ cap protects mRNAs from the 
activity of XRN1, the 5′-3′ exo-ribonuclease (Green, Maniatis et al. 1983; Stevens, Hsu et al. 
1991; Larimer, Hsu et al. 1992; Schwer, Mao et al. 1998), by blocking access of the enzyme to 
its substrate, which is a 5′ monophosphate.  XRN1 is highly processive; once an mRNA has been 
decapped, XRN1 rapidly destroys the body of the mRNA (Jinek, Coyle et al. 2011).   
  
 Deadenylation activated decapping, and subsequent 5′-3′ degradation represents the 
major pathway for mRNA turnover in the cytoplasm (Beelman, Stevens et al. 1996).  
Alternatively, mRNAs can be degraded by a complex termed the exosome which degrades RNA 
in a 3′-5′ manner (Anderson and Parker 1998; Lykke-Andersen, Brodersen et al. 2009; Lykke-
Andersen, Tomecki et al. 2011).  
 
Interplay Between Translation and mRNA Decay: 
 Decay enzymes generally do not have ready access to naked mRNAs; instead they must 
compete with proteins that promote mRNA translation and stability.  The eIF-4F complex results 
in a circularized mRNA by virtue of eIF-4E bound to the 5’ cap, Pabp bound to the poly(A) tail, 
and eIF-4G bridging the two proteins.  One consequence of mRNA circularization is that the 
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decapping and deadenylase machinery are not able to engage their respective substrates: the 5′ 
cap and 3′ poly(A) tail.  In vitro, eIF-4E is able to outcompete the decapping enzyme for binding 
to the 5′ cap, and this strongly inhibits removal of the cap simply by eIF-4E binding tightly to it, 
and refusing the decapping enzyme access (Schwartz and Parker 2000; Tharun and Parker 2001).  
The activities of mRNA decay and translation are fundamentally opposed, and also tightly 
interwoven.  For mRNA decay machinery to gain access to an mRNA, a transition must occur 
wherein the translation and stability promoting proteins are removed from the mRNA, and in a 




Figure 1.2 Post-transcriptional repression involves inhibition of translation and/or 
activation of mRNA decay. 
 
Post-transcriptional silencing of mRNA expression can occur through inhibition of translation initiation, or 
activation of mRNA decapping and destruction.  Both pathways require eviction of the eIF-4F complex, and 
mRNA de-circularization.  eIF-4E-Binding Proteins (4EBPs) block the interaction between eIF-4E and eIF-4G, 
resulting in a blockage of ribosome recruitment.  Alternatively, an mRNA targeted for destruction is initially 
deadenylated, causing dissociation of Pabp, this is followed by recruitment of the mRNA decapping (DCP2), and 
decay machinery (XRN1).  These two pathways are linked in some cases, where translational silencing can 






Cis-Elements Affecting mRNA Expression:  
AU-Rich Elements 
 The stability of a particular mRNA is dictated in many cases by sequence elements found 
both in the Open Reading Frame (ORF), as well as in the 5′ and 3′ Untranslated Regions (UTRs) 
of an mRNA.  Regulatory information is encoded in an mRNA is several ways that can have 
both stabilizing and destabilizing effects (Rabbitts, Forster et al. 1985; Jones and Cole 1987; 
Harland and Misher 1988; Wright, Rosenzweig et al. 1989; Oliveira and McCarthy 1995; Peng, 
Chen et al. 1998).  mRNAs that produce proteins involved in functions related to cell cycle 
progression, apoptosis, or anti-proliferative activity often exhibit significantly shorter half-lives 
than average mRNAs (Capasso, Bleecker et al. 1987; Raghavan, Ogilvie et al. 2002).   
 
One of the first sequence elements to be identified which confer instability to an mRNA 
was AU-Rich sequence Elements (AREs).  ARE sequences were identified as a conserved, often 
overlapping AUUUA sequence found in proximity to uridine rich sequences, generally found 
within the 3′ UTR of an mRNA, but not exclusively (Shaw and Kamen 1986).  The ARE 
sequence serves as a recognition element for a group of RNA-Binding Proteins referred to as 
AU-Rich Element Binding Proteins, (ARE-BPs).   There are several well-known ARE-BPs, and 
the regulatory consequences of binding depend on the identity of the particular ARE-BP 
(Barreau, Paillard et al. 2005).   
 
Tristetraproline (TTP) is one example of an ARE-BP that confers negative regulation to a 
targeted ARE-containing mRNA.  Through a combination of electrophoretic mobility-shift 
assays (EMSAs), analysis of reporter constructs bearing the identified TTP-binding ARE 
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sequence, and TTP knock-out analysis on endogenous ARE-containing messages it was 
concluded that TTP binds to an ARE and this results in destabilization of the TTP-bound mRNA 
(Ogilvie, Abelson et al. 2005).  TTP elicits mRNA destabilization by associating with the 
decapping enzyme, the 5′ – 3′ exonuclease, the 3′ – 5′ exosome, as well as deadenylase enzymes, 
which leads to strict regulation of the targeted mRNA presumably due to an increased local 
concentration of decay enzymes  (Chen, Gherzi et al. 2001; Lykke-Andersen and Wagner 2005). 
 
In contrast to the activity of TTP, the ARE-BP HuR is a well-studied example of an 
ARE-BP which increases the stability of bound mRNAs.  During times of low oxygen partial 
pressure, the Vascular Endothelial Growth Factor (VEGF) mRNA is stabilized (Shima, Deutsch 
et al. 1995; White, Carroll et al. 1995).  Further work on the mechanism of stabilization revealed 
that the HuR binds to an ARE sequence in the 3′UTR of VEGF.  Reduction of HuR levels with 
an anti-sense HuR construct resulted in a decrease in VEGF stability, and conversely, 
overexpression caused an increase in stability (Levy, Chung et al. 1998).   
 
Very little is known about the mechanism underlying HuRs ability to stabilize bound 
mRNAs.  One approach utilized three complementary methods to identify HuR-bound, and 
functionally regulated mRNAs.  The approach used Photoactivatable-Ribonucleoside-Enhanced 
Crosslinking and Immunoprecipitation (PAR-CLIP), followed by Illumina Sequencing of the 
isolated HuR bound mRNAs, the authors also performed RNA-Immunoprecipitation on HuR, 
and identified bound mRNAs via microarray.  Finally, HuR was knocked-down via siRNA, and 
global transcript analysis was compared to non-targeting control knockdown.   Interestingly, 
statistical analysis of bound mRNAs, and mRNAs affected by HuR knock-down revealed a 
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potential mechanism for transcript stabilization.  An increase in the number of HuR binding sites 
correlated with increased HuR stabilizing effects, and these effects were stronger when the sites 
were found both within an intron and in the 3′UTR of a given mRNA. The authors suggested that 
HuR may regulate exon inclusion and exclusion, another intriguing finding was that mRNAs 
with demonstrated miRNA binding sites were strongly enriched also for HuR binding sites in 
relatively close proximity.  Therefore, one potential model for HuR mediated stability may 
involve a physical competition with the repressive micro-RNA (miRNA) RNA-Induced 
Silencing Complex (RISC) (Mukherjee, Corcoran et al. 2011); however this data is of a 
correlative nature and must be interpreted cautiously. 
 
Pumilio Binding Elements: 
Another classic example of a cis-element conferring regulation to an mRNA comes from 
study of the hunchback (hb)  mRNA in D. melanogaster, which encodes a major determinant of 
the posterior-anterior body-axis in flies (Bender, Horikami et al. 1988).  During oogenesis, the hb 
mRNA is maternally deposited and is found throughout the oocyte (Tautz, et al., 1997) (Bender, 
et al., 1998).  The hb gene encodes a transcription factor responsible for inhibiting production of 
genes involved in abdomen development (Struhl, et al., 1992).  Once an oocyte is fertilized, hb 
mRNA is repressed in the anterior, and this requires sequence elements found in the 3′ UTR of 
the hb mRNA; repression of Hb is achieved through the action of two proteins, Nanos and 
Pumilio (PUM) (Hulskamp, Schroder et al. 1989; Murata and Wharton 1995).   
 
Repression of maternal hb mRNA in the posterior leads to a gradient of Hunchback 
activity emanating from the anterior pole (Wharton and Struhl 1991).  The 3′ UTR sequence 
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element required for graded Hunchback activity was termed a Nanos Response Element (NRE), 
however, subsequent analysis of proteins bound to hb mRNA showed that the protein bound to 
the NRE was PUM.  In vitro binding analysis through electrophoretic mobility shift assays 
(EMSAs) revealed that PUM binds the NRE with high-affinity (20nM), via a conserved RNA-
Binding Domain (RBD) (Wharton and Struhl 1991; Zamore, Williamson et al. 1997; Zamore, 
Bartel et al. 1999).  For the sake of accuracy and simplicity, the NRE will be referred to hereafter 
as the Pumilio Binding Element (PBE).  Further analysis of mRNAs bound by Pumilio in D. 
melanogaster, through RNA-immunoprecipitation and DNA micro-array, showed that PUM 
associates with nearly 1000 distinct mRNAs, and interestingly, the subset of mRNAs bound 
changes significantly depending on the developmental stage of the fly (Gerber, Luschnig et al. 
2006). 
  
Trans-acting factors: eIF-4E Binding Proteins:  
Study of the family of eIF-4E binding proteins (4EBPs) has been a useful tool to illustrate 
the nuanced nature of mRNA regulation. 4EBPs are prototypical post-transcriptional mRNA 
regulators; the family is defined by the amino acid motif: tyrosine, three non-specific amino 
acids, followed by a leucine and a  hydrophobic residue,  (YXXXLφ) which binds to a conserved 
surface on the eIF-4E protein.  The founding member of this family, rat Phas-I, was identified 
through efforts to delineate the effects of insulin signaling on translation.  Translation initiation 
is often subject to regulation as it is the rate limiting step in translation.  Early work on the 
impact of insulin signaling on translation showed that insulin causes an increase in general 
translation initiation (Lyons, Nordeen, Young, 1980).  Further work on the Phas-I protein 
revealed that it is phosphorylated in response to insulin by the Mitogen Activated Protein Kinase, 
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and this was shown to be responsible for the increase in translation initiation (Haystead , 
Lawrence, 1994) (Lin, Lawrence, 1994)(Graves, Lawrence, 1995).    
 
In an effort to identify functional orthologs in human cells, a far western assay was 
employed to find proteins that interact with eIF-4E.  The far western assay is a method to 
identify proteins that interact with a protein of interest (Mahlknecht U. et al., 2001) (Blanar and 
Rutter, 1992).  The eIF-4E cDNA was expressed in E. coli, then purified over a cap-analog 
affinity column, and labeled with a radioactive phosphate at the N-terminus.  Labeled eIF-4E 
was then screened for interaction with a phage library expressing human placental cDNAs.  
Clones that interacted with eIF-4E were sequenced, and 4E-BP1 and 4E-BP2 were subsequently 
identified.  The authors tested the ability of 4E-BP1 and 4E-BP2 to inhibit translation with an in 
vitro bi-cistronic reporter assay composed of a cap-dependent Chloramphenicol Acetyl 
Transferase gene (CAT), and a luciferase gene that is translated via an Internal Ribosome Entry 
Site (IRES).  This experiment demonstrated that cap-dependent translation of the CAT reporter 
was inhibited by both 4EBPs, but the IRES driven luciferase gene was unaffected.  Also, 
addition of excess eIF-4E relieved the inhibition (Pause Sonenberg, 1994); this suggests that 4E-
BPs probably inhibit translation through competition with a translation promoting factor.  A 
minimal fragment of eIF-4G that still retained eIF-4E binding activity in both yeast and humans 
was identified, further sequence analysis showed that eIF-4G proteins from several different 
eukaryotes all contain the conserved motif  YXXXLφ which forms the eIF-4E interaction surface 
on eIF-4G.  These findings were extended by deletion of the eIF-4E binding motif in 4E-BP1 





Given that eIF-4G and 4E-BPs occupy the same surface on eIF-4E, it was proposed that 
4EBPs compete with eIF-4G to inhibit translation initiation.  This hypothesis was borne out 
through competition binding experiments which showed that the eIF-4F complex never contains 
a 4EBP, and conversely, eIF-4E bound to a 4EBP precluded the association of eIF-4G, as well as 
eIF-4A.  When the eIF-4E binding motif was mutated in either 4E-BP1 or 4E-BP2, they were no 
longer able to displace eIF-4G from eIF-4E, and were not capable of repressing translation, 
showing a requirement for 4EBP binding to eIF-4E to occlude eIF-4G, and inhibit translation 
(Haghighat Sonenberg, 1995). 
. 
While all mRNAs have a 5′ cap and the vast majority utilize eIF-4E to direct translation, 
some mRNAs are more susceptible to 4EBP regulation than others (Dowling, Topisirovic et al. 
2010; Thoreen, Chantranupong et al. 2012).  Regulation and dysregulation of eIF-4E is a 
linchpin in the maintenance of cellular homeostasis.  Overexpression of eIF-4E drives 
transformation in cell culture, but the transformation is reversed by expression of 4E-BP1 and 
4EBP2 (Rousseau, Gingras et al. 1996).  Also, overexpression of eIF-4E is found in a wide 
variety of human cancers, and in some cases is a prognostic indicator (De Benedetti and Graff 
2004). Another important process that is impacted by eIF-4E regulation is synaptic plasticity 
(Gkogkas, Sonenberg et al. 2010), where 4E-BP2 knock-out mice show autism-like behaviors.  
Therefore, understanding the mechanisms used by the various 4EBPs will be important for the 





Conservation and Divergence of 4EBPs 
 While the 4E-binding motif is conserved in most eukaryotes, 4EBP orthologs diverge 
significantly outside of this motif.  eIF-4E is an important central target for control of eukaryotic 
gene expression, however all 4EBPs may not function in the same manner.  Several 4EBP 
orthologs contain C terminal extensions (Table 1.1) which may modulate the activity of the 
particular 4EBP through association with alternative binding partners, such as RNA binding 
proteins, or mRNA decay enzymes.  Extensive work has been done to elucidate how mammalian 
4E-BP1 and 4E-BP2 repress mRNA translation with very little impact on mRNA stability.  
However, previous as well as recent work has highlighted the diversity of mechanisms utilized 
by other 4EBPs, invoking regulation of mRNA stability, translation, as well as localization of the 
mRNA, and eIF-4E respectively.   
  
Table 1.1. 4EBP orthologues 
 
Schematic of 4EBP orthologues from H. sapiens (hs), D. melanogaster (dm), and S. cerevisiae (sc). 
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 eIF-4E Transporter family of 4EBPs 
 H. sapiens 4E-T was identified by virtue of its ability to bind eIF-4E via far-western 
assay as described above.  Subsequent cloning and characterization of the gene product revealed 
that 4E-T contains a functional bipartite nuclear import sequence, as well two nuclear export 
sequences which allow the protein to mediate the transport of eIF-4E between the nucleus and 
cytoplasm (Dostie, Ferraiuolo et al. 2000). Additional work showed that 4E-T co-localizes with 
mRNA decay factors and P-bodies that are thought to be sites of active mRNA degradation 
and/or translational repression through increased local concentration of decay enzymes and 
repressive co-factors.  siRNA knock-down of 4E-T resulted in increased stability of an ARE 
reporter mRNA.  The characterization of 4E-Transporter provided the first demonstration of a 
4EBP impacting mRNA stability (Ferraiuolo, Basak et al. 2005).  
  
 More recent work on the D. melanogaster member of the 4E-T family, Cup, has exposed 
even more diverse mechanisms of repression used by this family of 4E-BPs.  Cup contains 
several functionally identified regions which direct distinct activities: the N-terminus binds eIF-
4E and stabilizes the mRNA, in contrast, a mid-domain, as well as a Q-rich domain both activate 
deadenylation and decay independently of each other (Igreja and Izaurralde 2011).  Full-length 
Cup activates removal of the poly(A) tail, which results in translational repression, yet Cup is 
also able to stabilize the mRNA through a non-canonical eIF-4E binding motif.  Interestingly 
when this motif is removed, Cup activates deadenylation, and as well as mRNA decapping and 
decay.  These data indicate that the extended regions of 4EBPs do in fact modulate independent 




 CAF20 and EAP1: 
 As indicated in Table 1.1, S. cerevisiae encodes two 4E-BP proteins: Caf20p, and Eap1p. 
CAF20 was originally identified as p20, a 20kDa protein that was routinely found associated 
with cap-bound eIF-4E (Altmann, Krieger et al. 1989). A sequence motif was identified in 
Caf20p that closely resembles the region of eIF-4G that binds to eIF-4E.   In vivo and in vitro 
competition binding assays demonstrated that Caf20p outcompetes eIF-4G for eIF-4E binding; 
when Caf20p is bound to eIF-4E, eIF-4G was displaced.  In vitro translation assays using yeast 
extract suggested that CAF20 inhibited cap-dependent translation in the same manner as the 
mammalian 4E-BP1 and 4E-BP2 (Altmann, Schmitz et al. 1997).   
  
 EAP1 was identified as a 4EBP functional ortholog, through the use of a far-western 
assay to probe for 4E-interacting yeast proteins (Cosentino, Schmelzle et al. 2000).  As shown in 
the Table 1.1 schematic, Eap1p contains a large C-terminal extension with no identifiable 
conservation of sequence motifs aside from the eIF-4E binding motif.  Using an m
7
G cap affinity 
column, association of eIF-4E with eIF-4G was monitored in the presence or absence of EAP1; 
the presence of EAP1 effectively displaced eIF-4G from cap-bound eIF-4E.  These findings were 
extended with the use of an in vitro yeast extract that can be programmed with a 
Chloramphenicol Acetyl Transferase (CAT) reporter mRNAs that rely on either cap-dependent, 
cap-independent translation intiation.  Increasing amounts of Eap1p were added to translation 
extracts programmed with either cap-driven or Internal Ribosome Entry Site (IRES) driven 
reporter, CAT activity was then measured via autoradiogram.  Eap1p repressed expression of the 
cap-dependent reporter, but not the IRES driven reporter, leading to the conclusion the Eap1p 
inhibits cap-dependent translation.  On the surface it appeared that Eap1p and Caf20p repress 
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mRNA translation via the same mechanism as 4E-BP1 and 4E-BP2; however it must be noted 
that mRNA levels were not monitored in this study, and that mRNA decay was not shown to be 
active in the in vitro extract.   
  
 micro-RNA Pathway 
 Another way that eukaryotes modulate gene-expression in trans is through the micro-
RNA (miRNA) pathway.  miRNAs are 22-23 nucleotide non-coding RNA molecules that are 
evolutionarily conserved and generally carry-out negative regulation on specific mRNAs (Lau, 
Lim et al. 2001; Lee and Ambros 2001).  Repression by miRNAs involves base-pairing of the 
miRNA to a sequence in an mRNA allowing each miRNA to target a subset of mRNAs 
containing partially complementary sequences (Lai 2002).  The miRNA is bound by a 
RiboNucleoProtein (RNP) complex; the conserved central component of this complex is the 
Argonaute (Ago) protein family (Mourelatos, Dostie et al. 2002).   
  
 Once complexed with a miRNA, the RNA-Induced Silencing Complex (RISC) engages a 
target sequence and recruits inhibitory effector proteins to elicit repression (Wu, Fan et al. 2006; 
Wakiyama, Takimoto et al. 2007; Chen, Zheng et al. 2009; Zdanowicz, Thermann et al. 2009).  
Ago engages a miRNA and mRNA target, then recruits GW182 which associates with 
deadenylase and decapping enzymes, causing destruction of the targeted mRNA (Eystathioy, 
Chan et al. 2002; Behm-Ansmant, Rehwinkel et al. 2006).  However, GW182 is also able to eject 
poly(A) binding protein and eIF-4E from a targeted mRNA, and elicit translational repression 
through mRNA de-circularization (Zekri, Kuzuoglu-Ozturk et al. 2013).  Post-transcriptional 
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control of gene expression via the miRNA pathway affords nuanced utilization of general factors 
to target specific mRNAs for inhibition. 
  
Activators of mRNA Decay: 
 Enzymes that carry out destruction of mRNAs frequently do so with the assistance of co-
factors that either catalytically activate enzymatic activity, or facilitate access of the enzymes to 
an mRNA substrate.  Purification of decapping activity from S. cerevisaie highlights the utility of 
enzymatic co-activators.  Initial work to identify the protein responsible for yeast decapping 
activity suggested that the Dcp1p protein was enzymatically responsible for 5′ mRNA cap 
removal.  Genetic inactivation of DCP1 nearly completely blocked decapping, and purified 
Dcp1p retained the decapping activity (Beelman, Stevens et al. 1996; LaGrandeur and Parker 
1998).  Several years later, a mutant yeast protein named Dcp2p was identified to be necessary 
for decapping in vivo (Dunckley and Parker 1999), and it was hypothesized that Dcp2p was a co-
factor for Dcp1p decapping activity.  Further work utilizing recombinant, purified Dcp1p and 
Dcp2p showed conclusively that Dcp2p was able to catalyze 5′ cap removal on its own but with 
reduced activity compared with the purified yeast complex.  However, co-purification of Dcp1p 
and Dcp2p dramatically stimulated the decapping activity, redefining Dcp2p as the decapping 
enzyme, and Dcp1p as an important co-activator of decapping (Steiger, Carr-Schmid et al. 2003). 
  
 Nuclear Magnetic Resonance (NMR) structures of Dcp2p and a non-hydrolyzable capped 
RNA substrate show that Dcp2p specifically binds the 5′ cap structure, as well as 
electrostatically to the RNA phosphate backbone adjacent to the cap.  However, binding alone 
does not support efficient catalysis.  Analysis of in vitro decapping by Dcp2p alone, and with the 
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holoenzyme including Dcp1p, under conditions of excess enzyme to substrate to study single-
turnover conditions showed that Dcp1p activates the catalytic activity of Dcp2p 1000-fold 
(Deshmukh, Jones et al. 2008).  Dcp2p appears as a lobed structure, and has been observed in a 
both "open" and "closed" conformation, with the "closed" conformation being more catalytically 
active.  The mechanism of catalytic activation of Dcp2p by Dcp1p appears to stem from Dcp1p 
stabilizing the "closed" conformation (She, Decker et al. 2008).  In metazoans another co-factor, 
Hedls, is also required for similar reasons (Fenger-Gron, Fillman et al. 2005). 
  
 Decapping is only one step in mRNA destruction, if decapping and 5′ - 3′ decay were not 
coordinated the cell would have to rely on diffusion to ensure that decapped mRNAs are in fact 
destroyed.  However, the processes of mRNA decapping and 5′ - 3′ decay have been 
demonstrated to be functionally and physically linked, in Drosphila; this is due to physical 
association of Dcp1 with the 5′- 3′ exonuclease Xrn1/Pacman (Braun, Truffault et al. 2012). 
  
 Because translation of mRNAs involves the circularization of the mRNA, both the 5′ cap, 
and 3′ poly(A) tail are protected.  For the decapping enzyme to gain access to the 5′ cap, the 
circularized mRNA must be remodeled to transition an mRNA from an eIF-4E/eIF-4G/eIF-4A-
bound complex to an mRNA bound by the decapping machinery and committed to destruction.  
One way that this is achieved is through the action of the activators of mRNA decapping: Dhh1p 
and Pat1p.  Deletion of Dhh1p and Pat1p cause accumulation of deadenylated capped mRNAs, 
indicating that these proteins are involved in a step of mRNA decay post-deadenylation and 
preceding decapping (Fischer and Weis 2002).  Pat1p plays a dual role in this process, wherein it 
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is able to inhibit small and large ribosomal subunit joining, as well as catalytically activate the 
decapping enzyme.   
  
 Dhh1p also inhibits ribosomal subunit joining but does not affect the catalytic activity of 
Dcp2p (Nissan, Rajyaguru et al. 2010).  Dhh1p is part of the DEAD box helicase family, a 
plausible mechanism that explains the function of Dhh1p in inhibition of translation initiation 
may involve Dhh1p facilitation of the removal of the eIF-4F complex through its helicase 
activity.  Intriguingly, Dhh1p was initially found as a high-copy suppressor of both POP2 and 
CCR4 deletions.  During this time, POP2 and CCR4 were thought to be transcription factors, in 
time, analysis of the enzymatic activity of Pop2p, and Ccr4p revealed that these proteins function 
specifically to remove the poly(A) tail.  Nonetheless, while the activities of the deadenylase 
complex had yet to be identified, the authors noted an association between Dhh1p, and the Ccr4p 
complex (Hata, Sakai, 1998).  Much like the link between decapping and 5′- 3′ decay, it is also 
clear that deadenylation is intimately linked to decapping via physical associations of a 
functional mRNA destruction complex. 
  
 mRNA-Binding Proteins: 
 RNA-binding proteins are often involved in recruiting specific regulators to an mRNA 
based on sequence specific recognition of RNA cis-elements.  PUF (Pumilio and Fem-binding 
Factor) proteins serve as an excellent model to study regulation of gene expression via RNA-
binding proteins (Murata and Wharton 1995; Zamore, Williamson et al. 1997; Zhang, Gallegos 




 The PUF domain is defined by eight repeats, each of which confers specificity for a 
single RNA nucleotide base.  A large amount work has been done to identify the sequences that 
the PUF domain recognizes.  Several techniques were used to determine the high-affinity 
consensus sequence which PUFs bind, among them were: initial identification of the 3′ UTR 
sequence element that is important for PUF regulation of the hb mRNA, RNA immuno-
precipitation and microarray detection of mRNAs which associate with PUFs, as well as 
Systematic Evolution of Ligands by Exponential Enrichment (SELEX).  Each of the above 
referenced experiments revealed a striking detail about PUF RNA-binding, across eukaryotes the 
high affinity PUF site begins almost invariably with the bases UGUA, highlighting the 
evolutionary advantage to retaining both the PUF RNA-Binding Domain (RBD) as well PUF 
Binding Elements (PBEs) in certain mRNAs.  The sequence recognized diverges somewhat in 
the final four nucleotides for each PUF ortholog depending on changes to repeats 5-8, dictating 
the specific subset of mRNAs each PUF associates with (Gavis 2001).   
  
 PUF proteins are found in all eukaryotes, once bound to a target mRNA, PUF proteins 
repress mRNA expression through mechanisms which are still incompletely understood.  Several 
mechanisms of repression have been proposed to account for the ability of PUF proteins to 
repress mRNA expression and the common theme involves PUF binding to its target sequence 
and recruitment of proteins which carry out negative regulation (Wreden, Verrotti et al. 1997; 






PUF Activation of Deadenylation and mRNA Decay 
 Deadenylation is functionally linked to mRNA decay through physical interactions 
between deadenylase and mRNA decay enzymes.  These processes work on all mRNAs, 
however, some mRNAs experience greatly increased rates of deadenylation and decay.  PUF 
proteins in both yeast and humans provide a well documented example of activation of 
deadenylation and mRNA decay for target mRNAs.  In yeast, both Puf4p, and Puf5p bind 
distinct sites in the 3′ UTR of the HO endonuclease.  In vitro experiments using recombinant 
Puf4p and Puf5p as well as the deadenylase complex, Ccr4p/Pop2p, demonstrated that both 
PUFs are able to significantly accelerate the rate of deadenylation in vitro.  In vivo reporter 
repression assays, as well as analysis of HO mRNA deadenylation in vivo showed that Puf4p and 
Puf5p were required for both repression and deadenylation.  Interestingly, genetic inactivation of 
deadenylation completely abolished the ability of Puf4p to repress the reporter, but Puf5p 
retained its full repressive activity.  Deletion of either PUF4 or PUF5 dramatically increased the 
half-life of the HO mRNA, and deletion of both PUFs had an additive effect on HO half-life; this 
suggests that the two proteins exert their destabilizing effects through distinct pathways that 
require deadenylation for Puf4p, and an unknown mRNA decay pathway for Puf5p (Hook 
Wickens, 2007). 
  
 Analysis of the activity of human PUM1 and PUM2 in a HEK293 cell culture model has 
shown that expression of either PUM strongly reduces PUM-targeted reporter mRNA levels by 
78%, and reporter protein by 71%, suggesting that mRNA decay activation by both PUM1 and 
PUM2 is responsible for the repression of reporter protein output.  As interactions between the 
deadenylase complex and PUFs has been established in yeast, the authors asked whether human 
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PUMs may also retain a conserved association with the deadenylase complex.  Indeed, co-
immunoprecipitation of both PUM1 and PUM2 in RNase treated extracts showed that the human 
deadenylase complex orthologues:  CNOT6, CNOT6L, CNOT7, and CNOT8, all associate with 
human PUMs in the absence of RNA indicating that the interaction is not simply bridged by a 
co-bound mRNA, or alternatively the associations may reflect an extremely close proximity 
which protects a small fragment of bridging RNA (Van Etten, Schagat et al. 2012).   
 
CNOT7 and CNOT8 are mammalian orthologs of yeast POP2 (Shimizu-Yoshida, 
Sasamoto et al. 1999).  In yeast, Puf4p and Puf5p both directly bind Pop2p (Goldstrohm, Hook et 
al. 2006), and in humans both CNOT7 and CNOT8 directly interact with PUM1 and PUM2 in 
the absence of any other factors (Van Etten, Schagat et al. 2012).  Thus PUF proteins from yeast 
to humans retain a conserved binding interface that enables a specific interaction with the 
CCR4/NOT deadenylase complex; the specific residues required for this interaction have yet to 
be identified.  Having established PUM-directed mRNA decay, and interactions with the 
deadenylase complex in vivo, and in vitro, the importance of deadenylase activity for PUM 
repression was tested with the use of dominant negative deadenylase mutants that have a mutated 
catalytic core; expression of dominant negative CNOT8 inhibited PUM repression in a dose-
dependent manner.   
  
 The authors also tested the ability of human PUMs to repress an mRNA that does not 
contain a poly(A) tail.  Both Drosophila, and human PUFs, are able to repress a non-adenylated 
mRNA robustly (Chagnovich and Lehmann 2001; Van Etten, Schagat et al. 2012).  Interestingly, 
repression of the non-adenylated reporter by human PUM was no longer associated with a 
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decrease in mRNA levels; these results indicate that PUF proteins are capable of carrying out 
repression via multiple mechanisms that appear to be utilizing distinct and separate repressive 
pathways. 
  
Translational Repression by PUM 
 As mentioned above, PUM is also capable of repressing a target mRNA through a 
putative translational mechanism that does not require the presence of a poly(A) tail and does not 
impact mRNA levels, however, in the case of Drosphila PUM,  the 5′ cap was found to be 
necessary for PUM repression; this was interpreted to mean that cap-dependent translation 
initiation is a target for PUM repression (Chagnovich and Lehmann 2001).    Work to identify 
the effectors of PUM-mediated translational repression of hb mRNA identified Brat.  Little was 
known about the mechanism of regulation via Brat at this time, but Brat mutant flies exhibited 
dysregulation of the spatial pattern of expression for the Hunchback transcription factor in 
developing embryos.   
  
 Because PUM and Nanos are necessary for hb regulation the authors tested whether 
PUM, Nanos, and Brat form a repressive complex.  A yeast-four hybrid assay was employed 
using a GAL4-activation domain fusion library, the PUM RBD, Nanos, and a PBE containing 
mRNA.  This showed that Nanos, the PUM RBD, and Brat form a ternary complex on the PBE 
RNA.  Physical interaction between Nanos, PUM RBD, and Brat was then demonstrated with an 
in vitro binding assay.  Finally, a glycine to aspartic acid mutation in Brat (G1330D) was shown 
to be defective for PUM RBD binding, but still associated with Nanos.  As little, if any, effects 
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on the level of mRNA stability have been noted for pre-zygotic hb mRNA, Brat binding to 
Nanos and PUM was proposed to inhibit translation of hb (Sonoda and Wharton 2001). 
  
 Previous work had implicated PUM activated deadenylation of hb mRNA as the 
mechanism of translational silencing (Wreden, Verrotti et al. 1997).  In an attempt to determine 
if translation initiation is inhibited by a PUM recruited complex, an inhibitory homologue of eIF-
4E, 4E Homologous Protein (4EHP), was tested for involvement in hb repression.  4EHP binds 
to the 5′ cap much like eIF-4E, but 4EHP is unable to bind eIF-4G, this results in the formation 
of a complex that inhibits translation initiation.  Mutant 4EHP alleles caused a shift in the 
Hunchback gradient in fly embryos, suggesting that it may be involved in hb regulation.  A direct 
interaction with Brat was subsequently shown through in vitro binding assays.  To further 
delineate 4EHPs role in hb regulation the authors formed a ternary Brat/PUM/PBE RNA 
complex in vitro, and asked if 4EHP was capable of binding to this complex, and in fact this was 
the case.  These results were taken to suggest that PUM, Brat, and 4EHP form a repressive 
complex on hb mRNA, and this results in translational repression. 
  
 More recently, an intriguing mechanism has been proposed which suggests that the PUM 
RBD represses translation elongation at a step immediately post-initiation (Friend, Campbell et 
al. 2012).  The authors suggest that the conserved PUF RBD associates with Ago proteins, which 
are involved in small RNA silencing pathways.  Ago proteins are thought to complex with a 
number of effector proteins, as well as a 22-23nt miRNA which directs the repressive complex to 
specific mRNAs through base-pairing interactions  However, Ago's involvement in PUF 
repression was reported to not require a miRNA.  Also, a component of the translation 
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elongation machinery, eEF1A, was proposed to be the target of PUF/Ago repression.  During 
translation elongation eEF1A hydrolyzes GTP to GDP which facilitates ribosome translocation 
to the next codon.  In vitro GTP hydrolysis assays were used to argue that PUFs inhibit GTP 
hydrolysis by eEF1A and in this way stall ribosomes immediately after initiation at the start 
codon (Friend, Campbell et al. 2012).  This model proposes a very striking, and completely 
unexpected mechanism for PUF repression via the conserved RBD.  However, this model is 
generated from a variety of in vitro experiments and it will be beneficial to test the validity of it 
with a system amenable to in vivo mechanistic analysis of PUM repression.  
 .   
 The Pumilio N-terminus 
 Another important detail to consider is that the work implicating Ago and eEF1A was 
performed using the Pumilio RBD.  Initial work on PUM in the developing Drosophila embryo 
utilized only the RBD to rescue a segmentation defect that Pumilio mutants exhibit during 
Drosophila development; however RBD rescue constructs expressed in Pumilio mutants were 
not viable and only marginally rescued the segmentation defect.  This indicates that the N-
terminus of PUM has activity that is important for mRNA regulation in vivo (Wharton, Sonoda et 
al. 1998).  In fact, recent work on Drosophila Schneider 2 (S2) cells in culture demonstrated that 
full-length Pumilio represses its target mRNA 6-fold more strongly than the RBD alone; the 
repressive activity of the PUM RBD is weak in comparison to the N-terminus of PUM 





 Three autonomous repressor domains were identified in the Pumilio N-terminus which 
are each capable of individually exerting strong repression on target mRNAs in a modular 
fashion (Weidmann and Goldstrohm 2012).  Removal of the poly(A) tail generally initiates 
mRNA decay, and there are several reports of PUF proteins associating with the deadenylase 
machinery and functionally promoting deadenylation. (Goldstrohm, Hook et al. 2006; 
Goldstrohm, Seay et al. 2007; Goldstrohm and Wickens 2008; Suh, Crittenden et al. 2009; Van 
Etten, Schagat et al. 2012)  It seems likely that Pumilio may be activating deadenylation, and 
subsequent decapping, and also translational repression. 
  
 When bound to an mRNA, the PUM RBD provides a surface for interaction with 
negative regulators, lending specificity to general mRNA repression pathways.  It is remarkable 
that this relatively small domain (335 amino acids) is able to exert multiple modes of repression.  
Activation of deadenylation and mRNA decay, inhibition of translation initiation, as well as 
blocking translation elongation all has been described.  How can these mechanisms be 
reconciled?  There is no doubt that Brat and 4EHP influence Hb gradient formation in the 
developing Drosophila embryo, and are capable of forming a ternary complex on the PBE.  
However, neither Brat, nor 4EHP are required for repression in S2 cells, it may be that in the 
developing embryo Brat and 4EHP activities augment PUM-activated deadenylation of Hb 
mRNA in a combinatorial manner.  Only recently, a report suggested a radical model for 
repression via the PUM RBD which invoked inhibition of ribosome translocation immediately 
after initiation (Friend, Campbell et al. 2012).  While compelling, it is unclear what contribution 
the proposed PUM-Ago interaction plays with regard to PUM repression in vivo.  The specific 




Another unresolved question is: how is yeast Puf5p able to inhibit HO mRNA in the 
absence of deadenylation?  Puf5p accelerates the decay of HO mRNA, yet decay usually initiates 
with deadenylation.  As with Drosophila Pumilio, Puf5p appears capable of exerting multiple 
mechanisms of repression.  One way RNA binding proteins are known to exert regulation is 
through association with 4EBPs, as is the case with the Cytoplasmic Polyadenylation Element 
Binding protein (CPEB) (Stebbins-Boaz, Cao et al. 1999).   It is possible that Puf5p may cause 
translational repression through an unknown co-factor, in addition to activation of deadenylation.  
It is clear that PUFs retain the conserved ability to activate deadenylation and mRNA decay in 
yeast, flies, and humans.  Yet we know much less about the contribution of other repressive 
pathways.  Our understanding of the fundamental processes of development, germ-line 
maintenance, and synaptic plasticity will be served well through detailed mechanistic definition 
















A quantitative assay for measuring mRNA decapping by splinted ligation reverse 
transcription polymerase chain reaction: qSL-RT-PCR 
  
 2.1 Introduction 
 Eukaryotic mRNAs are capped by a 7-methyl guanosine linked to the mRNA by a 5’ to 
5’ triphosphate – the 5’ cap. This structure promotes translation and protects mRNAs from 
degradation by exoribonucleases (Furuichi, LaFiandra et al. 1977; Green, Maniatis et al. 1983; 
Schwer, Mao et al. 1998). Enzymatic removal of the cap, referred to as decapping, results in 
reduced translation and rapid degradation of the mRNA (Coller and Parker 2004).  
mRNAs are normally degraded by two competing pathways (Parker and Song 2004; Garneau, 
Wilusz et al. 2007). In the 5’ pathway, decapping follows deadenylation and is catalyzed by the 
Dcp2 enzyme to produce a 7-methyl-GDP product (Figure 1.1)(Dunckley and Parker 1999; 
Wang, Jiao et al. 2002; Steiger, Carr-Schmid et al. 2003). The remaining mRNA, with a 5’ 
monophosphate, is rapidly destroyed in a 5’ to 3’ direction by the exoribonuclease Xrn1 (Figure 
1.1)(Hsu and Stevens 1993; Muhlrad, Decker et al. 1994; Muhlrad, Decker et al. 1995). In the 3’ 
decay pathway, deadenylation is followed by exonucleolytic degradation from the 3’ end 
(Muhlrad, Decker et al. 1995; Anderson and Parker 1998; Brown, Bai et al. 2000; Araki, 
Takahashi et al. 2001; Wang and Kiledjian 2001; Mukherjee, Gao et al. 2002). The DcpS 
“scavenger” decapping enzyme degrades the remaining capped species, yielding 7-methyl-GMP 





The 5′ mRNA decay pathway. (A) mRNAs possess a 5′ 7-methyl guanosine cap (7mGppp), open reading frame 
(ORF) and a 3′ poly-adenosine tail, averaging 60–80 nt in yeast. mRNA decay via the 5′ pathway initiates with 
deadenylation of the poly-Adenosine tail to a short oligo-adenylated form (Aoligo). Dcp2 decapping enzyme 
subsequently removes the cap. The decapped mRNA, with a 5′ monophosphate, is destroyed by Xrn1, producing 
monophosphorylated nucleotides (NMP). (B) Schematic of the quantitative splinted-ligation reverse transcriptase 
polymerase chain reaction assay (qSL-RT-PCR). First, Anchor RNA and complementary DNA Splint 
oligonucleotides are annealed to the 5′ end of the target mRNA. mRNAs containing a 5′ cap cannot be ligated, as 
the cap prevents ligation. Decapped RNAs have a 5′ monophosphate that is ligated to the Anchor RNA 3′ 
hydroxyl by T4 DNA ligase. After ligation, the splint is destroyed by DNase I. The ligated RNA is converted to 
cDNA by reverse transcription with a reverse gene-specific primer (GSP-R). The resulting cDNA is then 
detected by quantitative PCR using GSP-R and a forward primer that anneals to the anchor (Anchor Primer). An 
internal control qPCR is performed on the same cDNA samples using gene-specific primers that amplify within 







 Decapping is highly regulated (Franks and Lykke-Andersen 2008). Trans-acting proteins 
modulate decapping activity. Decapping of specific mRNAs is influenced by cis-acting 
sequences and the sequence-specific RNA-binding factors that recognize them. Small RNAs also 
affect decapping (Rehwinkel, Behm-Ansmant et al. 2005; Behm-Ansmant, Rehwinkel et al. 
2006).  Assays that measure the decapped products are essential to study regulation of 
decapping. The ideal assay should be sensitive, rapid, reproducible, and have a broad linear 
range. The reagents should be readily available, and the assay should be feasible for any mRNA. 
In this report, we describe a new quantitative assay for detecting decapped mRNAs. First, 
discussion of previous assays is informative. 
  
 Detection of decapped mRNA produced in vivo has been a longstanding challenge. 
Several methods have been utilized including: selective binding to anti-cap antibody (Muhlrad, 
Decker et al. 1994; Muhlrad, Decker et al. 1995; Beelman, Stevens et al. 1996; Dunckley and 
Parker 1999; He and Jacobson 2001), selective degradation by Xrn1 (Hsu and Stevens 1993; 
Fischer and Weis 2002), and by trapping mRNA decay intermediates with a strong secondary 
structure (Decker and Parker 1993; Poole and Stevens 1997). Primer extension has been used to 
detect capped and uncapped RNA (Hsu and Stevens 1993; Muhlrad, Decker et al. 1995; Schwer, 
Mao et al. 1998; Coller, Tucker et al. 2001; Hu, Sweet et al. 2009; Hu, Petzold et al. 2010). 
Ligation mediated RT-PCR was also employed (Fromont-Racine, Bertrand et al. 1993; Couttet, 
Fromont-Racine et al. 1997; Couttet and Grange 2004). Recently, a modified ligation method 
was developed to detect decapped mRNAs by RT-PCR (Hu, Sweet et al. 2009; Hu, Petzold et al. 
2010). A bridging DNA oligonucleotide – a “splint” – mediates specific and efficient ligation of 
a 5’ anchor RNA oligonucleotide to the mRNA of interest. This splinted ligation method has 
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been used to create hybrid RNAs in vitro (Moore and Query 2000) and for detection of small 
RNAs (Maroney, Chamnongpol et al. 2007; Maroney, Chamnongpol et al. 2008) and 5’ ends of 
bacterial mRNAs (Celesnik, Deana et al. 2007; Celesnik, Deana et al. 2008). 
  
 In this report, we advance the splinted ligation method to create a quantitative decapping 
assay with broad linear response and sensitivity, hereon referred to as quantitative splinted 
ligation reverse transcription PCR assay, or qSL-RT-PCR. This method measures decapped 
mRNA levels with at least four orders of magnitude in detection range from as little as 1.5 
nanograms of total cellular RNA. We then apply qSL-RT-PCR to measure the in vivo decapping 



















 The qSL-RT-PCR assay specifically detects and quantitates decapped mRNA. With 
the goal of measuring decapped mRNA, we coupled splinted ligation with reverse transcription 
and quantitative polymerase chain reaction. The RPL41A mRNA from Saccharomyces cerevisiae 
(encoded by YDL184C) was used because the 5’ end is mapped and the mRNA is abundant (50 
copies per cell)(Yu and Warner 2001). RPL41A coding sequence is closely related to RPL41B, 
yet these mRNAs differ substantially in their UTR sequences, making it possible to develop a 
detection strategy specific for RPL41A (Yu and Warner 2001). An overview of the qSL-RT-PCR 
assay is shown in Figure 2.1B. First, an RNA Anchor oligonucleotide is ligated to the 5’ end of 
the mRNA of interest. The 5’ half of the DNA splint specifically anneals to the 5’ end of the 
mRNA of interest while the 3’ half anneals to an Anchor RNA oligonucleotide. DNA ligase joins 
the 3’ hydroxyl of the RNA anchor to the 5’ monophosphate of the decapped mRNA. Following 
ligation, the DNA splint is destroyed by DNAse 1. Next, the ligated RNA is purified and 
analyzed by quantitative RT-PCR. 
  
 To begin the qSL-RT-PCR assay, total RNA was purified from yeast cells lacking the 
XRN1 gene (Figure 2.1A). This genetic background stabilizes the decapped mRNA to permit 
efficient detection (Muhlrad, Decker et al. 1995). qSL-RT-PCR was performed to measure the 
cycle threshold (Ct) and melting temperature of the amplified product. Reactions were separated 
by agarose gel electrophoresis to detect the expected product of 224 basepairs (Figure 2.2A, lane 
1). As an internal control, the RPL41A was detected using standard qRT-PCR with specific 
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primers to amply an internal 158 basepair product (Figure 2.2A, lane 2). 
  
 Control reactions are necessary to demonstrate specificity of the assay (Figure 2.2B). 
First, RNA was treated with the exoribonuclease, Terminator, which selectively degrades 
uncapped mRNA, but not capped mRNA. Terminator abolished detection of decapped mRNA 
(Figure 2.2A, lane 3). As a positive control, mRNA was decapped with Tobacco Acid 
Pyrophosphatase (TAP), which increased the amount of decapped RPL41A mRNA detected 
(Figure 2.2A, lanes 5). Total RPL41A was detected by qRT-PCR in these samples (Figure 2.2A, 
lanes 4 and 6). We note that TAP treatment did not decrease the Ct of qSL-RT-PCR to 
equivalent value of qRT-PCR. Several considerations account for this: First, the amplicons and 
forward primer differ, and therefore parameters of reverse transcription and quantitative PCR 
differ. Second, the qSL-RT-PCR signal depends on the efficiency of Anchor ligation and TAP. 
Importantly, the TAP control demonstrates that qSL-RT-PCR detects an increase in decapped 
RPL41A mRNA in ∆xrn1 cells (Figure 2.2A, compare lanes 1 and 5) and ∆dcp2 cells (Figure 
2.2A, compare lanes 11 and 13).  Ligation of the anchor RNA to the decapped mRNA is 
requisite for detection by qSL-RT-PCR (Figure 2.2B). Therefore, omission of DNA ligase is an 
important negative control that resulted in loss of signal from the qSL-RT-PCR assay (Figure 
2.2A, lane 7), but does not affect the internal qRT-PCR (Figure 2.2A, lane 8). This control is 
crucial to exclude artifactual amplification by residual DNA splint. To control for DNA 
contamination, mock reverse transcription reactions were performed wherein reverse 
transcriptase is omitted (Figure 2.2B). As expected, no product was detected by either assay 






The qSL-RT-PCR assay specifically detects decapped mRNA. (A) qSL-RT-PCR was used to detect endogenous 
decapped RPL41A mRNA present in 10 μg of total RNA isolated from yeast strains lacking either the XRN1 
(Δxrn1) or the DCP2 (Δdcp2) genes (odd-numbered lanes). Standard qRT-PCR was used to detect total RPL41A 
RNA (even-numbered lanes). In control reactions, total RNA was treated as indicated at the top of the gel, 
including Terminator (lanes 3,4) or Tobacco Acid Pyrophosphatase (+TAP) treatment (lanes 5,6,13,14). In lanes 
7 and 8, DNA ligase was omitted (−Ligase). Reverse transcriptase was omitted from reactions in lanes 9 and 10 
(–RT). Cycle thresholds measured for each sample are indicated at the bottom of the figure. Reactions that did 
not yield a detectable cycle threshold are labeled “N.D.” (Not Detected). (B) Critical controls for the qSL-RT-
PCR assay demonstrate specificity for decapped mRNA. Control reactions are indicated on the left. In the 
middle, a diagram of each control is depicted. On the right, the expected outcome of qSL-RT-PCR is indicated 
for each control reaction. (Terminator) The Terminator enzyme specifically destroys uncapped mRNA with a 5′ 
monophosphate but does not degrade capped mRNA, thereby demonstrating specificity of the assay for 
decapped RNA. Tobacco Acid Phosphatase removes 5′ cap, leaving a 5′ monophosphate that is detected by the 
qSL-RT-PCR assay, thereby serving as a positive control. (No ligase) Omission of DNA ligase prevents ligation 
of anchor to mRNA, thereby preventing amplification of product. (No Reverse Transcriptase) In the absence of 
reverse transcriptase, no product should be generated, thereby demonstrating dependence on cDNA conversion 
of mRNA. (C) Relative amounts of decapped RPL41A mRNA in A were determined for the indicated reactions 





To further validate the detection of decapped mRNA, RNA was purified from cells 
lacking decapping enzyme, Dcp2 (Wang, Jiao et al. 2002; Parker and Song 2004). In this strain, 
no decapped RPL41A was detected by qSL-RT-PCR (Figure 2.1A, lane 11), yet RPL41A mRNA 
was present (Figure 2.2A, lane 12). This result demonstrates that the decapped RPL41A is 
generated by Dcp2. When this RNA sample was treated with TAP, decapped RNA was readily 
detected by qSL-RT-PCR (Figure 2.2A, lane 13). We conclude that the qSL-RT-PCR 
specifically detects decapped mRNA. 
  
 To compare the amounts of decapped mRNAs, we used the comparative Ct method 
(Livak and Schmittgen 2001; Schmittgen and Livak 2008). Ct values (Figure 2.2A) from the 
qSL-RT-PCR assay were normalized to the total amount of RPL41A using Ct values from qRT-
PCR for that sample. The amount of decapped RPL41A was then calculated relative to the TAP 
treated sample (Figure 2.2A, lanes 5 and 6), which was set to 100% for detected decapped 
RPL41A mRNA (Figure 2.2C). In the test sample, 6.7% of the RPL41A mRNA was decapped 
and detectable by qSL-RT-PCR. Terminator treatment completely destroyed decapped mRNA. 
When DNA ligase was omitted, the relative amount of decapped mRNA was 0.04%, or 147 fold 
below the test sample, thus background signal was low. Taken together, we conclude that the 
qSL-RT-PCR assay is highly specific for decapped mRNA and can measure differences in the 








The qSL-RT-PCR assay has a broad, linear dynamic range for sensitive detection of decapped RPL41A RNA. 
(A) Five 10-fold serial dilutions of total RNA from Δxrn1 cells were analyzed using qSL-RT-PCR and qRT-PCR 
assays to detect decapped and total RPL41A mRNA, respectively. Triplicate samples were analyzed and the 
mean cycle threshold (Ct) values are plotted against input RNA amount (15, 1.5, 0.15, 0.015, and 0.0015 μg) on 
a logarithmic scale. Standard deviation is indicated above and below each data point. (B) Mean Ct values and 
standard deviations (SD) from A are shown in the table. Nonlinear regression analysis was used to determine 
correlation coefficients (R
2
) for each curve. (C) qRT-PCR and qSL-RT-PCR assays were performed on 10 μg of 
total RNA to measure RPL41A mRNA in wild-type BY4742 cells (WT) and Δxrn1. Mean Ct values and standard 
deviations are indicated as determined from triplicate samples. Fold increase above background was calculated 
relative to control reactions lacking T4 DNA ligase for each strain, determined from ΔCt of qSL-RT-PCR. (D) 
qRT-PCR and qSL-RT-PCR assays were performed on 7.5 μg of total RNA to measure YLR084C mRNA in 
Δxrn1 cells. Control samples were treated with TAP or Terminator. T4 DNA ligase or Reverse Transcriptase 
were omitted from control reactions as indicated. Mean Ct values and standard deviations are indicated and were 
determined from triplicate samples. Fold change in decapped mRNA level was calculated from the ΔCt of qSL-




The qSL-RT-PCR assay has a broad linear detection range and high sensitivity. To 
determine the detection range and sensitivity of the qSL-RT-PCR, the amount of input RNA was 
varied. Total RNA was purified from yeast cells (Δxrn1) and a series of ten-fold dilutions were  
made. Three replicate dilutions series were made to assess variability. qSL-RT-PCR was 
performed on each sample and the resulting mean Ct values were plotted against the amount of 
input RNA (Figure 2.3A). Both decapped and total RPL41A mRNA were detected over the entire 
range of RNA concentrations. Signal of the decapped mRNA was proportional to the input RNA. 
Linearity of the response was excellent: non-linear regression analysis yielded correlation 
coefficients of R
2
 = 0.9793 for qSL-RT-PCR and R
2
= 0.9992 for qRT-PCR (Figure 2.3A). 
Strikingly, decapped RPL41A was measured in as little as 1.5 nanograms of input RNA. These 
results were reproducible, as shown in Figure 2.3A, in which plots the mean Ct values for three 
replicates are graphed with standard deviations for each measurement. Because standard 
deviations are small, the values are also listed in Figure 2.3B. These results demonstrate that the 
qSL-RT-PCR assay provides a sensitive means to measure decapped mRNA with a broad, linear 
detection range and excellent reproducibility. 
  
 Based on the observed sensitivity, we tested the ability of qSL-RT-PCR to detect 
decapped RPL41A mRNA in wild-type cells. Equal mass of RNA (10 μg), purified from wild-
type or Δxrn1 yeast cells, was analyzed by qRT-PCR and qSL-RT-PCR. The mean Ct values 
were determined for each assay from three replicates (Figure 2.3C). As a control for false-
positive background signal, DNA ligase was ommitted from control reactions. The amount of 
RPL41A mRNA in each strain was measured by qRT-PCR (Figure 2.3C). In Δxrn1 cells, 
decapped mRNA was detected 171 fold above background (ΔCt=7.42, P=0.000074), whereas in 
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wild-type cells, decapped RNA was 2.53 fold above background (ΔCt=1.43, P=0.00018). 
Therefore, decapped RPL41A mRNA was detectable in wild-type cells, though the signal is close 
to background under these conditions. It is noteworthy that Hu and coworkers detected decapped 
mRNA in wild-type cells using splinted ligation and RT-PCR (Hu, Sweet et al. 2009; Hu, 
Petzold et al. 2010). As expected, decapped mRNA is stabilized by deletion of XRN1 and, 
therefore, is readily detectable above background. 
  
 To further demonstrate the sensitivity of qSL-RT-PCR, we tested its ability to detect a 
low abundance, cell cycle regulated mRNA encoded by the YLR084C gene. YLR084C mRNA 
was measured by qRT-PCR from replicate RNA purifications from Δxrn1 strain and detected at 
a mean Ct of 24.61 (Figure 2.3D), which is approximately 1000 fold below that of RPL41A 
(Mean Ct ~ 14, Figure 2.2A and 2.3C). To detect decapped YLR084C mRNA, we first mapped 
the 5’ end of this mRNA using 5’ rapid amplification of cDNA ends. A specific splint DNA 
oligonucleotide was created and used in the qSL-RT-PCR assay to detect decapped YLR084C 
mRNA (Mean Ct = 31.57, Figure 2.3D). Treatment of the RNA with TAP increased the 
decapped YLR084C by 5.81 fold, whereas Terminator treatment decreased it by 45.6 fold (Figure 
2.3D). Ommision of ligase completely abolished detection of decapped YLR084C mRNA but had 
no effect on detection by qRT-PCR (Figure 2.3D). Ommision of reverse transcriptase resulted in 
significant loss of detection of both total and decapped YLR084C mRNA (Figure 2.3D). Taken 
together, the results presented here demonstrate that qSL-RT-PCR detects abundant (RPL41A) 







The in vivo decapping rate of RPL41A mRNA was determined using qSL-RT-PCR assay. The half-life of 
RPL41A was measured in wild-type yeast (A) and in a strain wherein the XRN1 gene is deleted (Δxrn1) (B). (C) 
Decapped RPL41A mRNA was measured using the qSL-RT-PCR assay in the Δxrn1 strain following 
transcription shutoff. Relative amount of decapped RNA was calculated after normalization to total RPL41A at 
each time-point, relative to time = 0. (D) The rate of decapping was determined by linear regression analysis of 
the data in the graph in C with linear reaction kinetics between 5 and 30 min. The slope of the line, the reaction 
rate, is shown along with error and correlation coefficient. In all graphs, the mean value of the replicates is 
plotted and standard error is indicated above and below the data points. 
 
Measurement of in vivo decapping rate. To determine the rate of decapping of RPL41A 
mRNA in vivo, transcription was inhibited with Thiolutin, samples were collected at time points, 
and accumulation of decapped RPL41A was measured. The half-life of RPL41A is 33 minutes in 
wild-type yeast cells (Figure 2.4A). To measure the accumulation of decapped mRNA, 
degradation was blocked by deletion of XRN1 gene, which greatly stabilized RPL41A, with over 
70% of the mRNA remaining after 60 minutes (Figure 2.4B). Thus, RPL41A mRNA is 
predominantly degraded by the 5’ pathway. qSL-RT-PCR was then performed on each time 
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point. The resulting Ct values were normalized to total RPL41A detected in that sample. Next, 
the amount of decapped RPL41A at each time point was determined using the comparative Ct 
method (Schmittgen and Livak 2008). As expected, decapped RPL41A increased over the time 
course (Figure 2.4C). Mean Ct values from biological replicates were plotted with standard error 
for each measurement (Figure 2.4). The resulting curve demonstrated a brief lag phase during the 
first 5 minutes, followed by a linear phase until 30 minutes (Figure 2.4C). The curve then 
plateaus between 30 and 60 minutes. The linear phase between 5 and 30 minutes was analyzed 
using linear regression analysis. The slope of the resulting line measures the rate constant of 
0.171 +/- 0.0226 min
-1
. Therefore, qSL-RT-PCR detected accumulation of decapped endogenous 



















 In this report, we develop a quantitative assay, qSL-RT-PCR, that measures decapped 
mRNA produced in vivo by natural mRNA decay. The assay is versatile; any endogenous mRNA 
may be analyzed using qSL-RT-PCR. The assay has broad dynamic range with a linear response 
over four orders of magnitude of input RNA (Figure 2.3). The sensitivity of qSL-RT-PCR far 
exceeds northern blotting. Indeed, decapped mRNA can be detected from as little as 1.5 
nanogram of total cellular RNA (Figure 2.3). The measurements are highly reproducible (Figures 
2.3 and 2.4). qSL-RT-PCR is fast and all of the reagents are readily available. 
  
 The specificity of qSL-RT-PCR is a major strength. By design, qSL-RT-PCR measures 
only one species - decapped mRNA. Specificity is imparted by splinted ligation; T4 DNA ligase 
has strong preference for perfect base pairing on each side of the nick to be ligated (Engler 1982; 
Wu and Wallace 1989). A 3’ hydroxyl and 5’ monophosphate are essential for ligation; 
therefore, RNAs that do not receive a 5’ cap (with a 5’ triphosphate) or degradation products 
from RNase A (with a 5’ hydroxyl) are not detected. Specificity also imposes restrictions. First, 
the mRNA’s 5’ end must be mapped with single nucleotide resolution. Second, decapped 
products that are dephosphorylated or trimmed will not be detected. Third, competing decay 






When performing qSL-RT-PCR, we recommend optimization of several parameters. 
First, the critical controls described here should be performed. To optimize splinted ligation, the 
length of the DNA splint oligonucleotide is important – longer splints work better. The effect of 
splint length on ligation efficiency was systematically investigated: greater than 40 base pairs of 
complementarity worked best (Kurschat, Muller et al. 2005). Titration of the splint can improve 
the assay and reduce background. Efficient DNase I digestion of the splint after ligation is 
crucial. PCR conditions should be optimized, specifically primer design and amplification 
efficiencies. 
  
 Measurement of decapping rates in vivo has proven difficult, yet meeting this challenge is 
essential to study regulation of decapping. We have demonstrated the ability of qSL-RT-PCR to 
measure the decapping rate constant of a natural mRNA. To stabilize the decapped mRNA, 5’ 
decay must be inhibited by inactivation of Xrn1. As no specific inhibitors of Xrn1 have been 
identified, Xrn1 was inactivated genetically. In other eukaryotes, genetic inactivation or RNAi-
mediated depletion of Xrn1 may block decay of decapped mRNAs, thereby permitting 
determination of decapping rates. 
  
 Comparison of the RPL41A decapping rate with the previously estimated rates for MFA2 
and PGK1 mRNAs is informative. MFA2 and PGK1 mRNAs, modified with a secondary 
structure, were monitored by Northern blot (Muhlrad and Parker 1992; Muhlrad, Decker et al. 
1995; Cao and Parker 2001). The half-life of oligo-adenylated mRNA intermediate was 
measured for each mRNA and used to calculate respective decapping rate constants (Cao and 





Comparison of mRNA half-life, decay, and decapping reaction rates. The 
reaction rates of decay (in black) and decapping (in white) are compared 
with mRNA half-lives of three mRNAs, MFA2, PGK1, and RPL41A. 
Decay rates were derived from each mRNA's half-life. The trend-line 
curve plots the decay rate for mRNAs with half-lives ranging from 1 to 33 
min. Decapping rates and mRNA half-lives for PGK1 and MFA2 were 
measured previously by Northern blot analysis of the poly(G) tract 
containing RNA (Muhlrad and Parker 1992; Muhlrad et al. 1995; Cao and 
Parker 2001). RPL41A decapping rate and half-life were measured by 
qSL-RT-PCR and qRT-PCR, respectively, as shown in Figure 4. 
the first-order decay rates of each mRNA, calculated from their half-lives, are plotted on the 
same graph (Figure 2.5).  
  
 From this data, 
several observations 
emerge. First, the 
decapping rate constants 
measured by the two 
methods are similar in 
magnitude (MFA2 = 0.462 
min
-1
, PGK1 = 0.2772 min
-
1
, RPL41A = 0.171 min
-1
). 
Second, the mRNAs with 
short half-lives are 
decapped faster than those 
with longer half-lives (Figure 1.5). Third, decapping rates are faster than the decay rate, 
indicating that decapping is not the rate-determining step. Indeed, deadenylation is often the rate-
limiting step of mRNA decay (Shyu, Belasco et al. 1991; Muhlrad and Parker 1992; Decker and 
Parker 1993). Interestingly, the in vivo decapping rates are slower than those measured in vitro 
with purified enzyme and substrate (Jones, Quang-Dang et al. 2008). This discrepancy likely 
reflects competitive binding of other proteins to the cap in vivo, such as eIF4E, or perhaps 
limiting concentration of decapping enzyme.  We anticipate that qSL-RT-PCR assay will prove 
useful for analysis of other RNAs and processes, for instance other processing events such as 
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endonucleolytic cleavage (Gatfield and Izaurralde 2004; Doma and Parker 2006; Eberle, Lykke-
Andersen et al. 2009; Tomecki and Dziembowski 2010). Lastly, the ability to monitor decapping 
rates of natural mRNAs in vivo will greatly facilitate study of the features and factors that 
























2.4 Materials and Methods 
 
Yeast Strains 
AGY81: BY4742 MATalpha his3delta1 leu2delta0 lys2delta0 ura3delta0 Open Biosystems 
AGY95: BY4742 MATalpha xrn1::KANr 
AGY39: yRP1358 MATa his4-539 leu2-3112 lys2-201 trp1 ura3-52 dcp2::TRP1  
(Dunckley and Parker 1999) 
Oligonucleotides: Synthetic oligonucleotides were purchased from Integrated DNA 
technologies. 
NB33: Anchor RNA oligonucleotide  
5’-GCUGAUGGCGAUGAAUGAACACUGCGUUUGCUGGCUUUGAUG-3’  
NB34: RPL41A splint  
5’GCTCTCATTTCGATTGAATCGATGTGGTCTCATCAAAGCCAGCAAACGCAGTGTTC
ATTCATCGCCATCAGC-3’ 
NB35: Anchor forward PCR primer  
5’-GCTGATGGCGATGAATGAACACTGC-3’ 
NB39: RPL41A reverse PCR primer  
5’-CTAACATGTTAATTCATCAATGACATTACGATACTCTTG-3’  
NB47: RPL41A forward PCR primer  
5’-GAGAGCCAAGTGGAGAAAGAAGAGAACTAGA-3’  





NB56: YLR084C reverse transcription primer  
5’-GAGTGTCCAGAGACGATGAACAAAC-3’ 
NB58: YLR084C reverse PCR primer  
5’- GTTTTCTCTTGCGTTTCTTCGTTTCCCG-3’ 
NB63: YLR084C forward PCR primer  
5’-GCGCTTTAATCATCCCCATACTAGACTTTG-3’ 
RNA purification: Yeast cultures were grown in YPAD media at 30 ⁰C to an O.D.600nm of 0.8. 
Cells were harvested at 4000 x g for 10 minutes and washed once with H2O, and suspended in 
400 µL of TES (10 mM Tris-HCl pH 6.8, 10 mM EDTA, 0.2% w/v SDS). Next, the RNA was 
extracted using acid phenol (pH 4.3) at 65 ⁰C, extracted twice with chloroform, and precipitated 
with ethanol and 0.3 M sodium acetate (pH 5.2) at -20 ⁰C. RNA was pelleted by centrifugation 
and washed with 70% ethanol. Purified RNA was resuspended in RNAse-free H2O and analyzed 
using a Nanodrop spectrophotometer (Thermo Scientific) and by formaldehyde gel 
electrophoresis. 
Transcription shut-off: To measure mRNA decay rates, thiolutin, provided by Pfizer, was used 
to inhibit transcription (Jimenez, Tipper et al. 1973; Passos and Parker 2008). Cultures of yeast 
(35 mL) were grown in YPAD to an O.D. 600nm of 0.8. Cells were treated with 5 µg/mL thiolutin 
and 5 mL samples were collected at the indicated times. Cells were pelleted at 13,000 x g for 1 
minute and rapidly frozen in a dry ice-ethanol bath. Total RNA was then extracted from each 
sample. 
Splinted-Ligation: Total RNA (10 µg, unless otherwise indicated) was mixed with 20 
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picomoles of RPL41A splint oligonucleotide NB34 and 30 picomoles of RNA anchor NB33. For 
YLR084C, 7.5 
anchor NB33. To anneal oligos, samples were sequentially incubated for 5 minutes from 70 ⁰C 
to 60 ⁰C to 42 ⁰C and finally to 25 ⁰C. Next, 20 units RNase Inhibitor Plus (Promega), 20 units 
High Concentration T4 DNA ligase (Promega) and T4 DNA ligase buffer were added to each 
sample and incubated overnight at 15 ⁰C. To degrade the splint and genomic DNA, each sample 
was treated with 10 units of RQ1 DNase (Promega) or Turbo DNase (Ambion) in the supplied 1 
x DNase buffer for up to 3 hours at 37 ⁰C. RNA was then extracted using acid-
phenol:chloroform and then chloroform. The RNA was precipitated with ethanol and 0.3 M 
sodium acetate (pH 5.2) and 20 µg glycoblue co-precipitant (Ambion). After washing with 70% 
ethanol, the RNA was suspended in 13.3 µL RNase-free H2O.  
Reverse transcription: Prior to reverse transcription, RNA samples were treated with DNase 1 
to destroy any contaminating genomic DNA. For splinted ligation samples, this step is 
incorporated into the Splinted Ligation method, described above. One unit of RQ DNase 1 
(Promega) was used per µg of total RNA. DNase treatment was performed in supplied DNase 
buffer for 1 hour at 37 ⁰C. Reactions were then heat-inactivated for 15 minutes at 65 ⁰C in 1 x 
DNase stop buffer. Two µg, unless otherwise noted, of DNase-treated RNA was added to reverse 
transcriptase assays. Reverse transcription reactions contained 20 picomoles of gene-specific 
reverse primer (NB39 for RPL41A or NB56 for YLR084C), 0.5 mM each dNTP, 1.2 mM MgCl2, 
1 x GoScript buffer, and 1 µL of GoScript (Promega) in a 20 µL reaction and incubated 1 hour at 
42 ⁰C, then heat-inactivated 15 minutes at 65 ⁰C. 
Quantitative PCR: Amplification of PCR products was measured using GoTaq qPCR master 
mix (Promega) with 200 nM of each primer in 50 µL reactions. For detection of splinted ligation 
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products, the anchor forward PCR primer NB35 and RPL41A reverse PCR primer NB39 were 
used with 2 µL of template cDNA from splinted ligation reactions. For detection of total 
RPL41A mRNA, primers NB47 and NB39 were used. Splinted ligation product of YLR084C was 
detected using NB35 and NB58. Total YLR084C mRNA was detected using NB58 and NB63. A 
Bio-Rad CFX 96 C1000 real-time PCR instrument was used for all assays. Cycling parameters 
were: Step 1) 95 ⁰C for 2 minutes, 2) 95 ⁰C for 30 seconds, 3) 57 ⁰C for 30 seconds, 4) 72 ⁰C for 
40 seconds with steps 2-4 repeated 40 cycles. Reactions were analyzed by thermal melting curve 
and by gel electrophoresis. PCR amplification efficiencies of each primer set were determined 
(Pfaffl 2001). Primers NB35 and NB39 amplification efficiency was 102.7% and primers NB47 
and NB39 were 102.9%.  
Tobacco Acid Pyrophosphatase treatment: Ten µg total RNA was decapped by treatment with 
20 units RNase Inhibitor Plus (Promega) and 5 units Tabacco Acid Pyrophosphatase (Epicentre 
Biosystems) in the supplied 1 x TAP buffer for 30 minutes at 37 ⁰C.  
Terminator treatment. Ten µg of total RNA was incubated with 20 units RNase Inhibitor Plus 
and 10 units of Terminator (Epicentre Biosystems) in the supplied 1 x Terminator buffer for 30 
minutes at 37 ⁰C. 
Data analysis. Quantitative PCR assays were analyzed and cycle threshold (Ct) values 
determined using CFX Manager software (Bio-Rad). Calculations and graphs were created using 
Graphpad Prism version 5.0. Students t-test was used to measure significance. Relative changes 
were calculated using the comparative Ct method, ΔΔCt (Livak and Schmittgen 2001; 
Schmittgen and Livak 2008). First, the Ct value from qSL-RT-PCR assay for each timepoint 
sample (“target”) was normalized to the Ct of total RPL41A detected by qRT-PCR in that same 
sample (“reference”) by calculating ΔCttest = Cttarget test - Ctreference test. For time-course 
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experiments, the ΔCt of decapped RPL41A RNA at time = 0 minutes (“calibrator”) was 
calculated using the equation ΔCtcalibrator = Cttarget calilbrator – Ctreference calibrator. The ΔΔCt for each 
timepoint was then calculated from the equation ΔΔCt = ΔCttest - ΔCtcalibrator. Relative expression 
for each timepoint was then calculated using the equation Ratio = 2
-ΔΔCt
 (Livak and Schmittgen 
2001; Schmittgen and Livak 2008). The relative amount of decapped RNA detected, relative to 
time = 0 minutes, was then plotted against the time the sample was harvested following 
transcription shutoff. The decapping rate was then determined by linear regression curve fitting 
using GraphPad Prism. The measured rate was 0.1710 +/- 0.0228 min
-1
 with a correlation 
coefficient of 0.9053 between 5 and 30 minutes determined from two biological replicates 
(Figure 3). 
To determine the percentage of decapped RNA (Figure 2), relative expression was determined 
using the ΔΔCt method (Livak and Schmittgen 2001; Schmittgen and Livak 2008). To do so, 
ΔΔCt = ΔCttest was calculated for each sample (including test, terminator treated, TAP treated, no 
DNA ligase, and no reverse transcriptase controls) and - ΔCtcalibrator was calculated using the TAP 
treated sample as the “calibrator”. Next, the ratio relative was calculated and the TAP treated 
sample (ratio = 1) was set to 100%. 
RPL41A mRNA half-lives were determined from the qRT-PCR analysis of time-course samples 
following addition of Thiolutin transcription inhibitor (Figure 4A and B). The amounts of mRNA 
remaining at each timepoint relative to time = 0 minutes were determined from Ct values by 
calculating 2
ΔCt
 where ΔCt = [Ct (calibrator t=0) - Ct (test timepoint)]. Half-life of RPL41A in 
wild-type cells is based on six biological replicates and half-life in Δxrn1 cells is determined 
from two biological replicates. The resulting data was then plotted against time and non-linear 
regression analysis of three biological replicate samples were fitted using first order decay 
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kinetics (GraphPad Prism 5)(Figure 4A and B). mRNA decay rates for RPL41A, PGK1, and 
MFA2 (Figure 5) were calculated from the measured mRNA half-lives (Muhlrad and Parker 
1992; Muhlrad, Decker et al. 1995) using the equation Rate = ln(2)/(t1/2).  
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Copyright © American Society for Microbiology, Mol Cell Biol. 2012 Oct;32(20):4181-94. 
 
3.1 INTRODUCTION 
 Precise regulatory mechanisms are crucial for the execution of gene expression programs 
and integration of signals.  As intermediaries between genes and proteins, messenger RNAs 
(mRNAs) are an important nexus for regulation.  Post-transcriptional control of mRNA stability 
and translation is achieved through the concerted action of RNA binding factors, RNA decay 
enzymes and the translation machinery (Parker and Song 2004; Sonenberg and Hinnebusch 
2009).   Specific mRNAs are targeted for regulation by RNA binding factors that recognize 
sequences often found in the 3’ untranslated region (3’UTR).  One class of regulator is PUF 
proteins (Pumilio and Fem-3 binding factor) (Wickens, Bernstein et al. 2002; Miller and Olivas 
2011), defined by a conserved RNA binding domain that mediates high affinity binding to 
specific, 8-10 nucleotide, single-stranded RNA sequences (Murata and Wharton 1995; Zamore, 
Williamson et al. 1997; Zhang, Gallegos et al. 1997; Wang, McLachlan et al. 2002; Lu, Dolgner 
et al. 2009).  PUFs control diverse biological processes including cell proliferation, development, 
fertility, and neurological functions (Lehmann and Nusslein-Volhard 1987; Lin and Spradling 
1997; Wreden, Verrotti et al. 1997; Zhang, Gallegos et al. 1997; Forbes and Lehmann 1998; 
Asaoka-Taguchi, Yamada et al. 1999; Parisi and Lin 1999; Crittenden, Bernstein et al. 2002; 
Schweers, Walters et al. 2002; Dubnau, Chiang et al. 2003; Menon, Sanyal et al. 2004; Kedde, 
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van Kouwenhove et al. 2010; Chen, Zheng et al. 2012).  At the root of these functions lies the 
ability of PUFs to repress protein production from target mRNAs (Miller and Olivas 2011).  The 
preponderance of evidence indicates that the major mechanism of PUF mediated translational 
repression is by enhancing mRNA degradation (Olivas and Parker 2000; Goldstrohm, Hook et al. 
2006; Miller and Olivas 2011; Weidmann and Goldstrohm 2012).  In several cases, PUFs were 
shown to accelerate mRNA decay by removal of the 3’ poly(adenosine) tail (Olivas and Parker 
2000; Chagnovich and Lehmann 2001; Gamberi, Peterson et al. 2002; Goldstrohm, Hook et al. 
2006; Goldstrohm, Seay et al. 2007; Hook, Goldstrohm et al. 2007).  PUFs were also reported to 
inhibit translation (Wharton, Sonoda et al. 1998; Sonoda and Wharton 2001; Gu, Deng et al. 
2004; Cho, Gamberi et al. 2006; Chritton and Wickens 2010).  A remaining challenge is to 
discover the co-repressors and mechanisms of PUF mediated repression. 
  
 S. cerevisiae possess six PUFs, each of which bind a distinct set of mRNAs, dictated by 
their unique RNA binding specificities (Wickens, Bernstein et al. 2002; Gerber, Herschlag et al. 
2004).  Puf4p and Puf5p/Mpt5p bind multiple mRNAs (Gerber, Herschlag et al. 2004; Seay, 
Hook et al. 2006) and share at least one well-characterized target, the mRNA encoding HO 
endonuclease, which catalyzes switching of mating type (Tadauchi, Matsumoto et al. 2001; 
Goldstrohm, Hook et al. 2006; Hook, Goldstrohm et al. 2007).  Puf4p and Puf5p were previously 
shown to bind specific sites in the HO mRNA 3’UTR and accelerate deadenylation and 
degradation of the message (Goldstrohm, Hook et al. 2006; Hook, Goldstrohm et al. 2007).  
Deadenylation is essential for repression by Puf4p (Hook, Goldstrohm et al. 2007); however, 
Puf5p can still repress HO mRNA when deadenylation was blocked by deletion of the CCR4 
gene (Goldstrohm, Hook et al. 2006), which encodes the major deadenylase (Tucker, Valencia-
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Sanchez et al. 2001; Tucker, Staples et al. 2002; Goldstrohm, Seay et al. 2007).  This finding 
indicated that Puf5p can repress by a second, deadenylation independent mechanism (Hook, 
Goldstrohm et al. 2007).  Additional co-repressor(s) may be necessary for Puf5p activity. 
  
 We report here that an eIF4E binding protein (4E-BP), Eap1p, serves as an essential co-
repressor for Puf5p.  4EBPs are found throughout eukaryotes and are thought to inhibit 
translation by binding to the 5’ cap bound initiation factor eIF4E, thereby blocking interaction 
with initiation factor, eIF4G (Sonenberg and Hinnebusch 2009).  4E-BPs possess a conserved 
eIF4E binding motif, YxxxxL (φ indicates a hydrophobic amino acid, x indicates any residue) 
(Haghighat, Mader et al. 1995; Mader, Lee et al. 1995).  4E-BPs might globally reduce cap-
dependent translation; however, specific examples demonstrate more specialized roles 
(Sonenberg and Hinnebusch 2009).  Two 4E-BPs have been identified in S. cerevisiae, Caf20p 
and Eap1p (Altmann, Schmitz et al. 1997; Cosentino, Schmelzle et al. 2000).  Both contain an 
eIF4E-binding motif, but are otherwise unrelated.  Neither protein is essential for growth under 
standard conditions, but several mutant phenotypes have been described (Chial, Stemm-Wolf et 
al. 2000; Cosentino, Schmelzle et al. 2000; Mendelsohn, Li et al. 2003; Ibrahimo, Holmes et al. 
2006; Meier, Deloche et al. 2006; Sezen, Seedorf et al. 2009).  Eap1p was originally identified 
based on its ability to bind to eIF4E and was shown to compete with eIF4G (Cosentino, 
Schmelzle et al. 2000).  Therefore, like other 4E-BPs, Eap1p was proposed to repress by 
inhibiting translation initiation. 
  
 In this work, we show that Eap1p is required for Puf5p mediated mRNA repression, but 
is not necessary for Puf4p function.  In contrast, Caf20p is fully dispensable for regulation by 
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both Puf4p and Puf5p.  Translational analysis demonstrates that Eap1p does not affect global 
translation nor does it inhibit poly-ribosome association of Puf5p targeted mRNAs.  Instead, we 
identify a novel activity of Eap1p to promote degradation of specific mRNAs, including a Puf5p 
target mRNA.  Intriguingly, this activity is facilitated by the interaction of Eap1p with eIF4E.  
We find that deletion of EAP1 gene causes deadenylated, capped mRNA to substantially 
accumulate, indicating that Eap1p functions to promote removal of the mRNA’s 5’ 7-methyl 
guanosine cap.  In accordance, co-immunoprecipitation experiments indicate that Eap1p 
associates with Puf5p and the decapping factor Dhh1p.  Together, these results provide a new 
regulatory mechanism for a member of the diverse class of eIF4E binding proteins: enhancement 




















 The eIF4E binding protein, Eap1p, is essential for Puf5p mediated repression.  To 
identify co-repressors necessary for PUF mediated repression, we undertook a genetic approach 
using a reporter gene that is repressed by Puf4p and Puf5p (Goldstrohm, Hook et al. 2006; Hook, 
Goldstrohm et al. 2007).  The HIS3-HO 3’UTR reporter gene was created by replacing the open 
reading frame of HO with the auxotrophic marker gene HIS3 (Fig. 3.1A)(Goldstrohm, Hook et 
al. 2006).  In wild type cells, wherein Puf4p and Puf5p levels do not fully silence the reporter, 
introduction of the reporter confers histidine biosynthesis and thus growth on medium lacking 
histidine (Fig. 3.1B, WT strain).  As previously demonstrated (Goldstrohm, Hook et al. 2006; 
Hook, Goldstrohm et al. 2007), increased expression of Puf4p or Puf5p repressed HIS3-HO 
expression, thereby abrogating growth in the absence of histidine (Fig. 3.1B, wild type strain 
with PUF5 and PUF4 expression plasmids).  Importantly, repression depends on the PUF 
binding sites and the RNA binding activity of each PUF (Goldstrohm, Hook et al. 2006; Hook, 
Goldstrohm et al. 2007).    If a co-repressor is required for PUF repression, deletion of its gene 
will result in loss of repression and thus growth on medium lacking histidine.  We tested 
candidate genes with known roles in mRNA degradation and translational control.  Deletion of 
one gene encoding a 4E-BP, EAP1, abrogated Puf5p repression, but had no effect on Puf4p 
repression (Fig. 3.1B, eap1 strain with PUF5 versus PUF4).  Therefore, EAP1 is necessary for 
Puf5p repression and dispensable for Puf4p function, indicating a unique mode of repression by 
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Puf5p.  Because Eap1p binds to eIF4E (Cosentino, Schmelzle et al. 2000), our data suggests that 




FIG. 3.1  EAP1 is required for Puf5p mediated repression.  A)  The HIS3-HO 3’UTR reporter contains the 
HIS3 open reading frame (ORF) with the HO 3’ untranslated region (3’UTR) containing Puf4p ( Puf4BS) and 
Puf5p (PUF5BS) binding sites.  B) Growth assays measure repression of HIS3-HO reporter in wild type (WT), 
eap1 (Δeap1) or caf20 (Δcaf20) deletion strains transformed with plasmids expressing PUF4, PUF5, or control 
plasmid. The indicated number of cells were spotted onto media with histidine (control) or without histidine (- 
histidine).  Repression by each gene was scored by no growth on media lacking histidine, “+”, or growth “-“.   
C)  Growth assay for repression by PUF5 and EAP1 in wild type and puf5 puf5) cells.  D) Diagram 
of the LacZ-HO 3’UTR reporter mRNA. The LacZ HO 3’UTR mt reporter was created by mutating the Puf4p 
and Puf5p binding sites (Puf4BS mt and Puf5BS mt).  E) Graph of -galactosidase activity from wild type (WT) 
or mutant (mt) LacZ puf5 eap1 cells.  Fold 
change in relative light unit values are plotted relative to wild type reporter in wild type cells. F) Graph of fold 
change in LacZ HO (WT or mt) mRNA levels, as measured by northern blot (Fig. S1) and calculated relative to 
wild type reporter in wild type cells.  G) Graph of fold change in ratio of β-galactosidase activity in Panel E to 






 We also tested the second known yeast 4E-BP, CAF20.  In contrast to Eap1p, Caf20p is 
not necessary for repression by either PUF4 or PUF5, as revealed by the ability of each PUF to 
repress in cells lacking the CAF20 gene (Fig. 3.1B, ∆caf20).  This indicates that Puf4p represses  
through a separate mechanism that does not require a 4E-BP. 
  
 To further measure the contribution of Eap1p to Puf5p to repression, we created a 
reporter gene encoding β-galactosidase (β-gal) controlled by the HO 3’UTR (LacZ-HO 3’UTR, 
Fig. 3.1D).  Protein expression from LacZ-HO was measured from identical number of cells 
using a luminescence-based β-gal activity assay in three genetic backgrounds: wild type, eap1 
deletion, and puf5 deletion.  If Eap1p and Puf5p function together to repress HO, then β-gal 
activity should increase when each is absent.  Indeed, deletion of PUF5 resulted in a 6.5-fold 
increase in β-gal activity relative to wild type (Fig. 3.1E) and deletion of EAP1 caused a 14.8-
fold fold increase (Fig. 3.1E).  As a positive control for comparison, mutation of both PUF 
binding sites (Fig. 3.1D, LacZ-HO 3’UTR mt) resulted in a 6.2-fold increase (Fig. 3.1E)(Hook, 
Goldstrohm et al. 2007).  These results indicate that Eap1p represses β-gal synthesis or promotes 
its decay.   
  
 To gain additional insight, the steady-state level of LacZ mRNA was measured by 
northern blot (Fig. 3.S1).  Deletion of EAP1 increased LacZ-HO mRNA by 2.5-fold (Fig. 3.1F), 
suggesting that Eap1p represses LacZ mRNA synthesis or promotes mRNA degradation.  
Consistent with their role in promoting decay of HO mRNA, PUF binding site mutations or 
deletion of PUF5 caused a 2.3-fold increase the reporter mRNA (Fig. 3.1F).  Deletion of EAP1 
increased the ratio of β-gal activity to LacZ mRNA by 5.6-fold relative to wild type cells (Fig. 
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3.1G), suggesting that the amount of protein synthesized per mRNA may increase.  Together, our 
data demonstrate that both Puf5p and Eap1p repress a target mRNA and that Puf5p activity is 
dependent on Eap1p.  The results show that Eap1p reduces both protein and mRNA expression 
and, given that 4E-BPs are generally thought to inhibit translation, we next investigated the 
affect of Eap1p on HO translation. 
  
 Eap1p does not inhibit poly-ribosome association of a Puf5p regulated mRNA.  4E-
BPs are proposed to inhibit translation by blocking interaction of eIF4E and eIF4G during 
initiation (Sonenberg and Hinnebusch 2009).  In this context, we hypothesized that Puf5p may 
utilize Eap1p to inhibit HO translation.  To measure the effect of Eap1p on the translation state 
of HO mRNA, we performed sucrose gradient ultracentrifugation to separate ribosome bound 
and unbound mRNAs.  If Eap1p inhibits initiation, Eap1p should decrease the percentage of HO 
mRNA bound to ribosomes (ribosome occupancy) and reduce the number of ribosomes bound to 
HO mRNA.  Therefore, deletion of EAP1 should increase the ribosome occupancy and density of 
HO mRNA.   
  
 To test these predictions, cell extracts from wild type and eap1 deletion strains were 
separated on 7-47% sucrose gradients.  Each gradient was fractionated while monitoring UV 
absorption to show separation of 80S ribosomes and poly-ribosomes (Fig. 3.2A and 3.2B), 
corroborated by ethidium bromide staining of ribosomal RNAs (Fig. 3.2C).  The chromatograms 
of wild type and eap1 deletion strains were highly similar, indicating that Eap1p does not 
substantially alter global translation (compare Fig. 3.2A, WT and Fig.3.2B, ∆eap1). 
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 We next detected HO mRNA in the gradient fractions from three biological replicates to 
quantitate HO translation state.  In wild type cells, 97% of total HO mRNA was in poly-
ribosome bound fractions (Fig. 3.2D and 3.2E, WT, fractions 7-19).  For comparison, the 
average ribosome occupancy for mRNAs in S. cerevisiae is 71% (Arava, Wang et al. 2003).  HO 
mRNA was predominantly detected in fractions containing 3 or more ribosomes, steadily 
increasing into the fractions containing 7 or more ribosomes (Fig. 3.2D, WT fractions 9-19).  
Less than 1% of HO mRNA was found in ribosome free fractions (Fig. 3.2D, fraction 1-3) and 
only 2% was present in fractions containing mono-ribosomes (Fig. 3.2D, lanes 1-9).  As a 
control, poly-ribosomes were dissociated with EDTA.  This treatment caused HO mRNA to shift 
from the bottom to the top of the gradient (Fig. 3.S2), consistent with HO being poly-ribosome 
associated.  These results indicate that HO mRNA efficiently engages with ribosomes in wild 
type cells, contradicting the prediction that Eap1p inhibits translation initiation of HO mRNA. 
  
 Next, the effect of Eap1p on HO translation state was investigated.  Deletion of EAP1 did 
not alter the ribosome occupancy of HO mRNA; 98% associated with poly-ribosomes, nearly 
identical to wild type (Fig. 3.2D and 2E, ∆eap1 fractions 7-19).  Like wild type, less than 1% of 
HO mRNA was present in the ribosome free fractions (Fig. 3.2D, Δeap1, fractions 1-3).  The 
ribosome density of HO mRNA actually decreased slightly in the eap1 deletion strain, with the 
peak density shifting from poly-ribosome fraction 16 in wild type cells to less dense fraction 15 
in eap1 deletion cells (Fig. 3.2D and 2.2E, Δeap1).  These observations contradict the prediction 







FIG. 3.2  Eap1p does not inhibit poly-ribosome association of a Puf5p regulated mRNA.  Ribosome profiles 
of sucrose density gradients from wild type (WT) (A) and eap1 deletion (Δeap1) (B) cells.  UV absorbance at 
260 nm (A260 nm) was measured during collection of fractions to generate the chromatograms.  “Top” and 
“Bottom” refer to the relative position in the gradient tube.  Ribosome species are indicated within the 
chromatogram.  C) The ethidium bromide stained gel shows the ribosomal RNA (26S and 18S rRNA) content of 
each fraction from WT cells.  D) Northern blot of HO mRNA in gradient fractions from wild type (WT) and 
Δeap1 strains.  E) Quantitation of HO mRNA profile across gradient fractions from three biological replicate 
samples of wild type and Δeap1 strains.  Mean values are plotted with standard errors.  Northern blot of RNR1 






 The major difference observed between wild type and eap1 deletion strains is a change in 
the abundance of HO mRNA, which increased by 1.7 fold in the eap1 deletion (Fig. 3.2D and 
3.2E, ∆eap1).  We conclude that Eap1p does not inhibit translation initiation of HO mRNA but 
instead decreases the abundance of HO mRNA, suggesting an effect on HO mRNA synthesis or 
stability. 
 
 We also investigated the effect of Eap1p on the translation state of two mRNAs that are 
not PUF targets: the ribonucleotide reductase mRNA, RNR1, and the large ribosomal subunit 
protein L47 mRNA, RPL41A (Gerber, Herschlag et al. 2004; Goldstrohm, Hook et al. 2006; 
Seay, Hook et al. 2006).  Like HO, RNR1 is a low-abundance, cell-cycle regulated mRNA with a 
large ORF of 2667 nucleotides (compared to HO ORF 1761nt).  The distribution of RNR1 
mRNA was not altered by Eap1p (Fig. 3.2F).  All RNR1 associated with poly-ribosomes in wild 
type and eap1 deletion cells (Fig. 3F. compare fractions 12-19 from WT and Δeap1).  RPL41A is 
an abundant mRNA with a 78 nucleotide ORF that engages, on average, one ribosome in wild 
type cells (Fig. 3.2G, WT, peak fractions 4-6)(Arava, Wang et al. 2003).  The ribosome 
association of RPL41A mRNA was not altered by deletion of EAP1 (Fig. 3.2G, Δeap1).  
Therefore, EAP1 does not change the ribosome association of two mRNAs that are not targeted 
by PUFs.   
  
 Eap1p associates with poly-ribosomes.  We next evaluated whether Eap1p associates 
with ribosomes.  If Eap1p blocks translation initiation, then Eap1p would be expected to be 
found exclusively in translationally inactive, ribosome free fractions of the sucrose gradient.  
Eap1p with a FLAG tag was expressed in the eap1 deletion strain and extracts were fractionated 
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by sucrose density gradients using conditions that separate ribosomal subunits, mono- and poly-
ribosomes (Fig. 3.3A).  Three peaks of Eap1p were observed in the gradient fractions.  At the top 
of the gradient, a peak was present in the ribosome free fractions (Fig. 3.3A, fractions 1 and 2).  
A second peak cofractionated with 60S ribosomal subunit (Fig. 3.3A, fraction 5 and 6).  A third 
major peak of Eap1p fractionated with poly-ribosomes (Fig. 3.3A, fractions 14-16).  
Interestingly, a slower migrating Eap1p species was observed in the first two gradient fractions, 
perhaps the result of post-translational modification(s). 
  
 Eap1p binds eIF4E and this interaction may mediate Eap1p association with poly-
ribosomes.  First, we assessed the distribution of eIF4E in the gradient fractions.  Western blot of 
eIF4E revealed that the protein was distributed throughout the gradient, with a major peak at the 
top of the gradient (Fig. 2.3A, middle panel, fractions 1-4) and a secondary peak corresponding 
to the 80S mono-ribosome (Fig. 2.3A, fractions 6-8).  Like Eap1p, eIF4E was also present in 
poly-ribosome fractions (Fig. 2.3A, fractions 9-16).  To test if Eap1p binding to eIF4E is 
necessary for poly-ribosome association, the eIF4E binding motif, Y109XXXXL114, was mutated 
by introducing two alanine substitutions, Y109A and L114A, to create Eap1p mt (Cosentino, 
Schmelzle et al. 2000).  This mutant was expressed in the eap1 deletion strain and then extract 
from these cells was fractionated on a sucrose gradient.  The Eap1p mutant was only detected in 
the first three fractions at the top of the gradient (Fig. 2.3A, Eap1 mt, fractions 1-3), indicating 








FIG. 3.3.   Eap1p fractionates with poly-ribosomes.  A)  Top panel: Absorbance (A260 nm) chromatogram of 
sucrose density gradient of sample from eap1 deletion strain expressing FLAG-tagged Eap1p with T7-tagged 
eIF4E.  Western blots of wild type Eap1p (second panel), eIF4E (third panel) and Eap1p with mutations in the 
eIF4E binding motif, Y109A and L114A, (Eap1 mt, bottom panel) in gradient fractions.  Cycloheximide was 
present in each sample.  Western blot of Eap1 mt was over-exposed 10 fold relative to wild type Eap1.  The “*” 
indicates Eap1p with slower electrophoretic mobility than the expected 70 kDa size.  B) Western blots of RNase 
treated immunoprecipitations of FLAG-tagged, wild type or mutant Eap1p from cells co-expressing T7-tagged 
eIF4E.  Mock FLAG immunoprecipitation was from cells expressing eIF4E-T7 but not Eap1p-FLAG.  C) 
Chromatogram from cell extracts treated with EDTA to dissociate poly-ribosomes.  FLAG-tagged Eap1p was 
detected by western blot.  D) Chromatogram from extracts incubated in the absence of cycloheximide resulted in 






 To confirm that Eap1p mt no longer bound to eIF4E, wild type Eap1p or Eap1p mt were 
immunoprecipated.  eIF4E was detected only in the wild type Eap1p immunoprecipitate (Fig. 
3.3B); therefore, the mutations disrupted interaction with eIF4E.   
  
 Two controls were performed to verify that Eap1p associated with poly-ribosomes.  First, 
extracts were treated with EDTA, resulting in collapse of poly-ribosomes into 40S and 60S peaks 
(Fig. 3.3C) and causing Eap1p to fractionate predominantly at the top of the gradient (Fig. 3.3C, 
fractions 1-7).  Importantly, the portion of Eap1p that fractionated with poly-ribosomes in wild 
type cells (Fig. 3.3A, fractions 9-16) was greatly diminished (Fig. 3.3C, fractions 9-16).  Second, 
ribosomes were allowed to elongate and “run-off” by omitting cycloheximide (Lee, Udagawa et 
al. 2007), resulting in accumulation of 80S particles (Fig. 3.3D, fractions 6-7).  If Eap1p is 
engaged with translating poly-ribosomes, then run-off should cause Eap1p to shift into lighter 
fractions.  Indeed, Eap1p was only detected at the top of the gradient (Fig. 3.3D, fractions 1-2).  
Collectively, these data indicate that Eap1p associates with poly-ribosomes.  This finding was 
unexpected and is not consistent with the model that Eap1p inhibits translation initiation.  
Instead, our findings indicate that Eap1p may promote a distinct mode of repression that 







Eap1p accelerates mRNA decay.  Puf5p promotes degradation of the mRNAs it targets 
(Goldstrohm, Hook et al. 2006; Seay, Hook et al. 2006; Goldstrohm, Seay et al. 2007; Hook, 
Goldstrohm et al. 2007).  Because Eap1p serves as a co-repressor for Puf5p, and that HO (Fig. 
3.2D) and LacZ-HO 3’UTR (Fig. 3.1F) mRNA levels increased in the eap1 deletion, we 
reasoned that Eap1p may affect mRNA decay.  To test this hypothesis, mRNA decay rates were 
measured in the presence or absence of Eap1p.  Cells were treated with thiolutin to inhibit 
transcription and RNA samples were collected over time.  Next, specific mRNAs were detected 
by northern blot (Fig. 3.4).  In wild-type cells, HO mRNA half-life was 12 minutes (Fig. 3.4A), 
consistent with past measurements (Goldstrohm, Hook et al. 2006; Hook, Goldstrohm et al. 
2007).  Deletion of EAP1 dramatically stabilized HO, increasing the half-life to 41 minutes (Fig. 
3.4A).  These results represent the first demonstration that EAP1 affects the rate of mRNA 
decay. 
 
We next tested whether the interaction of Eap1p with eIF4E was required for acceleration 
of mRNA decay.  To do so, the eap1 deletion strain was complemented with plasmid expressing 
either wild type Eap1p (EAP1) or eIF4E binding defective mutant (EAP1 mt).  HO mRNA half 
life was then measured in each strain.  When wild type Eap1p was expressed in eap1 deletion 
cells, HO mRNA half-life was 7.5 minutes (Fig. 3.4A, ∆eap1 + EAP1), a substantial reduction 
relative to 41 minutes in the eap1 deletion and slightly shorter than the 12 minutes observed in 
wild type cells.  These results, summarized in Figure 4E, support the conclusion that Eap1p 
promotes HO mRNA decay.  Eap1p mt also accelerated decay of HO mRNA, resulting in a half 
life of 20 minutes (Fig. 3.4A, ∆eap1 + EAP1 mt).  Thus, binding to eIF4E facilitates but is not 





FIG. 3.4.   Eap1p accelerates mRNA degradation.  mRNA half-lives were measured by transcription shut-off 
with thiolutin.  RNA samples were collected at the indicated time points, in minutes.  Blots from duplicate 
samples are shown for each condition.  Average mRNA half lives are indicated below each sample.  A) Northern 
blot of HO mRNA from wild type (WT), eap1 deletion (∆eap1), or eap1 deletion cells complemented with 
plasmids expressing wild type Eap1p (∆eap1+EAP1) or eIF4E binding defective mutant Eap1p (∆eap1+EAP1 
mt).  B)  Northern blots of RPL41A mRNA from samples in panel A.  C)  Northern blots of RNR1 mRNA from 
samples in A.  D)  Northern blots of the stable ribosomal 18S rRNA from samples in panel A.  E)  Graph of HO 
mRNA half-lives in wild type, ∆eap1, ∆eap1+EAP1 and ∆eap1+EAP1 mt strains.  F)  Graph of RNR1 mRNA 






 To determine if the effect of Eap1p on mRNA stability was specific to PUF regulated 
mRNAs, we analyzed two mRNAs that are not regulated by PUFs, RNR1 and RPL41A.  RPL41A 
had a half-life of about 60 minutes that was not altered by deletion of EAP1 or complementation 
with wild type or mutant EAP1 (Fig. 3.4B).  In contrast, the half-life of RNR1 mRNA increased 
from 18 minutes in wild type cells to 53 minutes in the eap1 deletion strain (Fig. 3.4C).  
Importantly, expression of wild type Eap1p in the deletion strain restored RNR1 half life to 16 
minutes (∆eap1 + EAP1, Fig. 3.4C).  EAP1 mt also restored RNR1 decay to 22 minutes, albeit 
less effectively than wild type EAP1 (∆eap1 + EAP1 mt, Fig. 3.4C).  These results are 
summarized in Figure 3.4F.  The effect on RNR1 demonstrates that Eap1p promotes degradation 
of an mRNA that is not a known PUF target.  These results reveal a novel activity of Eap1p to 
promote mRNA degradation.  Importantly, Eap1p binding to eIF4E facilitates decay but this 
interaction is not obligatory for enhanced mRNA degradation. 
  
 Eap1p promotes decapping of mRNAs.  Having established that Eap1p accelerates 
mRNA degradation, we next investigated which step of decay is affected.  mRNA degradation 
generally initiates by removal of the poly-adenosine tail (i.e. deadenylation).  Once the tail is 
shortened to about 10 nucleotides (pA10), the mRNA is decapped and degraded in a 5’ to 3’ 
direction or by the  alternative 3’-5’ decay pathway (Coller and Parker 2004).  Previous research 
demonstrated that Puf5p and Puf4p enhance deadenylation (Goldstrohm, Hook et al. 2006; 
Goldstrohm, Seay et al. 2007; Hook, Goldstrohm et al. 2007).  Because Eap1p serves as a Puf5p 
co-repressor, we speculated that it may affect deadenylation.  To compare the rate of HO 
deadenylation in wild type and eap1 deletion cells, transcription was inhibited with thiolutin and 
RNA samples were collected over time.  To resolve the poly(A) tail length, HO mRNA was 
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cleaved with RNase H and a complementary DNA oligonucleotide to generate a 253 nucleotide, 
3’ fragment with a poly(A) tail of up to 80 nucleotides (Fig. 3.5A).  Products were resolved by 
denaturing polyacrylamide gel electrophoresis and detected by northern blot (Fig. 3.5B).  In wild 
type cells, HO 3’UTR had a poly(A) tails ranging from 80 to 10 adenosines (Fig. 3.5B, WT, time 
= 0 minutes, lane 2).  Treatment with RNase H and oligo(dT) provided a marker for 
deadenylated HO mRNA (Fig. 3.5B, lane 1).  The stable non-coding RNA, SCR1, served as a 
loading control (Fig. 3.5B).  Following transcription shut-off, the tail was quickly shortened over 
the first ten minutes to a length of about 10 nucleotides. This oligo-adenylated intermediate 
subsequently decayed with a 6 minute half life (Fig. 3.5B, lanes 3-7), consistent with our past 
observations (Goldstrohm, Hook et al. 2006).  HO mRNA was deadenylated within ten minutes 
in the eap1 deletion strain, exhibiting the same kinetics observed in wild type cells (Fig. 3.5B, 
lanes 9-10).  To more closely analyze the effect of Eap1p on HO deadenylation, we repeated the 
experiment using 3 minute intervals (Fig. 3.5C).  In wild type and eap1 deletion cells, HO 
poly(A) tails progressively shorten at equivalent rates (Fig.3.5C).  Therefore, deadenylation does 
not appear to be affected by Eap1p.  However, a major difference was observed in the eap1 
strain: the oligo-adenylated intermediate accumulated and persisted throughout the time course 
with a half life greater than 50 minutes (Fig. 3.5B, lanes 10-14; Fig.3.5C, lanes 9-14).  This 
pattern of decay, wherein an oligo-adenylated mRNA accumulates, is identical to that caused by 
mutations in decapping factors (Beelman, Stevens et al. 1996; Tharun, He et al. 2000; Coller, 







FIG. 3.5.   Eap1p promotes decapping of HO mRNA.  A) HO mRNA was cleaved with RNase H and a DNA 
oligonucleotide to produce a 1600 nucleotide 5’ fragment and a 253 nucleotide 3’ fragment with a poly(A) tail of 
up to 80 adenosines (pA80).  B)  Northern blot analysis of HO mRNA decay in wild type (WT) or eap1 deletion 
strain. RNA samples were collected over a time course (minutes) following addition of thiolutin and then 
cleaved as shown in panel A.  The t=0 minute samples were also treated with RNase H and oligo dT15 
(designated 0+dT) to remove the poly(A) tail (pA0).  Top panel:  Northern analysis of poly(A) tail length and 
decay rate of the HO 3’UTR with a specific probe to the 3’ fragment.  The oligo-adenylated HO intermediate is 
indicated on the right (pA~10).  Middle panel: Northern blot of the HO 5’ fragment.  Bottom panel:  SCR1 RNA 
was detected by northern blot as a control for sample loading.  C) Analysis of HO mRNA decay and 
deadenylation over the initial 15 minutes of decay following addition of thiolutin.  D) Duplicate RNA samples 
from panel B were treated (as indicated by a “+”) with recombinant Xrn1 or not treated (“-“) to assess status of 
5’ cap.  As a control, where indicated, samples were also treated with Tobacco Acid Pyrophosphatase (TAP) to 
remove the 5’ cap.  Northern blot for HO and RNR1 mRNA as indicated on the left. Before transfer to 
membrane, the gel was stained with ethidium bromide (EtBr, bottom panel) to visualize degradation of uncapped 
18S and 26S ribosomal RNA.  E)  Xrn1 sensitivity assay of HO mRNA decay intermediates from the 20 and 40 






 To further characterize the impact of Eap1p on HO mRNA decay, we detected the 5’ HO 
mRNA fragment by northern blot (Fig. 3.5B, HO 5’ fragment).  In wild type cells, the 5’ 
fragment began to rapidly disappear as the oligo-adenylated species appeared, consistent with the 
mRNA being degraded by the 5’ decay pathway (Fig. 3.5B, lane 2-3).  In contrast, when EAP1 
was deleted, the 5’ fragment persisted throughout the time course (Fig. 3.5B, lanes 9-14).  These 
results demonstrate that Eap1p accelerates degradation of HO mRNA at a step following 
deadenylation and preceding 5’ decay. 
  
 We next sought to determine if the HO mRNA that accumulated in the eap1 deletion 
retained a 5’ cap or was decapped but not subsequently degraded by the processive, 5’ to 3’ 
exonuclease, Xrn1p.  To assess the presence of the 5’ cap, RNA was treated with recombinant 
Xrn1p.  Decapped mRNA is sensitive to degradation by Xrn1p whereas capped mRNA is 
resistant.  Ninety-five percent of HO mRNA in wild type cells was resistant to Xrn1p, consistent 
with the presence of a 5’ cap (Fig. 3.5D, lanes 3 and 4).  HO mRNA from eap1 cells was fully 
resistant to Xrn1p and thus retained a 5’ cap (Fig. 3.5D, lanes 7 and 8).  Thus, deletion of EAP1 
causes accumulation of capped HO mRNA.  We also observed that the RNR1 mRNA that 
accumulated in eap1 deletion cells was also resistant to digestion with Xrn1p, indicating that it 
too remained capped (Fig. 3.5D).  Two controls were performed to verify the Xrn1p assay.  First, 
RNA was decapped with tobacco acid pyrophosphatase (TAP) and then incubated with Xrn1p, 
resulting in a 64% reduction of HO and RNR1 mRNAs (Fig. 3.5D, lanes 11 and 12) (Blewett, 
Coller et al. 2011).  Second, ethidium bromide staining the RNA samples demonstrated that 
Xrn1p degraded the uncapped 26S and 18S ribosomal RNAs (Fig. 3.5D, lanes 3-4, 7-8, 11-12).  
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As observed in Figure 3.5B, the predominant HO mRNA decay intermediate in the eap1 strain at 
20 and 40 minutes after transcription shut-off has an oligo-adenylate tail. We used Xrn1p 
sensitivity to determine if this mRNA species possesses a 5’ cap.  At 20 minutes, 76% of the HO 
intermediate was resistant to Xrn1p. At the 40 minute time point, the HO intermediate was fully 
resistant to Xrn1p digestion (Fig. 3.5E, lanes 3 and 4).  Removal of the 5’ cap with TAP and then 
digestion with Xrn1p resulted in decapping and destruction of 95% of the oligo-adenylated HO 
intermediate (Fig. 3.5E, lanes 5 and 6).  Collectively, these results support the conclusion that 
deletion of EAP1 causes the accumulation of capped, oligo-adenylated HO mRNA.  We 
conclude that Eap1p promotes decapping, a novel function for a 4E-BP. 
  
 Eap1p associates with Puf5p and Dhh1p.  We next asked if Puf5p associates with 
Eap1p.  FLAG tagged Eap1p (Eap1-FLAG), was co-expressed with T7 tagged Puf5p (Puf5-T7) 
in wild type cells.  Eap1p was then immunoprecipitated with FLAG antibody resin, washed 
extensively and specifically eluted with FLAG peptide.  Eluates were then analyzed by western 
blotting (Fig. 3.6A).  As a negative control, a mock FLAG immunoprecipitation was performed 
on cells expressing only Puf5p-T7 (Fig. 3.6A).  Puf5p was detected in the Eap1p 
immunoprecipitate (Fig. 3.6A).  As a negative control, the Actin protein, which is abundant in 
the input extracts, was not detected in the FLAG eluates (Fig. 3.6A).  Because these extracts  
were extensively treated with both RNase A and RNase One to degrade RNA prior to 
immunoprecipitation (Fig. 3.6B), we conclude that Puf5p likely associates with Eap1p via 






FIG. 3.6.   Eap1p associates with Puf5p and Dhh1p.  A)  T7-tagged Puf5p co-immunoprecipitates with 
FLAG-tagged Eap1p from cell extracts (input) treated with RNases A and One.  Western blot detection of input 
lysates and FLAG peptide eluates from mock or Eap1-FLAG immunoprecipitations.  B) RNase mediated 
destruction of RNA in extracts from panel A was confirmed ethidium bromide (EtBr) staining of nucleic acids. 
RNA size markers are shown on the left (M).  C)  T7-tagged Dhh1p co-immunoprecipitates with Eap1-FLAG 








 The observation that Eap1p enhanced decapping suggested that it may physically 
associate with the decapping machinery.  The Dhh1 protein, a DExD/H box helicase, is a well 
known activator of decapping (Coller and Parker 2004).  T7 tagged Dhh1p 
coimmunoprecipitated with Eap1p-FLAG but was not present in mock immunoprecipitate (Fig. 
3.6C).  These extracts were also RNase treated prior to immunoprecipitation; therefore, 
association of Eap1p and Dhh1p is not dependent on RNA.  This result provides a physical link 
between Eap1p and the decapping machinery.  In addition to this physical interaction, the mRNA 
decay phenotypes caused by deletion of EAP1 (Fig. 3.5A) and DHH1 (Fig. S3)(Coller, Tucker et 
al. 2001) were remarkably similar; HO mRNA was stabilized (t1/2 > 50 minutes) and 
accumulated as an oligo-adenylated species. 
 
Eap1p associates with HO mRNA in a Puf5p dependent manner.  Our data show that 
Eap1p participates in Puf5p mediated degradation of HO mRNA.  Puf5p binds directly to the HO 
3’UTR and may recruit Eap1p to the message.  Alternatively, Eap1p may associate with HO 
mRNA by binding to eIF4E.  To test these models, we expressed FLAG tagged Eap1p or the 
eIF4E binding defective Eap1p mt and asked if HO mRNA coimmunoprecipitated with each 
protein.  To assess the role of Puf5p in recruiting Eap1p, wild type Eap1p-FLAG was 
immunoprecipitated from the puf5 deletion strain.  As a negative control, a mock 
immunoprecipitation was performed using extract from wild type cells.  The FLAG eluates were 
analyzed by western blotting to confirm purification of Eap1p and Eap1 mt (Fig. 2.7A).  HO 
mRNA was measured in the eluates by reverse transcription and quantitative polymerase chain 
reaction.  HO mRNA was nearly undetectable in mock eluates whereas it was enriched 1400 fold 
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FIG. 3.7.  Eap1p associates with HO mRNA, dependent on Puf5p.  A)  FLAG-tagged wild type Eap1p (WT) 
or eIF4E binding defect mutant Eap1p (mt) were expressed and immunopurified from wild type or Δpuf5 cells. 
Negative control Mock immunoprecipitation was performed form cells that did not express tagged Eap1p.  Anti-
FLAG western blot of FLAG peptide eluates.  B)  Graph of fold enrichment of HO mRNA purified from eluted 
samples in panel A, detected using qRT-PCR.  Fold enrichment was calculated relative to mock 
immunoprecipitation, normalized to input levels. As a negative control, 18S rRNA was also measured. Note that 
conditions used in this assay did not preserve poly-ribosomes. 
 
 









Purification of Eap1p from a puf5 deletion strain reduced its association with HO mRNA 
by 35-fold relative to wild-type strain (Fig. 2.7B, 49 fold enrichment); therefore, Puf5p facilitates 
Eap1p association with HO mRNA.  We next tested the contribution of Eap1p interaction with 
eIF4E.  No significant change was observed relative to wild type Eap1p; HO mRNA was 
enriched 1400 fold in the Eap1 mt FLAG eluates (Fig. 3.7B).  As a negative control, the non-
coding 18S ribosomal RNA was not enriched in these immunoprecipitates.  These findings 






















 Eap1p is required for Puf5p-mediated repression.  Yeast PUF proteins have a well 
documented role in accelerating mRNA degradation (Olivas and Parker 2000; Jackson, 
Houshmandi et al. 2004; Houshmandi and Olivas 2005; Goldstrohm, Hook et al. 2006; Seay, 
Hook et al. 2006; Goldstrohm, Seay et al. 2007; Hook, Goldstrohm et al. 2007; Ulbricht and 
Olivas 2008) and deadenylation plays an important role.  Both Puf4p and Puf5p enhance 
deadenylation of HO mRNA in vivo and in vitro (Goldstrohm, Hook et al. 2006; Goldstrohm, 
Seay et al. 2007; Hook, Goldstrohm et al. 2007).  Puf4p repression depends on both POP2 and 
CCR4 genes, which encode subunits of the Ccr4-Not deadenylase complex, and the catalytic 
activity of Ccr4p deadenylase (Goldstrohm, Seay et al. 2007; Hook, Goldstrohm et al. 2007).  
That said, several clues indicate that additional mechanisms are utilized by specific PUFs.  First, 
Puf5p represses a target mRNA even when deadenylation is genetically blocked by removal of 
the CCR4 gene (Goldstrohm, Hook et al. 2006).  Further evidence of a deadenylation 
independent mechanism was revealed from analysis of HO mRNA half-lives in different genetic 
backgrounds.  HO mRNA is stabilized ten-fold when both PUF4 and PUF5 are deleted, whereas 
deletion of CCR4 stabilizes HO only three-fold (Goldstrohm, Hook et al. 2006; Goldstrohm, 
Seay et al. 2007; Hook, Goldstrohm et al. 2007).  While deadenylation of HO is blocked by the 
absence of Ccr4p, the mRNA is still degraded (Goldstrohm, Seay et al. 2007), indicating that 




We hypothesized that Puf5p recruits additional co-repressor proteins (Goldstrohm, Hook 
et al. 2006; Goldstrohm, Seay et al. 2007; Hook, Goldstrohm et al. 2007).  In the present work, 
we provide strong evidence that the eIF4E binding protein, Eap1p, participates in Puf5-mediated 
repression.  Deletion of EAP1 blocks the repression by Puf5p (Fig. 3.1).  In reciprocal tests, 
Eap1p represses an HO reporter mRNA, dependent on the PUF5 gene.  Together, these results 
indicate that Eap1p is a Puf5p co-repressor.  The requirement of Eap1p is specific to Puf5p, as 
Puf4p repression is not EAP1 dependent (Fig. 3.1).  Additionally, Eap1p and Puf5p associate 
with each other (Fig. 3.6) and HO mRNA (Fig. 2.7), biochemically connecting both regulators to 
the target mRNA. 
  
 Eap1p is one of two 4E-BPs encoded by the S. cerevisiae genome (Altmann, Schmitz et 
al. 1997; Cosentino, Schmelzle et al. 2000).  The second 4E-BP, Caf20p, was reported to 
associate with Puf4 and Puf5p in an RNA dependent manner (Cridge, Castelli et al. 2010), 
though the function was not tested. Our functional analysis demonstrates that CAF20 is 
dispensable for repression by Puf4p and Puf5p (Fig. 3.1).  Thus, a general 4E-BP function is not 
essential for PUF repression.  Instead, our data indicate that Puf5p specifically utilizes Eap1p to 
elicit repression.  We conclude that Puf4p and Puf5p exert their repressive effects through 
distinguishable mechanisms.  Both PUFs enhance deadenylation while Puf5p also promotes 
Eap1p dependent repression (Fig. 3.8) (Goldstrohm, Hook et al. 2006; Goldstrohm, Seay et al. 
2007; Hook, Goldstrohm et al. 2007).  The features of Puf5p that confer Eap1p dependence are 
currently not known.  While the conserved RNA binding domains of Puf4p and Puf5p bind to the 
Pop2p-Ccr4p deadenylase (Fig. 3.8) (Goldstrohm, Hook et al. 2006; Goldstrohm, Seay et al. 
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2007; Hook, Goldstrohm et al. 2007), unique domains of Puf5p may dictate specificity for 
Eap1p.  
 
The physical association of Eap1p with Puf5p and the dependence of Puf5p for Eap1p 
interaction with HO mRNA support a model wherein Puf5p binds HO mRNA and recruits Eap1p 
(Fig. 3.8).  How might Eap1p be recruited?  We have not detected a direct protein interaction 
between Eap1p and Puf5p, which could be a purely technical issue as both full length proteins 
are difficult to purify.  Alternatively, a factor that bridges the interaction may exist.  Because 
Puf5p and Eap1p co-immunoprecipitate from extracts extensively treated with RNases, RNA is 
not a likely bridging factor (Fig. 3.6).  Decapping factors may interconnect Eap1p and Puf5p, 
because decapping proteins associate with both regulators (Fig. 3.6)(Goldstrohm, Hook et al. 
2006).  Future biochemical analysis of Eap1p and Puf5p complexes may illuminate this aspect.  
  
 Eap1p does not inhibit HO poly-ribosome association.  The discovery that Eap1p is 
necessary for Puf5p repression suggested a mechanism based on the existing model of 4E-BP 
molecular function: Puf5p recruitment of Eap1p may block translation initiation, thereby 
reducing loading of ribosomes onto target mRNAs.  If accurate, then HO mRNA should 
inefficiently associate with ribosomes, resulting in accumulation of HO mRNA in the ribosome 
free fractions of sucrose gradients.  Our findings contradict this hypothesis.  First, nearly all HO 
mRNA associates with poly-ribosomes in wild type cells, indicating efficient translation (Fig. 
3.2).  HO mRNA remains associated with poly-ribosomes when EAP1 is deleted.  Instead of the 
predicted increase in ribosome density, eap1 deletion slightly reduced the density of poly-
ribosome associated HO mRNA.  These findings argue against Eap1p mediated translational 
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inhibition of HO.  The predominant effect of eap1 deletion was to increase the total amount of 
HO mRNA and increase its half-life, pointing towards a role of Eap1p in promoting mRNA 
decay.  The small reduction of HO ribosome density caused by the absence of Eap1p may reflect 
the accumulation of HO mRNA with short poly(A) tails in the eap1 deletion strain (Fig. 3.5). 
  
 If Eap1p inhibits translation initiation, then Eap1p would be predicted to be found in 
ribosome-free fractions at the top of the sucrose gradient.  Contrary to this, a significant portion 
of Eap1p associates with poly-ribosomes (Fig. 3.3).  Because poly-ribosomal mRNAs have 
undergone multiple rounds of initiation, poly-ribosome associated Eap1p cannot have blocked 
initiation.  Our data indicate that interaction of Eap1p with eIF4E mediates its association with 
poly-ribosomes.  This conclusion is supported by the observation that eIF4E was distributed 
across the gradient, including poly-ribosome fractions (Fig. 3.3).  Furthermore, mutations in 
Eap1p that disrupt binding to eIF4E cause a complete loss of Eap1p poly-ribosome association 
(Fig. 3.3).  Currently the functional significance of poly-ribosomal Eap1p remains unknown. 
  
 Eap1p is also present in two other peaks of the sucrose gradient.  One peak, in the 
ribosome free fractions at the top of the gradient, increases upon EDTA treatment, ribosome run-
off, and mutation of the eIF4E binding motif (Fig. 3.3).  These observations indicate that this 
pool of Eap1p is not bound to ribosomes or eIF4E.  An Eap1p species with slower 
electrophoretic mobility is present in this peak, suggesting that Eap1p may be modified post-
translationally. This idea is supported by proteomic identification of multiple phosphorylation 
sites in Eap1p (Ptacek, Devgan et al. 2005).  Eap1p phosphorylation could block its interaction 
with eIF4E in manner similar to other 4E-BPs (Sonenberg and Hinnebusch 2009).  A third peak 
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of Eap1p cofractionates with 60S ribosomal subunits.  This peak shifts to the ribosome free 
fractions upon ribosome run-off and mutation of the eIF4E binding motif; therefore, it might 
represent an intermediate in translation.  Future biochemical analysis of Eap1p complexes will be 
necessary to understand their composition and functions. 
  
 Deletion of EAP1 does not alter global translation state, as deduced from the identical 
chromatograms of poly-ribosomes from wild type and eap1 deletion strains (Fig. 3.2)(Ibrahimo, 
Holmes et al. 2006).  This conclusion is supported by analysis of ribosome association of RNR1 
and RPL41A mRNAs, which like HO, were not inhibited by Eap1p.  That said, based on the 
available data, we do not exclude the prospect that specific mRNAs may be translationally 
inhibited by Eap1p.  In the study that identified Eap1p, an in vitro translation assay indicated that 
Eap1p inhibits translation (Cosentino, Schmelzle et al. 2000); however, the role of eIF4E binding 
and impact on mRNA stability were not addressed.  More recently, a micro-array based study 
found that deletion of EAP1 changed the translation state of 329 mRNAs by greater than 1.8 
fold, as measured by the ratio of mRNA in poly-ribosomes to mono-ribosomes.  Of these, the 
ratios of 176 mRNAs increased, suggesting that Eap1p inhibits their translation.  In our analysis 
of HO mRNA, deletion of EAP1 caused a 1.6 fold increase in poly- to mono-ribosome ratio; 
however, this change reflects the 1.7 fold increase in HO abundance.  Moreover, eap1 deletion 
did not increase HO ribosome occupancy and density (Fig. 3.2).  It remains to be investigated 
whether Eap1p and Puf5p function together to regulate additional mRNAs.  The mRNAs 
affected by eap1 deletion did not correlate with those the co-immunoprecipitate with Puf5p 
(Cridge, Castelli et al. 2010).  Cridge et al. also reported that deletion of EAP1 altered steady 
state levels of 99 mRNAs more than two-fold, and of these, 56 increased, hinting that Eap1p may 
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affect stability of additional mRNAs (Cridge, Castelli et al. 2010).  Whether the observed effects 
of eap1 deletion on translation state and mRNA levels are direct remains to be established.  
Germane to the challenge of discerning direct Eap1p effects from indirect effects, our 
demonstration that an Eap1p regulated mRNA (i.e. HO) coimmunoprecipitates with Eap1p 
provides proof of principle for future ribonomic approaches to identify Eap1p target mRNAs. 
  
 In summary, our findings do not support a role of Eap1p in inhibition of translation 
initiation of Puf5p targeted HO mRNA. Instead, our results argue that Eap1p elicits a mode of 
repression that is divergent from the canonical 4E-BP mechanism of translation inhibition. 
  
 Eap1p accelerates mRNA decay.  We discovered a novel function for Eap1p in 
promoting mRNA degradation.  Deletion of EAP1 stabilizes HO mRNA more than three-fold.  
Conversely, over-expression of Eap1p enhances decay of HO mRNA beyond that observed in 
wild type cells.  Targeting of HO by Eap1p is likely directed by Puf5p, a hypothesis supported 
by their mutual interdependence for repression (Fig. 1) and the finding that association of Eap1p 
with HO mRNA depends on Puf5p (Fig. 3.7). 
  
 Enhancement of mRNA decay by Eap1p is not likely to be solely dependent on Puf5p, 
because we also observed an effect on RNR1 mRNA, which is not regulated by Puf5p 
(Goldstrohm, Hook et al. 2006; Seay, Hook et al. 2006) and is not known to associate with other 
PUF proteins (Gerber, Herschlag et al. 2004).  The factors that control RNR1 mRNA remain to 
be discovered in future work.  Other mRNAs, such as RPL41A, are unaffected by Eap1p, 
suggesting that Eap1p-enhanced mRNA decay may be restricted to specific messages. 
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 Is the eIF4E binding activity of Eap1p necessary for mRNA degradation? An Eap1p 
mutant that cannot bind eIF4E exhibits half of the mRNA decay activity of wild type protein 
(Fig. 4); therefore, we conclude that binding to eIF4E facilitates, but is not essential for, Eap1p 
mRNA decay activity.  Binding to eIF4E could promote decay by displacing eIF4G (Cosentino, 
Schmelzle et al. 2000), destabilizing the eIF4E-5’ cap interaction and facilitating access of 
mRNA degradation enzymes (Fig. 3.8).  This idea is supported by data showing that mutations in 
translation initiation factors, including eIF4E and eIF4G, increase mRNA decay (Schwartz and 
Parker 1999).  However, our data also indicate that this explanation in itself is not sufficient.  
First, the Eap1p mutant does not bind eIF4E (Fig. 3.3), nor does it associate with poly-ribosomes 
(Fig. 3.3), yet it still stimulates mRNA decay (Fig. 3.4), albeit with reduced efficiency.  We 
interpret this as evidence that Eap1p promotes mRNA decay by another means, perhaps by 
affecting decapping (Fig. 3.8), as discussed below. 
  
 Eap1p promotes decapping.  Degradation of yeast mRNAs typically initiates by 
shortening of the poly(A) tail to an oligo-adenylated length, followed by decapping (Coller and 
Parker 2004; Goldstrohm and Wickens 2008).  Decapped mRNA is then rapidly degraded in by 
Xrn1p.  As Puf5p enhances deadenylation of HO mRNA, we examined the effect of Eap1p.  
Loss of Eap1p does not affect poly(A) removal, which occurs rapidly in both wild type and eap1 
deletion cells (Fig. 3.5).  Instead, Eap1p dramatically affects the fate of the oligo-adenylated 
intermediate.  In wild type cells this species is rapidly degraded, coincident with disappearance 
of the 5’ end of the mRNA (Fig. 3.5).  When EAP1 is deleted, the oligo-adenylated mRNA is 
highly stabilized, as is the 5’ end of HO (Fig. 3.5).  The oligo-adenylated HO that accumulates is 
resistant to Xrn1p and thus remains capped (Fig 3.5).  We conclude that Eap1p promotes 
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decapping of HO mRNA.  Our data support that HO is degraded by the 5’ decapping pathway; 
deletion of decapping factor genes greatly stabilize HO mRNA including ∆pat1, t1/2 = 55 
minutes, and ∆dcp2, t1/2 > 60 minutes (unpublished data) and ∆dhh1, t1/2 > 50 minutes (Fig. 
3.S3).  Additionally, accumulation of deadenylated, capped mRNA species is identical to the 
effect of mutations in decapping factors including Dhh1p (Fig. 3.S3), Pat1p, and the Lsm1-7p 
complex (Beelman, Stevens et al. 1996; Tharun, He et al. 2000; Coller, Tucker et al. 2001; 
Fischer and Weis 2002).  We note that deletion of genes encoding the 3’ to 5’ exosome complex 
did not increase HO mRNA levels (Fig. S4), nor abrogate Puf5p repression (Goldstrohm, Hook 
et al. 2006); therefore, the 3’ decay pathway does not impact HO mRNA degradation. 
  
 Eap1p associates with the decapping factor Dhh1p.  This finding suggests that Eap1p 
recruits decapping factors or alters their activity (Fig. 3.8).  Puf5p also associates with decapping 
factors including Dhh1p and Dcp1p (Goldstrohm, Hook et al. 2006).  These associations do not 
depend on RNA, indicating that the proteins were not simply tethered to the same mRNA, 
though the direct protein contacts remain to be delineated. 
  
 We propose a model of post-transcriptional regulation of HO mRNA that integrates past 
and new data (Fig. 3.8).  Both Puf4p and Puf5p bind to their respective recognition sequence in 
the 3’UTR of HO and recruit the Ccr4-Not complex via direct contact with the Pop2p subunit, 
thereby enhancing deadenylation.  Puf5p also recruits Eap1p and decapping factor Dhh1p and 
decapping enzyme Dcp2-Dcp1 to promote removal of the 5’ cap.  Eap1p binding to eIF4E 






Model of post-transcriptional regulation of HO mRNA by PUFs and Eap1p.  Puf4p and Puf5p bind to 
respective sites in the 3’UTR of HO mRNA.  Both proteins recruit the Pop2p-Ccr4p deadenylase complex to 
accelerate deadenylation.  Puf5p also recruits Eap1p and decapping factors Dhh1p and decapping enzyme 
Dcp1-Dcp2 to enhance decapping.  Eap1p interacts with 5’ cap bound eIF4E to facilitate mRNA decay.  
Direct protein interactions are shown by black lines.  Grey lines indicate protein associations; direct protein-





 Recent evidence indicates that mRNA decay can occur co-translationally on poly-
ribosomes (Hu, Sweet et al. 2009; Hu, Petzold et al. 2010).  It is tempting to speculate that decay 
of HO mRNA, promoted by Eap1p, might occur on poly-ribosomes; however, because eIF4E 
binding defective Eap1p retains partial activity but does not associate with poly-ribosomes, 
ribosome association is unlikely to be an essential feature. 
  
 Our analysis does not exclude the possibility that PUFs block translation by additional 
mechanisms.  Chritton et al. reported that the Puf5p inhibits translation of a capped, poly-
adenylated reporter mRNA  in vitro  (Chritton and Wickens 2010).  Eap1-mediated decapping 
87 
 
may account for the observed regulation.  Alternatively, Puf5p may have an independent direct 
effect on translation.  Dhh1p can inhibit translation (Coller and Parker 2005); therefore, Puf5p 
recruitment of Dhh1p may impact translation. 
  
 Do other 4E-BPs affect mRNA decay?  Multiple 4E-BPs have been identified in 
eukaryotes (Pause, Belsham et al. 1994; Mader, Lee et al. 1995; Altmann, Schmitz et al. 1997; 
Poulin, Gingras et al. 1998; Stebbins-Boaz, Cao et al. 1999; Cosentino, Schmelzle et al. 2000; 
Wilhelm, Hilton et al. 2003; Matsuo, Muramatsu et al. 2004; Nakamura, Sato et al. 2004; 
Nelson, Leidal et al. 2004; Ferraiuolo, Basak et al. 2005; Jung, Lorenz et al. 2006).  The finding 
that Eap1p is required for repression by Puf5p is reminiscent of other examples wherein an RNA 
binding protein utilizes a 4E-BP to repress an mRNA (Stebbins-Boaz, Cao et al. 1999; Wilhelm, 
Hilton et al. 2003; Nakamura, Sato et al. 2004; Nelson, Leidal et al. 2004; Sonenberg and 
Hinnebusch 2009).  In these cases, translation inhibition is thought to be the means of repression.  
Our results showing that Eap1p enhanced decay and decapping were therefore unanticipated in 
the context of current understanding of 4E-BP repression.  Furthermore, Puf5p may not be the 
only RNA binding factor to use Eap1p as a co-repressor, as the yeast Vts1p protein employs 
Eap1p to enhance mRNA decay (Craig Smibert, University of Toronto, personal 
communication). 
  
 Additional clues are emerging that implicate specific 4E-BPs as versatile regulators that 
can influence steps of gene expression other than translation initiation.  The human eIF4E-
Transporter was implicated in the destabilization of ARE-containing mRNAs (Ferraiuolo, Basak 
et al. 2005).  A recent analysis of the Drosophila 4E-BP, Cup, found that it represses mRNAs by 
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specifically enhancing deadenylation (Igreja and Izaurralde 2011).  Interestingly, Cup 
subsequently stabilizes the deadenylated mRNA by blocking decapping (Igreja and Izaurralde 
2011).  These findings suggest the exciting possibility that each 4E-BP may have unique 
activities to control translation, localization, and degradation of distinct groups of mRNAs. 
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3.4 MATERIALS AND METHODS 
 Yeast strains.  Yeast strains were obtained from Open Biosystems unless otherwise 
noted. 
AGY111: BY4741 Mata his3∆1 leu2∆0 met15∆0 ura3∆0 
AGY153: BY4741 Mata eap1::KanR 
AGY152: BY4741 Mata caf20::KanR 
AGY150: BY4741 Mata puf5::KanR 
AGY109: BY4741 Mata puf4::KanR 
AGY151: BY4741 Mata dhh1::KanR 
  
 Plasmids. 
ACG858: YCp33 HIS3 HO 3’UTR was previously described by Goldstrohm et al, 2006. 
ACG399:YCp33 LacZ HO 3’UTR was derived from ACG858 by replacing the HIS3 open 
reading frame with the coding sequence for β-galactosidase. 
ACG441: YEp181 PUF5-T7 was previously described by Goldstrohm et al, 2006. 
ACG705: p415 GPD PUF4-T7 was previously described by Hook et al, 2007. 
ACG137: pACG1 NTB contains the ADH1 promoter and 3’UTR.  The plasmid has a 2μ origin 
of replication and Zeocin selectable marker. 
ACG693: pACG1 NTB-EAP1 was created by inserting the EAP1 open reading frame into Kpn1 
and Not1 sites in pACG1 NTB. 
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NB1: YEp181 EAP1-FLAG:  EAP1 was PCR-amplified from S288C genomic DNA, and cloned 
into Xma1 sites of YEp181.   The C-terminal FLAG epitope was added by inverse PCR using 
primers NB85/86.    
NB2: YEp181 EAP1 mt Y109A/L114A-FLAG:  Quickchange PCR (Stratagene) was performed 
on plasmid NB1 with primers AG787/788 to mutate Y109A and L114A.   
NB3: pACG1-eIF4E-T7:  The CDC33 ORF, encoding eIF4E, was PCR-amplified from S288C 
genomic DNA, and cloned into KpnI and NotI sites of pACG1 plasmid.  All plasmids were 
verified by restriction digests and DNA sequencing. 
Oligonucleotides. 
Synthetic oligonucleotides were purchased from Integrated DNA technologies. 































NB115: 5’- CATCAGCCGCTACAGTCAACAGCAA-3’ 
HO 3’UTR RNase H cleavage: 
NB99: 5’-ATACAGTGATGACCGCTG-3’ 













HO qRT-PCR primers: 
NB36: 5’-CCTCATAAGCAGCAATCAATTCTATCTAT-3’ 
NB90: 5’-TTTAATTTCACCGTTAGCCATCAGAA-3’ 
18S rRNA qRT-PCR primers: 
NB69: 5’-ACGGAAGGGCACCACCA-3’ 
NB70: 5’-CCACCCACAAAATCAAGAAAGAGCTCTC-3’ 
PUF repression assay.   Yeast growth assays were performed to detect repression by Puf4p and 
Puf5p as described in Goldstrohm et al, 2006, with the following modifications.  Wild type yeast 
strain BY4741 or gene-specific deletion strains were transformed with the reporter gene YCp33 
HOp HIS3-HO 3’UTR and either empty vector YEp181 or the PUF5 expression plasmid 
YEp181 PUF5 or p415 GPD PUF4.  Colonies were isolated and grown to mid-log phase at 30⁰C 
and the indicated number of cells was spotted onto selective minimal media with or without 
histidine. The His3p competitive inhibitor 3-aminotriazole was added at 1 mM final 
concentration to increase stringency.  For assays presented in Figure 1C, media was 
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supplemented with 300 µg/ml Zeocin to select for pACG1 NTB EAP1 or the negative control 
plasmid pACG1.  
β-galactosidase reporter assay.  Wild type or gene specific deletion strains were transformed 
with the YCp33 LacZ-HO3’UTR reporter gene.  Each strain was then grown to mid log phase 
and 3 O.D. units (8.9 x 10^7 cells) from each sample were harvested and resuspended in 100 µl 
of fresh media.  An equal volume of room temp Beta-Glo (Promega) reagent was added to each 
tube.  Samples were transferred to 96-well plate and incubated for 1 hour at 25⁰C.  
Luminescence measurements were made using a GloMax Multi+ detection system (Promega).  
Specific signals were 2 orders of magnitude above the background measured with Beta-Glo 
reagent, media or empty wells.  Each assay was performed with five biological replicates and 
data are plotted as the mean value of relative light units with standard error of the mean. 
Poly-ribosome fractionation.  Yeast cultures were seeded in 250 mL of the appropriate media 
at an Optical Density at 600nm (OD600 nm) of 0.2 and grown to an OD600 nm of 0.8.  Cells were 
rapidly harvested at 4°C and all subsequent steps were carried out in a cold room.  When 
indicated, cycloheximide (60 μg/ml) or EDTA (50 mM) was added to cultures, which were 
immediately poured into cold centrifuge bottles with one-third volume of crushed ice.  Cells 
were pelleted for five minutes at 3200 x g.  Media was decanted, cells were washed with 10 ml 
ice-cold 50 mM Tris-Cl pH 6.8, 100 mM NaCl, 30 mM MgCl2, and 50 µg/ml cycloheximide, (or 
when indicated, 50 mM EDTA was added in lieu of cycloheximide).  Cells were pelleted again 
and resuspended in 650 μl ice-cold 50 mM Tris-Cl pH 6.8, 100 mM NaCl, 30 mM MgCl2, and 
50 µg/ml cycloheximide, (or 50 mM EDTA was added in lieu of cycloheximide) with 20 
Units/mL RNasin, and 2X protease inhibitors (2 mM PMSF, 100 μg/mL aprotinin, 100 μg/mL 
pepstatin, 100 μg/mL leupeptin) in 1.5 mL tubes containing 650 μl glass beads.  Cells were lysed 
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in a FastPrep (MP) 2 times for 60 seconds at 6.5 m/s.  Cell debris and beads were removed from 
the extract by centrifugation for 5 minutes at 1400 x g.  The extracts were diluted 1/200 and the 
absorbance at 260 nm (A260nm) was measured with a NanoDrop spectrophotometer (Thermo 
Scientific).   Twenty A260nm units of extract were loaded onto each sucrose gradient.  Ribosome 
run-off was performed as above, except that cycloheximide was omitted from all steps.   
To fractionate ribosomes and poly-ribosomes, 7-47% sucrose gradients were prepared using a 
Gradient Master (BioComp).  Samples were applied to the top of each gradient.  For Figure 2, 
gradients were centrifuged 2 hours and 30 minutes at 28,000 rpm in an SW41 Ti rotor at 4°C.  
For Figure 3, gradients were centrifuged 4 hours to resolve 40S, 60S, 80S, and poly-ribosome 
peaks. Gradients were fractionated using a Biologic DuoFlow system with an Econo Gradient 
peristaltic pump (Bio-Rad) at a rate of 1.75 ml/min. while collecting 500 μl fractions.  Gradient 
tubes were pierced with a gradient fractionation device (Brandel), and gradients pumped from 
the bottom of the tube using Fluorinert.  A260nm readings were made continuously during 
fractionation using a Bio-Rad Quadtec spectrophotometer.  Samples were stored at -80°C after 
fractionation.  RNA was extracted from a total of 460 μl of each gradient fraction using the 
Maxwell RNA purification system and 16 cell LEV RNA purification kit (Promega).  The 
percentage of each mRNA in each fraction was calculated relative to the total detected by 
northern blot in all fractions.  Values from each fraction were represented as the mean value of 
multiple replicates.  For western blot analysis of fractions, 45 μl of each fraction was boiled 5 
minutes in 1xSDS-PAGE loading buffer and then separated in a 4-12% SDS-PAGE. 
Northern blotting.  RNAs was separated on 1.4% agarose - formaldehyde denaturing gels with 
1x MOPS running buffer and transferred to Immobilon NY+ membrane (Millipore) using 
downward transfer method.  Membranes were UV cross linked with a UVP CL1000.  Membrane 
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blocking and hybridization was performed using oligo-hyb or ultra-hyb buffers (Ambion).  End-
labeled oligonucleotide probes were hybridized in oligo-hyb buffer, overnight at 42°C, and 
washed 2 x 30 minutes in 2X SSC with 0.5% SDS at 42°C.  Body-labeled riboprobes for HO 
mRNA were hybridized in ultra-hyb at 68°C, and washed 2 x 5 minutes in 2X SSC with 0.1% 
SDS, then 2 x 15 minutes in 0.1X SSC with 0.1%SDS at 68°C.  Membranes were exposed to 
phosphor screens and scanned using a Typhoon Trio phosphorimager (General Electric). 
Measurement of mRNA half-life.  Transcription shut-off using thiolutin (Pfizer) and RNA 
purification was performed as described previously (Blewett, Coller et al. 2011).  Specific 
northern blot bands were quantitated on a Typhoon phosphorimager using ImageQuant TL 
software.  Each time point was normalized to the SCR1 RNA in that same sample and decay was 
calculated relative to the time of drug addition.  mRNA half-lives were calculated with GraphPad 
Prism software using non-linear regression, one-phase decay analysis of biological replicate 
samples. 
Poly-adenosine tail length analysis.  Forty micrograms of total RNA was first treated with 
Turbo DNase (Ambion).  RNA was precipitated with 1/10 volume 3M sodium acetate and 3 
volumes of 100% ethanol at -20°C.  Pellets were washed with 70% ethanol and resuspended in 
24 μl Buffer A (20 mM KCl, 1 mM EDTA), 20 pmol of cleavage oligonucleotide NB99, and 
either 5 μl of water, or 5 μl of oligo dT (500 ng/ul).   Samples were heated 5 minutes at 90°C, 
then cooled for 5 minutes at 65°C, then 20 minutes at room temperature.  To each sample, 30 μl 
of Buffer B (40 mM Tris-Cl pH8.0, 56 mM MgCl2) was added, along with 1 unit of RNase H 
(NEB), and 1 unit of RNasin Plus (Promega).  Samples were incubated for 1 hour at 37°C. RNA 
was then precipitated with 1/10 volume 3M sodium acetate, and 3 volumes ethanol at -20°C.  
RNA pellets were washed with 70% ethanol and resuspended in denaturing polyacrylamide 
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northern loading buffer.  After heating for 5 minutes at 95°C, the RNA was separated in a 6% 
polyacrylamide, 7M urea denaturing gel and transferred to Immobilon NY+ with a transblotter 
(Bio-Rad). Northern blots were performed as described above. 
Xrn1 sensitivity assay.  20 μg of total RNA extracted from wild type and eap1 strains was used 
for each reaction.  Where indicated, control samples were treated with 15 units of Tobacco Acid 
Pyrophosphatase (Epicentre) to remove 5’ cap structures using the supplied TAP reaction buffer 
for 1 hour at 37°C.  RNA was precipitated, pelleted and washed with 70% ethanol.  RNA was 
then digested with 10 units of Xrn1 (NEB) in reaction buffer with 1 unit RNase Inhibitor Plus for 
1 hour at 37°C.  The RNA was precipitated, washed with 70% ethanol, and resuspended in 
northern loading buffer. 
Protein co-immunoprecipitation.  Yeast expressing FLAG-EAP1, or empty vector (mock) as 
bait, and T7-tagged prey were grown overnight in appropriate media.  The next day yeast were 
seeded to an optical density, OD600 nm, of 0.2 in 1L of media and then grown to OD600 nm 0.8. 
Cells were then harvested, washed with TNMT250 (50 mM Tris-Cl pH 8.0, 250 mM NaCl, 2 
mM MgCl2 , 0.1% Tween-20), pelleted and stored at -80°C.   Anti-FLAG M2 agarose (Sigma), 
50 μl bed volume of beads, was pre-equilibrated in 10 ml TNMT250 with 300 μg/ml denatured 
salmon sperm DNA and 500 μg/ml BSA for 1 hour at 4°C.  Beads were then washed twice for 10 
minutes with TNMT250.  Cell pellets were thawed on ice, suspended in an equal volume of 
TNMT250 with 10 μg RNase A (Fermentas), 100 units of RNase One (Promega), and 2 x 
protease inhibitors. Cells were transferred to 15 ml tubes containing 700 μl acid-washed glass 
beads.  Lysis was performed with a FastPrep (MP) with three 60 second pulses at 6.5 m/s.  Cell 
debris was pelleted 10 min. at 6000 x g, supernatant was removed to fresh tube, and pelleted 10 
min again at 12000 x g.  The resulting lysate was pre-cleared by incubation with IgG-agarose to 
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remove non-specific interactions.  After pre-clearing, RNase-treated lysates were applied to 
Anti-FLAG M2 affinity agarose (Sigma) and incubated for 2 hours at 4°C.   Beads were pelleted 
5 min. at 1000 x g, supernatant was removed, and beads were washed 5 times for 15 minutes 
with 10 mL TNMT250.  After final wash, beads were transferred to a microfuge tube.  Beads 
were resuspended in 100 μl of TNMT250 and 150 ng of FLAG peptide (Sigma).  Elution was 
performed 30 minutes at 4°C with end-over-end rotation. After incubation, the supernatant was 
passed through a Bio-Rad mini-spin column to remove beads.  Eluates were then separated by 4-
12% SDS-PAGE gels and probed with anti-FLAG antibody (Sigma) and anti-mouse HRP 
conjugate monoclonal antibody (Thermo Scientific), anti-T7 monoclonal antibody linked to HRP 
(Novagen), or anti-Actin monoclonal antibody (MP Biomedical). 
RNA co-immunoprecipitation.  Co-immunoprecipitation of mRNA with Eap1p was performed 
as described above, with the following alterations.  Yeast were lysed in TKNM140 buffer (40 
mM Tris-Cl pH 8.0, 140 mM KCl, 0.1% NP-40, 2 mM MgCl2, 40 units/ml RNasin Plus with 2X 
protease inhibitors).  Beads were washed 5 x 10 min. in TKNM140, then protein and RNA were 
eluted as above with 150 ng of FLAG peptide. 
Quantitative PCR detection of HO mRNA immunoprecipitation.   Input and elution samples 
were first treated with 4 units of Turbo DNase (Ambion) in 1X Turbo buffer at 37°C for 30 
minutes.  RNA was precipitated with 1/10 volume sodium acetate and 3 volumes ethanol 1 hour 
at -20°C and pellets were washed with 70% ethanol.  qRT-PCR was carried out as described 
previously (Blewett, Coller et al. 2011).  Briefly, HO cDNA was generated with GoScript 
Reverse Transcriptase (Promega) using 20 pmol of primer NB90.  Amplification of PCR 
products was measured using GoTaq qPCR master mix (Promega) with 200 nM of each primer 
in 50 µL reactions. A Bio-Rad CFX 96 C1000 real-time PCR instrument was used for all assays.  
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Each immunoprecipitation was performed in triplicate and the elution C(t) was normalized to 
HO input C(t) for each sample.  Fold enrichment was then calculated relative to the mock 
immunoprecipitation samples using the ∆∆C(t) method (Livak and Schmittgen 2001; Schmittgen 

























 Northern blot detection of wild type and mutant LacZ-HO reporter mRNAs in wild type (WT), eap1 
deletion, and puf5 deletion strains. SCR1 RNA was also detected as to normalize for variations in 
sample loading. To resolve poly(A) tail lengths of the reporter, the mRNA was cleaved with RNase H 
and a specific oligonucleotide. RNA was then separated by denaturing poly-acrylamide gel 
electrophoresis and detected with a specific northern probe. Three biological replicates were analyzed 
for each test condition. 
 
 

























 Fig. S2. Dissociation of poly-ribosomes causes HO mRNA to shift to the top of the gradient. Cell 
extract from wild type yeast was treated with EDTA to dissociate poly-ribosomes and then fractionated 
by sucrose density gradient. The chromatogram is shown in the top panel. Northern blot of HO mRNA 







 Deletion of DHH1 gene causes accumulation of deadenylated, decapped HO mRNA. Thiolutin was 
used to inhibit transcription and samples were collected over a time course, indicated at the top. HO 
mRNA was cleaved with RNAse H as shown in Fig. 5A. Northern blot was probed to detect the 3’ end 






























Mechanisms of mRNA Regulation by D. melanogaster Pumilio 
Work in this chapter was accomplished through collaboration with Chase Weidmann.  C.W. 
performed drosphila cell culture, transfections, and luminescent assays. 
  
 4.1 Introduction:  Pumilio (PUM) is the founding member of the PUF protein family, its 
function has been studied extensively in the developing fly through genetic identification of 
factors involved in PUM regulation of the anterior-posterior body axis (Lehmann and Nusslein-
Volhard 1991; Barker, Wang et al. 1992; Cho, Gamberi et al. 2006), as well as through more 
direct biochemical analysis to identify the conserved high-affinity PUM Recognition Element 
(PRE)(Zamore, Bartel et al. 1999).  The majority of this work has been performed at the level of 
the whole organism, or in vitro, which highlights the need for mechanistic dissection of PUM-
mediated repression to define what co-factors contribute to, and are necessary for PUM 
repression in vivo. 
 
 The PUM RNA Binding Domain (RBD) is highly conserved in all eukaryotes studied, as 
such; much effort has been put into defining a conserved mode of repression via the PUM RBD.  
Over the last twenty years there has been significant debate over the mechanism of repression, 
proposed mechanisms range from: recruitment of proteins which inhibit translation initiation, 
recruitment of the deadenylase machinery and mRNA decay machinery, deadenylation-mediated 
translation repression, and most recently, inhibition of translation elongation.  The mechanism 
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involving elongation proposes a requirement for the microRNA (miRNA) pathway Argonaute 
(Ago) proteins.  Traditionally miRNA repression involves Ago, and several other factors that 
complex with a 22-23nt RNA that directs the complex to specific mRNAs via base-pairing 
between the miRNA, and target mRNA.   
  
 In the case of RBD-Ago mediated repression, the authors suggest that the miRNA 
pathway is not involved.  Along with the proposed Ago association, both nematode FBF-1 and 
human PUM2 were shown to associate with orthologues of the translation elongation factor 
eEF1A; eEF1A hydrolyzes GTP during ribosome translocation and this promotes elongation.  In 
vitro GTP hydrolysis, as well as separate translation assays indicated that the RBD inhibits GTP 
hydrolysis and that the RBD causes ribosomes to stall immediately after initiation.  This work 
also identified conserved residues in the RBD that are required for interaction with Ago and 
eEF1A respectively.  Repression was exerted on both polyadenylated and non-adenylated 
targets; this suggests the mechanism of repression does not require deadenylation.   
  
 Arguing for an alternate mechanism of repression is work by Weidmann et. al., 2012, 
which showed in a drosophila S2 cell culture model, that the conserved PUM RBD represses 
target mRNA expression via an unknown mechanism involving reduction of reporter mRNA 
levels.  Work in drosophila embryos indicates that PUM represses the hb mRNA via repression 
of translation through association with two factors: Brat and 4EHP.  Brat is an NHL domain 
protein that has been implicated in post-transcriptional mRNA regulation, but little is known 
about the mechanism (Slack 2000).  4EHP is similar to eIF-4E in that it specifically binds the 5' 
cap, unlike eIF-4E, 4EHP doesn't bind eIF-4G and instead forms a complex on the 5' cap that 
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represses translation initiation.  Both Brat, and 4EHP mutant flies exhibit defects in Hunchback 
gradient formation.  Also, PUM binding to a PBE in an mRNA has the ability to form a ternary 
complex with Brat and 4EHP (Sonoda, Wharton 2001) (Cho Sonenberg, 2006) (Weidmann and 
Goldstrohm 2012).  Traditionally, much of PUMs’ repressive activity has been thought to occur 
through inhibition of translation, but the story may be more complicated than one single 
pathway(Parisi and Lin 2000).   
  
 We report here that the conserved PUM RBD does not require Ago or eEF1A, but rather 
accelerates deadenylation through a Poly(A) Binding Protein (Pabp)-dependent mechanism.  
Interestingly, while Pabp promotes RBD activated deadenylation, the repressive activity of Pabp 
appears to function at the level of translational inhibition, at step preceding deadenylation.  
Furthermore, we demonstrate that deadenylation of a PUM-targeted mRNA is catalyzed by the 
Ccr4-Pop2 complex.  We also found that mRNA decapping is involved in PUM-activated 
mRNA decay as well as repression. In summary, our data suggest that post-transcriptional 
repression by the PUF RBD is exerted through inhibition of translation via PABP, which then 













 The PUM RBD, and Mutant RBDs that Abolish Ago and eEF1A-Binding all Reduce 
Reporter mRNA Levels to Similar Extent:  The PUM RBD was previously shown to reduce 
reporter mRNA levels via qRT-PCR(Weidmann and Goldstrohm 2012), we first sought to 
monitor the ability of the RBD to reduce reporter mRNA levels, testing mutations in the RBD 
that were reported to abrogate binding to Ago and eEF1A respectively.  Reporter mRNA levels 
were quantified via northern analysis, and reporter protein output was monitored with the 
DualGlo luciferase assay, a quantitative luminescence assay.  To assess PUM repression of the 
PBE, reporter constructs expressing PUM-targeted Renilla luciferase and a control firefly 
luciferase are transfected with a PUM RBD expression vector.  Percent repression is calculated 
by normalizing the PUM-targeted renilla luciferase to the untargeted firefly luciferase 
luminescence, after normalization the normalized relative response ratio is then divided by the 
normalized renilla signal from samples that were transfected a PUM RBD mutant which is 
unable to bind RNA and repress.  This allows quantitation of the specific repressive effects 
generated from PUM RBD binding to the targeted reporter mRNA.   
  
 To test the involvement of Ago and eEF1A, mutations were made on conserved residues 
in the PUM RBD that are required for binding to Ago and eEF1A respectively.   Plasmids were 
transfected that express either wild-type PUM RBD, a Threonine to Glutamic Acid mutation 
(T752E Ago binding defective, or a phenalanine to arginine mutation that disrupts binding to 





PUM RBD and Mutant RBDs Each Reduce Reporter Levels.  A) Northern blot, assaying the levels of 
RnLuc3XPRE mRNAin response to RBD and mutant RBD expression,  and the loading control 7SL 
ncRNA.  B)  Dual Glo luminescence assay from four biological replicates.  Renilla-PRE luminescence 
was normalized to control Firefly, the % repression was calculated relative to R7mut expression.   
(R7mut); destroys the ability of the RBD to bind its’ target sequence, inactivating repression.  
Two days post-transfection, the cells were harvested, and aliquots were removed to perform the 
DualGlo luciferase assay.  Repression relative to R7mut expression was compared between the 
Ago binding mutant, eEF1A binding mutant and wild-type RBD.  RNA was also extracted from 












Figure 4.1A shows that expression of the PUM RBD, as well as both the Ago and eEF1A 
binding defective mutants all reduce reporter mRNA levels.  Figure 3.1B shows the percent 
repression of PUM-targeted reporter for each mutant.  This also showed that repression at the 
level of protein is robust for the RBD mutants which cannot bind Ago, or eEF1A respectively.  
To further test the involvement of Ago-1 and Ago-2, they were knocked-down via double-
stranded siRNA, and the ability of the RBD repress was monitored via luminescent assay.  
Again, in the case of both ago-1 and ago-2 knock-down, the RBD consistently repressed the 
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reporter to the same extent, demonstrating that 80% reduction of Ago does not impair PUM 
RBD-mediated repression(data not shown).  Because mutants which are unable to bind Ago or 
eEF1A, and siRNA knock-down of Ago had no impact of RBD-mediated repression we 
conclude that Ago and eEF1A are not required for PUM repression in vivo. These results also 
indicate that repression via the PUM RBD may be exerted at the level of mRNA destruction, 
rather than a translational mechanism as suggested above.  However, these results only show that 
a reduction in mRNA levels is correlated with the reduction in reporter luminescence; it is 
possible that PUM is inhibiting translation of the reporter, leading to its’ destabilization. 
  
 The PUM RNA Binding Domain Activates Reporter mRNA Deadenylation:    
 The degradation of most mRNAs is initiated primarily through removal of the poly(A) 
tail, this is usually followed by decapping and 5’-3’ destruction of the message.  PUF proteins 
are known to associate with deadenylases in other organisms, and have been demonstrated to 
increase the rate of deadenylation on targeted mRNAs.  We asked whether this mechanism is 
conserved by the drosophila PUM RBD and accounts for the PUM-RBD mediated reduction in 
mRNA levels.  To begin to address this question, empty vector, the R7mut, or RBD were 
expressed along with either wild-type or a mutant 3X-PBE which the first UGU is mutated to 
ACA abolishing RBD recognition.  The poly(A) tail status of the reporter was then assessed via 
Rnase H cleavage of the message, directed with a DNA oligonucleotide, to liberate a 500 nt 3’ 
cleavage product.  RNA was separated in a high-resolution polyacrylamide gel, and probed for 






Figure 2. The PUM RBD Binds the 3X PRE and Activates Deadenylation.  Empty vector, 
R7mut and RBD were transfected along with wild-type PRE reporter, or a reporter in which the 
PBE is mutated to abolish PUMs ability to recognize the target.  This was followed by RNase H 
cleavage of the reporter mRNA and high-resolution PAGE, RNAs were detected with probes 
specific for the transcripts indicated.  The A0 sample was generated using the same oligo to cleave, 
in addition to oligo dT to cause the degradation of the poly(A) tail by RNase H in vitro. 
 It should be noted that there is a small amount of endogenous Pumilio expressed in D. 
melanogaster S2 cells, however, optimal repression by the PUM RBD requires higher expression 
levels(Weidmann and Goldstrohm 2012); Figure 3.2 shows that there is a some amount of 
activity coming from endogenous PUM  (compare empty vector with wild-type PBE vs. empty 
vector with mutant PBE, Figure 3.2).  Mutation of the PBE abolishes PUM binding to the 
reporter, and this results in a dramatic stabilization of the poly(A) tail when compared to the 
wild-type PBE reporter.  Expression of the RBD results in an increase of deadenylated reporter 
mRNA, and a decrease in fully-adenylated mRNA; this is consistent with the PUM RBD 
















 The PUM RBD Accelerates the Rate of Poly(A) Tail Removal:  We next asked 
whether the RBD in fact increases the rate of deadenylation for a target mRNA.  To do this, we 
expressed R7mut or the RBD along with the 3X-PBE reporter, and transcription was inhibited 
via addition of Actinomycin D.  An aliquot of cells was taken immediately after drug addition 
and frozen, and then time points were taken at half-hour intervals out to two hours.  RNA was 
extracted from these time points, cleaved with Rnase H and the poly(A) status of the reporter 
mRNA was monitored via northern blot.  Figure 3 shows that very little deadenylation occurs on 
the reporter when the R7mut is expressed.  Expression of the wild-type PUM RBD results in a 
dramatic acceleration of deadenylation, where the reporter is nearly fully deadenylated at the 1.5 
hour time point; this result demonstrates that the PUM RBD accelerates the rate of deadenylation 













Figure 3. The PUM RBD Accelerates the Rate of Deadenylation.  S2 cells expressing the 
3X-PRE reporter and wild-type RBD or R7mut were treated with the inhibitor of transcription, 
actinomycin D.  An aliquot of cells was taken immediately after drug was administered, and at 
the time points indicated.  RNA was extracted, and the PBE reporter cleaved with RNase H as 






Figure 4. CCR4/POP2 are Important for PUM RBD-Mediated Deadenylation.  A) siRNAs targeting CCR4 
and POP2, or a non-targeting siRNA were transfected along with PUM RBD and the 3X PBE reporter in to S2 
cells.  2 days post-transfection RNA was harvested, cleaved with Rnase H as described above, and separated 
with high-resolution PAGE. B) Is same gel with a higher gain level to visualize the reporter at a much lower 
level, due to PUM RBD mediated  deadenylation and degradation. 
 Activation of Deadenylation:    The enzyme in D. melanogaster that is responsible for 
the bulk of cytoplasmic deadenylation is Pop2, and its’ associated co-factor Ccr4.  In S. 
cerevisaie, Puf5p has been demonstrated to bind to Pop2p, also in drosophila PUM is able to 
bind to Pop2 (Kadyrova 2007), so we chose to test whether the Ccr4/Pop2 complex was involved 
in RBD-mediated activation of deadenylation in S2 cells.  To ask this question S2 cells were 
bathed in double stranded RNAs that target ccr4 and pop2 respectively, or non-targeting 
siRNAs, which should have no effect.  R7mut or RBD were also expressed along with the 3X-
PBE reporter, and transcription was inhibited using Actinomycin D to monitor deadenylation 
over time.  Figure 4.4 shows that siRNA knock-down of ccr4/pop2 results in a dramatic 3-4 fold 
increase in the reporter mRNA at the zero time point, strongly suggesting that deadenylation via 
Ccr4/Pop2 is important for the decay of this message.  RBD expression in the context of the non- 
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targeting siRNA showed robust activation of deadenylation as shown in figure 4.3, however, 
knock-down of ccr4/pop2 resulted in an almost complete inhibition of deadenylation mediated 
by the PUM RBD; these results show that the PUM RBD is utilizing the Ccr4/Pop2 complex to 
activate deadenylation. 
  
 Decapping and Deadenylation are Involved in PUM-Mediated Degradation of the 
Reporter mRNA:  The above result suggested that the canonical decay pathway involving 
deadenylation activated decapping and 5’ – 3’ degradation may be the pathway to destruction for 
a PUM-targeted mRNA.  To test this, ccr4/pop2, and the decapping co-factor dcp1 were knocked 
down individually, and in combination to determine the relative inputs of deadenylation and 
decapping on the PUM reporter mRNA.  It is important to note that siRNA knock-down is not 
100% effective; however knock-down efficiency was monitored at the mRNA level, and 
routinely reduced mRNA levels for targets by 80-90%.  Also, knock-down of dcp2 has been 
difficult, however, Dcp1 which catalytically activates Dcp2, and couples decapping to 5’-3’ 
degradation, can be knocked-down.  Figure 5 confirms that knock-down of ccr4/pop2 does result 
in a 4 fold increase in the mRNA level; strikingly PUM RBD expression still reduces the level of 
the reporter by 27% (Figure 4.5, lane 3 vs. lane 4).  Knock-down of dcp1 resulted in a 2-fold 
increase in mRNA levels, and in this case the RBD was slightly impaired in its’ ability to reduce 
the reporter levels.  ccr4/pop2 and dcp1 simultaneous knock-down caused an additive 10-fold 
increase in reporter mRNA levels, and the PUM RBD was only able to reduce the mRNA levels 
by 21%, compared to 30% in the non-targeting control siRNA.  Taken together, these results 
indicate that decapping may play a role in the regulation of PUM-targeted mRNA levels, and that 





Figure 5.  Deadenylation and Decapping Contribute to PUM RBD Mediated mRNA Degradation.  Either 
non-targeting, or siRNAs targeting the indicated factors were transfected with with R7mut, or RBD and the 
3XPRE reporter.  RNA was harvested and separated on agarose MOPS/formaldehyde gel and probed for the 
indicated RNAs.  The middle panel is the same gel as top panel with higher exposure level again to allow 
visualization of the lower abundance lanes. 
 
still occurring, and the knock-down does not remove all target enzyme, given the inhibited 
ability of the PUM RBD to cause reporter mRNA degradation in the context of dcp1 knock-
down.  
  
 We conclude that decapping is potentially involved in RBD-mediated regulation of target 
mRNA levels.  Knock-down of the decapping and deadenylation machinery together impaired 
the ability of the RBD to reduce mRNA levels, however, percent repression of reporter protein 
remains at 27%, this may suggest that the PUM RBD is capable of exerting translational 
repression as well as activating mRNA decay.  Removal of the poly(A) tail is known to result in 
decreased translation (Wiederhold and Passmore 2010), so it is likely that RBD-mediated 
112 
 
acceleration of deadenylation results in decreased translational efficiency for the reporter, and 
the RBD is also activating downstream decay steps which also serve to reduce protein output 
through reduction in mRNA levels.  It is also possible that the 3' -5' decay pathway is important 
for PUM RBD repression 
  
 Poly(A) Binding Protein is Required for PUM RBD-Mediated Deadenylation and 
Contributes Strongly to Overall Repression at the Level of Protein Output:  Several lines of 
evidence led us to question whether Pabp might be involved in repression by the PUM RBD.  In 
S. cerevisiae, Pab1p has been reported to bind internal poly(A) tracts and be important for the 
ability of PUF5 to repress the expression of reporter mRNAs in an in vitro translation extract 
(Chritton and Wickens 2011).  Also, mammalian miRNA-mediated repression of targets has 
recently been demonstrated to involve deadenylation, and the recruitment of PABP was shown to 
be important for repression (Fabian, Mathonnet et al. 2009).  To test the involvement of Pabp in 
RBD-mediated repression, pAbp-targeting dsRNAs were used, and either the R7mut, or RBD 
expression constructs were transfected along with the 3XPBE reporter.  Cultures were treated 
with Actinomycin D to inhibit transcription, and deadenylation was monitored over a 2 hour time 
course as above. 
 
Remarkably, pAbp knock-down completely abolished acceleration of deadenylation by 
the PUM RBD.  There is no discernible difference in the rate of poly(A) tail removal comparing 
R7mut expression to RBD expression; this strongly implies a role for pAbp in the execution of 
RBD-mediated deadenylation.  We also assayed the repression at the level of reporter protein 





PABP is Required for RBD-mediated Acceleration of Deadenylation, and Contributes Strongly to 
Repression by PUM.  A) siRNAs targeting PABP were transfected along with the 3X PRE reporter and either 
the R7mut, or RBD.  Rnase H cleavage was performed and the RNAs indicated were analyzed via high-
resolution northern blot.  B)  Dual-Glo luminenscence assay from biological quadruplicate samples.  Renilla-
3XPRE signal was normalized to non-regulated Firefly luciferase signal, then reduction in reporter output was 
calculated relative to R7mut expression.  S.E.M. is plotted to indicate error. 
As seen previously, ccr4/pop2 knock-down had no effect on the ability of the RBD to reduce 
reporter protein output.  Remarkably, knock-down of pAbp resulted in a 50% loss of repression  
 
by the RBD at the protein level; the RBD reduced protein output by 30% in the non-targeting 
control and only 12% with PABP knock-down.  As knock-down is not completely effective, and 
Pabp is fairly abundant, is possible that the residual repression by the RBD is still coming 
through Pabp-mediated effects.  Alternatively, it is equally possible that there remain additional 
effectors that the PUM RBD utilizes to direct repression, it is notable that the RBD does still 
reduce the reporter mRNA levels at time zero (Figure 3.5, compare R7 t0 vs. RBD t0).  It seems 
plausible that the PUM RBD directs both pAbp-dependent translational repression, as well as 
decay dependent repression.  While pAbp knock-down does not impair the ability of the RBD to 
reduce mRNA levels, repression at the level of reporter protein is compromised by 50%; this 
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suggests that pAbp-dependent deadenylation impairs translation of the message but does not 
necessarily lead to destruction.  Nonetheless, a portion of the repressive activity from the 

























 4.3 DISCUSSION 
 The Conserved PUM RBD Does not Require Ago or eEF1A to Reduce Reporter 
mRNA Levels or Exert Repression Overall.  To confirm previous findings(Weidmann and 
Goldstrohm 2012) and extend the investigation into the mechanism utilized by PUM RBD to 
repress target mRNA expression we first compared reporter mRNA levels by northern blot to 
reporter luminescence output.  In agreement with previous data, the PUM RBD reduced reporter 
mRNA levels to nearly the same extent as seen at the level of reporter protein.  Mutation to 
residues reported to be required for interaction with Ago and eEF1A, and be important for in 
vitro repression had no effect on the ability of the RBD to repress the target mRNA.  ago-1 and 
ago-2, were knocked-down with dsRNAs to approximately 10% of original levels (measured by 
qRT-PCR), and this too had no impact on RBD-mediated repression.  These results demonstrate 
through both mutations that abrogate binding, and siRNA knock-down that Ago and eEF1A are 
not important for PUM RBD-mRNA regulation in D. melanogaster cells.  Also, the PUM RBD 
causes a reduction in mRNA levels, and it appears that the mechanism of repression is intimately 
linked to mRNA decay.  Conversely, decapping and destruction of an mRNA is the ultimate 
translational inhibition, as the mRNA is no longer present to be translated 
 
PUM RBD Activates Reporter mRNA Deadenylation, and this Requires the 3X PBE 
and RNA Binding by the RBD.   PUF proteins activate deadenylation in yeast, flies, humans, 
and worms (Wreden, Verrotti et al. 1997; Goldstrohm, Seay et al. 2007; Suh, Crittenden et al. 
2009; Van Etten, Schagat et al. 2012)  While PUM activation of deadenylation has been 
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demonstrated in the developing fly embryo, it was important to mechanistically assess poly(A) 
regulation by PUM in our S2 cell culture model because it allows functional dissection of 
elements important for regulation.  We found that PUM does robustly accelerate deadenylation 
of a PBE reporter, and this activity was largely blocked by mutation of the PBE.   
 
We also wished to determine which enzymes are responsible for deadenylation of the 
PBE reporter.  D. melanogaster encodes six known deadenylase enzymes, Pop2, Pan, Ccr4, 
Nocturnin, Angel, and 2-PhosphoDiesterase.  We chose to test Ccr4 and Pop2 for their 
involvement in PUM-mediated deadenylation as PUFs in yeast, humans, and worms all are 
known to associate with Ccr4 and Pop2 orthologs, as well as functionally promote deadenylation 
via these enzymes.  We found that Ccr4 and Pop2 are required for PUM-activated deadenylation 
of the PBE reporter; dsRNAs targeting ccr4/pop2 completely abolished deadenylation of the 
PBE reporter.  While we have not tested the involvement of the other poly(A) nucleases, the 
activity of Ccr4 and Pop2 are necessary for PUM-mediated acceleration of deadenylation. 
   
 The Deadenylation and Decapping Pathways are Important for PUM-mediated 
 Degradation of a Targeted mRNA.  All poly-adenylated mRNAs are subject to 
deadenylation, but at varying rates that tend to correlate well with mRNA stability.  Because the 
Ccr4/Pop2 deadenylase machinery acts on all messages, perturbation of their activity can lead to 
global changes in post-transcriptional mRNA regulation.  Knock-down of ccr4/pop2 increased 
reporter mRNA levels by 6-fold when R7mut was expressed, and 4-fold when the RBD was 
expressed; the data suggest that Ccr4/Pop2 contribute to PUM-mediated reduction in mRNA 
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levels, and that the PUM RBD is also capable of reducing mRNA levels when deadenylation is 
impaired.   
 
Knock-down of the decapping co-factor, Dcp1 impaired PUM-mediated mRNA decay 
activity.  This is striking, because knock-down of Dcp1 reduces Dcp1 levels by 80%, but there is 
still some residual Dcp1 present in the cells.  Also, the decapping enzyme, Dcp2, was not 
targeted, so it is likely that decapping catalysis is still being stimulated by the small amount of 
Dcp1 which remains after dsRNA treatment.  Because Dcp1 knock-down impairs PUM 
repression by 10% it is very likely that decapping is an important regulatory step that is targeted 
by the PUM RBD.  This is particularly relevant in light of data from S. cerevisiae Puf5p, which 
is known to recruit Ccr4p/Pop2p and accelerate deadenylation. PUF5 can also repress its target 
mRNA when deadenylation is genetically abolished; PUF5 is able to circumvent the general 
requirement for deadenylation and directly recruits activators of decapping and the decapping 
enzyme (Goldstrohm, Hook et al. 2006; Hook, Goldstrohm et al. 2007).  Repression at the 
protein luminescence level was monitored for each of these experiments, and while ccr4/pop2 
knock-down had no effect on overall repression, dcp1 knock-down actually reduced repression 
by a modest 10 %(data not shown).  So, while the effects of dcp1 knock-down are likely partial, 
these results indicate a potential role for PUM RBD to impact 5’ cap removal. 
One conclusion reached from this experiment is that both deadenylation and decapping activities 
have additive effects on PUM-targeted mRNA levels, and that the PUM RBD activation of decay 




Poly(A) Binding Protein (PABP) is Required for RBD-Mediated Acceleration of 
Deadenylation, and Accounts for 50% of Overall RBD Repression.  Pabp, as its name 
suggests, binds stretches of A residues at least 5 bases in length.  It is commonly found in the 
context of a circularized mRNA, and is known to contact the initiation factor eIF-4G, which 
binds to cap-bound eIF-4E.  It’s function in this case is thought to play a protective role for the 
poly(A) tail, and also promote translation initiation by assisting forming of the eIF-4F complex 
(Mangus, Evans et al. 2003).   
  
 So how then does PABP promote PUM-mediated deadenylation, and also promote 
mRNA stability and translation initiation?  There are reports that Pabp has a conserved function 
in promoting the formation of repressed RNPs, as well as in activation of deadenylation.  Pab1p 
is important for post-transcriptional mRNA repression by: Puf5p, the miRNA RISC machinery, 
the RBP Sex Lethal,  as well as a neuronal RBP known as Musashi (Kawahara, Imai et al. 2008; 
Duncan, Strein et al. 2009; Fabian, Mathonnet et al. 2009; Chritton and Wickens 2011; 
Huntzinger, Kuzuoglu-Ozturk et al. 2013).  The mechanism of repression via PABP generally 
involves an RBP associating with PABP, which inhibits formation of the translation pre-
initiation complex.  Those activities, when viewed in the context of the results presented in 
Figure 6 provide a hint as to how PABP seems to retain both inhibitory and activating qualities 
for mRNA regulation.   In the case of Puf5p, Pab1p binding in close proximity to Puf5p strongly 





 There has been significant argument over the mechanism miRNA repression, specifically, 
what roles do deadenylation, translational repression, and mRNA decay play in the overall 
repression of a target message.  This situation is remarkably similar to the PUF protein story, 
with many of the same actors taking the stage.  One piece of evidence Figure 6 demonstrates is 
that pabp knock-down almost completely inhibits PUM activation of deadenylation, and also 
reduces overall repression by 50 %.  There is no reason to suspect that Pabp has exo-nuclease 
activity, and, as noted above, siRNAs against ccr4/pop2 completely block deadenylation.  
Therefore, it is likely PUFs target PABP  to inhibit translation, and this activity acts as a signal to 
promote deadenylation, possibly through association of the PUM RBD, PABP, and the 
Ccr4/Pop2 complex.  In this model, PUM bound in proximity to Pabp results in de-stabilization 
of the eIF-4F complex, which immediately exposes the 3’ end of the mRNA to deadenylases in 
recruited by PUM.  This result shows that the PUF RBD retains a conserved function to utilize 
PABP to direct translational represson, and the Ccr4/Pop2 deadenylase complex to elicit 
deadenylation 
 
While pAbp knock-down resulted in a 50% loss or repression, the RBD still retains half 
of its’ repressive activity.  It is clear that the canonical deadenylation and decapping pathways 
are acting on the PUF-targeted mRNA.  It is enticing to speculate that the PUM RBD may 
activate decapping independently of deadenylation, in yeast, the HO mRNA is deadenylated 
extremely rapidly, and this is promoted by Puf5p.  However, deadenylation is not required for 
repression by Puf5p.  Eap1p is required however, and has no impact on the rate of deadenylation, 
but promotes removal of the 5’ cap; demonstrating the ability of a PUF protein to independently 
120 
 
activate multiple steps of mRNA regulation that have varying degrees of impact on the overall 
protein output of the mRNA.  
 
There are several open questions that will more clearly define the specific mechanism of 
repression by the PUM RBD.   One important question is: does the PUM RBD directly contact 
the decapping enzyme, and/or Pabp?  It seems likely that the PUM RBD may be a central 
physical link that allows for the formation of a large repressive complex on a targeted mRNA.  
To address this it will be important to delineate the direct physical connections that PUM forms 
with each of these co-factors.  It is also crucial to determine what the mechanism is behind PUM 
targeting Pabp for translational repressive activities.  Both the Musashi and Sex Lethal RBPs 
bind to PABP and block binding to eIF-4G, effectively de-circularizing the mRNA.  Is this the 
case with the PUM RBD?   
 
In vitro competition binding experiments will be helpful to determine if the PUM RBD 
blocks eIF-4G binding to PABP.  Finally, there is still significant decay elicited by the PUM 
RBD when deadenylation and decapping are impaired.  Two likely possibilities can explain this: 
decapping is not blocked by Dcp1 knock-down, therefore PUM activated degradation of the 
mRNA may be caused by recruitment of the decapping machinery to a targeted mRNA, 
alternatively, the PUM RBD may recruit the 3’ – 5’ exonuclease machinery to destroy the 
mRNA after deadenylation.  Therefore, knock-down of exosome subunits will be a useful tool to 
ask if 3’ -5’ decay is important for PUM repression.  Also, the use of dominant negative 
decapping enzyme along with knockd-down of Dcp1 should more severely impair decapping, 
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and thus we would expect  much less repression and degradation promoting activity via the PUM 


























4.4 Materials and Methods: 
Northern Analysis:  For detailed protocol refer to Blewett et. al., MCB 2012.  Briefly 20μg 
RNA was separated in a 0.85% agarose MOPS/formaldehyde gel.  RNAs were transferred to 
nytran membrane with TurboBlotter™ for 3 hours.  Membranes were U.V. crosslinked and 
probed for the RNAs indicated. 
Rnase H Cleavage:  For detailed protocol refer to Blewett et. al., MCB 2012.  Briefly, 15-20μg 
RNA was annealed to cleavage oligo NB119.  2U Rnase H was added to each reaction, oligo dT 
reaction received 5ug oligo dT.  RNAs were cleaved 1 hour at 37 °C, then precipitated with 1/10 
volume 3M Sodium Acetate, and 3 volumes 100% Ethanol for 1 hour at -20°C  RNAs were 
pelleted, washed with 70% ethanol and resuspended in denaturing RNA loading buffer.  RNAs 
were separated in 5% polyacrylamide, 7M urea, 0.5X TBE gels.  Electrophoretic transfer was 
performed with BioRad TransBlot Cell for 1 hour at 60V.  Membranes were then probed for the 
indicated RNAs. 
Oligos: 
Renilla-3X NRE T7 transcription primers: 
Forward 
NB113: 5’ GCCCGTGGCTAGATGCATCATCC 3’ 
T7 promoter Reverse: 
NB114: 5’ GGATCCTAATACGACTCACTATAGGGCGGACAATCTGGACGACGTCGG3’ 
Rnase H cleavage oligo: 
NB120: 5’ CCTTGAATGGCTCCAGGTA 3’ 
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Renilla-3X NRE poly(A) tail T7 transcription primers 
Forward: 
NB119: 5’ GGGCGAGGTTAGACGGCCTACCCT  3’ 
T7 promoter Reverse: 
NB118: 5’ GGATCCTAATACGACTCACTATAGGGGCGGCCAGCGGCCTTGG 3’ 
YL41 oligo probe: 
NB129: 5’ TTTAGGGCCACCATTTTAGGGCTACCCAGTCGGCG 3’ 
7SL ncRNA oligo probe: 
NB117: 5’ CACCCCTGGCCCGGTTCATCCCTCCTTAGCCAACCTGAATGCCACGG 3’ 
LacZ control, forward primer: 5’ 
dGGATCCTAATACGACTCACTATAGGGTGACGTCTCGTTGCTGCATAAAC3’ 
LacZ reverse primer: 5’ 
dGGATCCTAATACGACTCACTATAGGGGGCGTTAAAGTTGTTCTGCTTCATC; 
Pop2, forward primer:  
5 –dGGATCCTAATACGACTCACTATAGGGGGACACCGAGTTTCCAGGCG 
reverse primer:  
5 –dGGATCCTAATACGACTCACTATAGGGGAAGAAGGCCATGCCCGTCAGC 
Ccr4, forward primer:  
5 –dGGATCCTAATACGACTCACTATAGGGGGAAGTACGTCGATGGCTGTGC 





 dsRNA templates:  From each PCR template, double-stranded RNA (dsRNA) was transcribed 
in vitro with the T7 RiboMAX large-scale RNA production system (Promega), treated with 
Turbo DNase (Ambion) for 3 h, and purified using the SV total RNA isolation system 
(Promega). For knockdown of each gene’s expression, 6 g of dsRNA per well of a 6-well plate 
was added to cells 10 min before transfection of reporters and expression vectors. 
 
RNAi Experiments: Double-stranded RNAs (dsRNAs) were generated for RNAi of non-
targeting control (NTC) LacZ, Pop2, and CCR4 as previously described (Weidmann, Van 
Etten). New primers with T7 promoter sequence underlined and gene specific regions bolded 
include:  AGO1 forward primer, 5’-
dGGATCCTAATACGACTCACTATAGGCCAATCACTTCCAGGTGACAATGC, and 
reverse primer, 5’-
dGGATCCTAATACGACTCACTATAGGCCACTGCGAGGGCCTTACG; AGO2 forward 
primer, 5’-dGGATCCTAATACGACTCACTATAGGGGATGGAGCAACTCAGGTGGC, 
and reverse primer, 5’-
dGGATCCTAATACGACTCACTATAGGGAGGAATAATCACAATTGCCAGATCG; 
pAbp forward primer, 5’-
dGGATCCTAATACGACTCACTATAGGGCGTATGCAGCAGCTGGGACAG, and reverse 
primer, 5’-
dGGATCCTAATACGACTCACTATAGGCCTTGCAATTGCTGTGGAATTGGC.  
Corresponding regions were amplified via PCR from D.mel-2 cells and dsRNA was transcribed 
in vitro and purified as previously described (Weidmann and Goldstrohm 2012). For knockdown, 
each 6-well of cells with total volume 2.2 mL was treated with 6µg dsRNA for 5 minutes before 
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transfection. For knockdown during transcription shutoff assays, 20mL total volume was treated 
with 60µg dsRNA 5 minutes before transfection. 
Transcription Shutoff:  Two days post-transfection in a T-150 flask transfection (14.6mL 
1M/mL D.mel-2 cells, 5.4 mL sf900iii media, 3636ng pIZ vector,  91ng Renilla vector, 45.5ng 
Firefly vector, 818µl EC buffer, 29.1µl Enhancer, 36.36µl Effectene), 5µg/mL of Actinomycin D 
was added. RNA was harvested from 3.5mL of transfection once immediately before addition of 
Actinomycin D (0hr) and at distinct time points after addition. Cells were washed twice in PBS 






Concluding Thoughts and Future Directions:
 Analysis of mRNA Decapping in vivo:  Removal of the 5′ cap from an mRNA is tightly 
regulated, and commits the mRNA to destruction.  The decapped mRNA is highly labile due to 
the activity of Xrn1p, the 5′ – 3′ exonuclease.  Because the decapped mRNA species is so 
fleeting, it has been difficult to measure the process of decapping quantitatively.  Several 
methods have been used to assess decapping, but these involve the use of: reporter mRNAs with 
extreme secondary structure to block 5′-3′ degradation (He and Parker 1999), or reconstituted in 
vitro systems (Zhang, Williams et al. 1999).  All of these methods have been useful in 
identifying and characterizing the 5′ mRNA decay pathway however, quantitative in vivo 
analysis of endogenous mRNA decapping has been difficult to achieve.  In Chapter 2, I 
presented a manuscript published in the journal RNA in 2011, a novel, quantitative-Splinted 
Ligation-Reverse Transcription Polymerase Chain Reaction (q-SL-RT-PCR) assay to measure 
decapping of endogenous mRNAs in vivo; this represents the first assay to quantitatively assess 
the rate of decapping for an endogenous mRNA (Blewett, Coller et al. 2011).  I have shown that 
decapped mRNA can be detected across several orders of magnitude, with precise 
reproducibility. 
   
Mechanistic analysis of decapping in mammalian cells has been recalcitrant to 
investigation, primarily because the use of strong secondary structure in a reporter mRNA does 
not block degradation of the mRNA as it does in yeast.  The q-SL-RT-PCR assay is well-suited 
to directly analyze mRNA decapping in mammalian cell culture models.  Efficient knock-down 
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of Xrn1 is crucial to quantitative analysis of decapping.  It may be worthwhile to establish Xrn1 
siRNA expressing, stable clonal lines for optimal knock-down.  Alternatively, RNAi in D. 
melanogaster S2 cells is particularly effective, and mechanistic analysis of decapping for PUM 
targets would be another valuable experimental path which would likely yield valuable insight 
into post-transcriptional control of eukaryotic gene expression. 
 
Given the role I have demonstrated for PUF5 in yeast in promotion of decapping and 
mRNA degradation (Blewett and Goldstrohm 2012), the role demonstrated for human PUM in 
activation of deadenylation and mRNA decay (Van Etten, Schagat et al. 2012), and the presence 
of PUM Recognition Elements in the 3′UTR of a tumor suppressor (Kedde, van Kouwenhove et 
al. 2010), it is likely that PUM controls the stability of mRNAs are involved in cell-cycle 
regulation and cancer formation.  It will be informative to analyze the decapping rate of mRNAs 
which contain PUF sites, and have been associated with cancer formation.  The qSL-RT-PCR 
assay could be used to compare the rate of decapping for PUM target mRNAs in healthy prostate 
cells, as well as prostate cancer cell lines.  The 5′ transcriptional start site (TSS) of the tumor 
suppressor p27 would be mapped via 5′ Rapid Amplification of cDNA Ends (5' RACE).  Based 
on the 5′ RACE identification of the p27 TSS a DNA splint would be designed which hybridizes 
to the 5′ end of the p27 mRNA, and to a synthetic RNA anchor.  Then, Xrn1 will be knocked 
down along with either non-targeting siRNAs, or siRNAs targeting both PUM1 and PUM2.  
Initially it will be beneficial to determine if there is a decrease in the amount of decapped p27 
when PUMs are knocked-down.  Subsequent experiments utilizing Actinomycin D will then be 
employed to determine the decapping rate on p27 with or without PUM knock-down.  As a 
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complement to this approach it will also be useful to determine the p27 mRNA half-life in these 
experiments, which can then be correlated with effects on decapping. 
 
PUF5 and EAP1: Control of mRNA Stability and Interplay with the Translational 
Machinery:  In Chapter 3, I presented a manuscript published in the journal Molecular Cellular 
Biology, in 2012, which demonstrated a novel function for the eIF-4E binding protein EAP1 in 
the activation of mRNA decapping.  I showed that EAP1 is required for PUF5 mediated 
repression of its target, HO mRNA, and that unexpectedly EAP1 did not inhibit the translation of 
HO mRNA, but accelerated its destruction.  The activity of EAP1 was not limited to HO mRNA; 
EAP1 also strongly accelerates the decay of the non-PUF target RNR1 mRNA without impacting 
the translation of this message either.  It should be noted that the abundant and stable RPL41 
mRNA was not impacted by EAP1 activity. 
 
 All mRNAs have a 5′ cap, and are bound by eIF-4E, but not all mRNAs are susceptible 
to 4EBP regulation equally (Dowling, Topisirovic et al. 2010; Blewett and Goldstrohm 2012).   
One way that RNA-binding proteins exert regulation on bound mRNAs is to recruit effector 
proteins through physical association, and increase the local concentration of repressive proteins.  
It is possible that Eap1p may be a component of the general decapping machinery, which is then 
recruited to certain mRNAs through a variety of RNA-binding proteins.  In fact, Puf5p is not the 
only RNA-binding protein to utilize Eap1p to activate mRNA degradation. Another RBP known 
as Vts1p has recently been demonstrated to associate with Eap1p, which results in activation of 
decapping and degradation (Rendl, Bieman et al. 2012).  It is likely that Puf5p and Vts1p are not 
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the only RNA-binding proteins to utilize Eap1p, and it is important to understand which, and 
how many mRNAs are affected by EAP1 at the level of stability.   
 
Global analysis of the effects of EAP1 on ribosome occupancy has been performed 
(Cridge, Castelli et al. 2010): however effects on mRNA half-life by EAP1 were not assessed.  It 
is important to note that eap1 deletion results in an increase in HO mRNA ribosome occupancy, 
however, this simply reflects an overall increase in total HO mRNA due to impaired decapping 
and degradation.  Therefore global analysis of mRNA half-lives in wild-type and eap1 yeast will 
yield valuable insight into the extent of Eap1p-mediated activation of mRNA decapping.  This 
could be achieved through inhibition of transcription, RNA would then be extracted at prescribed 
time points after inhibition from wild-type and eap1 mutant cultures with biological replicates. A 
high-throughput RNA-sequencing library would be produced and sequenced to generate global 
mRNA decay rates (Tani, Mizutani et al. 2012) between wild-type and eap1 mutants.  mRNAs 
that undergo EAP1-mediated degradation could then be searched for enrichment of known RNA-
binding protein recognition sequences; it is likely that this method will uncover novel, functional 
RBP-4EBP mediated mRNA regulatory complexes. 
 
 Another interesting facet of Eap1p post-transcriptional regulation is that no effects are 
seen on ribosome occupancy for repressed mRNAs.  In fact, polyribosome analysis of HO 
mRNA revealed somewhat surprisingly that in wild-type cells HO mRNA is 90% occupied by 
ribosomes; there is almost no free HO mRNA in the pre-80s fractions of the polysome sucrose 
density gradient.  Because there is very little detectable HO mRNA that is not engaged with 
ribosomes, there must be a very rapid transition between the translation of HO mRNA by several 
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ribosomes, to an mRNA which is committed to destruction.  Previous work has shown that 
decapped mRNAs can be engaged with multiple ribosomes, and suggests that Xrn1p destroys 
mRNAs in a 5′ -3′ manner immediately behind the last transiting ribosome (Hu, Sweet et al. 
2009; Hu, Petzold et al. 2010).    
  
 Destroying an mRNA immediately behind the final ribosome represents an efficient 
method of insuring complete silencing of gene expression.  In the case of HO endonuclease, 
there is a short window of expression to facilitate mating-type switching, but mis-expression of 
HO results in inappropriate HO endonuclease activity, and cell-cycle arrest, which highlights the 
need for efficient, rapid destruction of the message.  My findings are consistent with a model in 
which HO mRNA is exported into the cytoplasm, and is immediately engaged by several 
ribosomes.  Once Puf4p, and Puf5p bind to the 3′ UTR, the deadenylase machinery as well as 
Eap1p are recruited.  Eap1p disrupts the interaction between eIF-4E and eIF-4G, causing 
decircularization of the mRNA and exposing the Poly(A) tail to recruited deadenylases.  
Disruption of the eIF-4F complex weakens the association of eIF-4E with the 5′ cap, allowing 
the decapping machinery to compete more effectively with eIF-4E for binding to the 5′ cap, the 
mRNA is then destroyed by the processive activity of Xrn1p immediately behind the last 
transiting ribosome.   
  
 Several questions remain unanswered regarding the specific physical interactions that 
link Puf5p and Eap1p.  I have shown that Puf5p, Dhh1p, and Eap1p associate in vivo, but it 
remains unclear if Eap1p directly contacts Puf5p or Dhh1p, or rather, if the observed association 
is bridged by another protein.   Efforts to produce recombinant, purified, full-length Eap1p and 
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Puf5p were not successful.  The majority of products produced in E. coli were truncated, to 
remedy this, efforts were made to supply rare tRNAs.  Also, several different translation 
induction protocols utilizing different temperatures, and times were attempted, none of which 
were successful.  EAP1 production was also attempted in wheat germ extract, as well as rabbit 
reticulocyte lysate, which both yielded poor results.  As a result of the limited amount of purified 
protein available, in vitro pull-down assays were inconclusive.  Previous work has demonstrated 
that Puf5p directly binds Pop2p, and also associates with the decapping enzyme co-factor, Dcp1p 
(Goldstrohm, Hook et al. 2006).  It would be very intriguing to understand mechanistically, and 
sequentially how Puf5p co-ordinates the recruitment of deadenylases, Eap1p and the decapping 
machinery. 
 
 One way to define the specific protein contacts that form the complex, Puf5p, Eap1p, 
Dhh1p, and Dcp1p, is through a co-immunoprecipitation strategy where components of the 
proposed PUF-decapping complex are deleted.  Eap1p would be immunoprecipitated with Puf5p 
in the context of dhh1, pat1, pop2 or dcp1 mutant backgrounds to determine if the association 
between Eap1p and Puf5p relies on any of these proteins.  A similar strategy could be carried out 
to determine if Eap1p association with Dhh1p relies of Puf5p.  Because there are likely other 
proteins that associate with Puf5p and Eap1p and participate in the activation of decapping, this 
method will not prove that Eap1p and Puf5p physically associate, but it will serve to better 





 The function of the extended C-terminus of Eap1p remains unknown; there are no clear 
regions of sequence conservation in EAP1 outside of the eIF-4E binding motif.  In order to gain a 
clearer understanding of how Eap1p activates mRNA decapping and degradation it will be useful 
to identify EAP1 mutants which are unable to rescue the decay phenotype of the eap1 deletion 
mutant.  I have shown that the eIF-4E binding activity is not absolutely necessary for activation 
of mRNA decay; therefore EAP1 could be divided into N and C-terminal fragments to ask which 
region promotes mRNA decay.  Further sub-division should yield a minimal EAP1 fragment 
which is still capable of accelerating mRNA decay.  After identification of regions important for 
activity, co-immunoprecipitation experiments could be performed to ask if Puf5p, and Dhh1p 
still associate with the inactive mutant.  Another benefit of this strategy is that smaller regions of 
EAP1, which are still active for decay promotion, may prove easier to translate either in E. coli., 
or with in vitro systems.  If sufficient amounts of Eap1p could be produced, in vitro pull-down 
experiments would then be a feasible option to determine if Eap1p contacts Puf5p, or Dhh1p 
directly.  The pull-down data could then be correlated to the functional rescue experiment 
outlined above to more precisely define how Puf5p recruits Eap1p, Dhh1p, and Dcp1p to HO 
mRNA.  Identification of the specific physical interactions that form the Puf5p recruited 
repressive complex will be crucial in determining specifically how Eap1p promotes decapping.  
This is a relevant question, as Eap1p can promote mRNA degradation in the absence of 
deadenylation.   
   
 The general mRNA decay pathway is thought to proceed via a step-wise process that 
initiates with deadenylation, and loss of Pab1p from the poly(A) tail, and eIF-4E from the 5′ cap.  
The Lsm complex along with Pat1p and Dhh1p then associate with the short  oligo(A) tailed 
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mRNA and recruit the decapping machinery to the exposed 5′ cap resulting in decapping and 5′ – 
3′ degradation of the mRNA.  Dhh1p stimulates the in vitro activity of the purified decapping 
enzyme (Fischer and Weis 2002), yet, Dhh1p is also able to destabilize the 48s pre-initiation 
complex, and inhibit both cap-dependent and cap-independent translation in vitro with no impact 
on mRNA stability (Coller and Parker 2005).  Another component of the general decapping 
machinery is Pat1p which was originally identified as an activator of decapping (Tharun, He et 
al. 2000).  Further work demonstrated that Pat1 inhibits the formation of, or destabilizes the 48s 
pre-initiation ternary complex in an in vitro translation extract, also, in vitro pull-down assays 
indicated that Pat1p directly interacts with Dhh1p as well as Dcp1p (Nissan, Rajyaguru et al. 
2010).  Pat1p and Dhh1p play multiple roles, both in direct activation of the decapping enzyme, 
and in destabilizing the 48s pre-initiatiation complex: it is not currently known if decapping 
activation and inhibition of early initiation steps by Pat1p or Dhh1p are separable activities.  
Aside from the multiple functional roles Pat1p plays in mRNA regulation, it also serves as a 
scaffold to physically link the components of the deadenylation, and decapping machinery, 
forming a complex on deadenylated mRNAs that simultaneously silences translation and 
activates mRNA decay.   
 
 Interestingly, repression by Puf5p does not require deadenylation, but does require 
Eap1p, which activates decapping, apparently circumventing the need for an initiating 
deadenylation event.  Puf5p may be able to activate deadenylation-independent decapping 
through direct recruitment of Pat1p, Dhh1p, and Eap1p.  The role of Dhh1p and Pat1p appear to 
be destabilization of the 48s pre-initiation complex, whereas Eap1p binding to eIF-4E results in 
dissociation of eIF-4G, causing linearization of the mRNA.  Puf5p also appears able to target 
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Pab1p for repression in vitro (Chritton and Wickens 2011).  Aside from recruitment of Eap1p to 
HO mRNA, Puf5p may also promote disruption of the circularized mRNA through association 
with Pab1p.   
  
 While difficult to undertake, a reconstituted system which re-capitulates the circularized 
protected mRNA would prove extremely useful to test the above model.  Cap-bound eIF-4E 
competes effectively with the decapping machinery, and inhibits decapping (Schwartz and 
Parker 2000).  Also, the eIF-4F complex consisting of cap-bound eIF-4E, eIF4G, and Pab1p 
bound to the poly(A) tail is known to strengthen the association of eIF-4E with the 5′ cap.  Our 
model suggests that Eap1p weakens the association of eIF-4E with the 5′ cap, in the context of 
competition with the decapping machinery, and it seems likely that Dhh1p may also be involved 
in evicting the translation initiation machinery, possibly through its ATPase/helicase activity.  
One way to test this model will be to mutate the ATPase domain of dhh1, and ask if the Dhh1p 
mutant is able to complement the defect in mRNA decay for HO mRNA seen in the dhh1 
deletion mutant. 
  
 To ask if Eap1p or Dhh1p facilitate access of the decapping machinery to a circularized 
mRNA, the first step is to recapitulate mRNA circularization in vitro, with purified eIF-4E, eIF-
4G, and poly(A) binding protein (Wells, Hillner et al. 1998; Deshmukh, Jones et al. 2008).  
Components of the eIF-4F complex, as well as the decapping complex Dcp1p/Dcp2p can be 
expressed and purified from bacteria with affinity tags (Steiger, Carr-Schmid et al. 2003).  For 
the purposes of this experiment it will be important to use an RNA substrate which is long 
enough to accommodate circularization, and also approximate an average mRNA.  A PCR 
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product would be generated to construct a T7 RNA polymerase template of roughly 1kb in 
length.  The synthetic RNA would be purified, and capped using commercially available 
vaccinia virus capping enzyme, the RNA will then be poly-adenylated using commercially 
available poly(A) polymerase.  
  
 The most important piece of the assay is Eap1p, as stated above; Eap1p is extremely 
difficult to produce in vitro or with bacteria translation systems.  There are two potential paths to 
overcome this limitation; the first involves successful identification of a smaller fragment of 
Eap1p that still retains the ability to activate decapping.  It is not guaranteed that a smaller 
fragment of Eap1p will be translated more efficiently, but it would be worth the effort, and be 
useful for a variety of experimental purposes.  As complement to the first approach, it could be 
informative to immunopurify Eap1p from yeast, in the context of various deletion strains such 
as: dhh1, puf5, dcp1, etc.  This approach would be geared towards understanding the nature of 
the complex that Eap1p is associated with, and its’ functional impact on decapping. 
  
 Given a supply of Eap1p, whether as a minimal fragment, or as a purified complex, the 
assay would be performed as follows:  The capped, poly-adenylated RNA will be pre-incubated 
with the eIF-4F components.  In one reaction Dcp1p/Dcp2p would be added.  In another 
reaction, the decapping machinery and Eap1p are added together.  Negative controls would 
include a reaction consisting of just eIF-4F complex alone. Another reaction will include naked 
RNA, or naked RNA and Eap1p by itself.  Several factors could be monitored from this reaction. 
First, because mRNA decay is not active, decapped RNA molecules will remain stable.  Thus, 
the accumulation of decapped RNA could be monitored over time with the qSL-RT-PCR assay 
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to afford quantitative assessment of decapping rates.  Alternatively, decapping could be 
monitored with the use of Thin Layer Chromatography to resolve the cleaved, radioactively-
labeled cap structure. 
  
 Our model predicts that, under competition with the decapping complex, Eap1p will 
promote the dissociation of eIF-4E from the cap.  To test this prediction eIF-4E could be 
immunoprecipitated from each of the above conditions using a radio-labeled synthetic capped 
RNA.  RNA would be extracted from eIF-4E pull-down in the context of the eIF-4F complex 
alone, or with the addition of Eap1p, Dhh1p, or both together.  The amount of RNA engaged 
with eIF-4E could then be quantitated by Northern blot and phosphorimage analysis.  If correct, 
our model would predict that addition of Eap1p would reduce the association of eIF-4E with the 
RNA.   
 
A complementary, however technically challenging, approach would be to use 
Fluorescence Resonance Energy Transfer (FRET) to ask if addition of Eap1p results in 
decircularization of the RNA.  I would take a similar approach to that used by (Abelson, Blanco 
et al. 2010); in this case I would label the extreme 5′ end of the RNA with a donor Cy3 and the 3′ 
UTR immediately adjacent to the synthetic poly(A) tail would be modified with acceptor Cy5 
flourophore.  The experimental conditions outlined above would be used, along with naked RNA 
to control for the natural conformational dynamics the RNA will undergo.  It will be very 
interesting just to monitor the difference in FRET values between the naked RNA and that bound 
by eIF-4E; this should increase the FRET value if bona fide circularization is occurring.  
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Subsequent addition of the decapping machinery and Eap1p respectively will allow us to test this 
model of Puf5p and Eap1p activated decapping. 
  
 There are certain to be technical challenges associated with the application of FRET to 
this assay.  The foremost challenge will be generation of robust, specific, reproducible FRET 
signal.  The orientation angle between the FRET donor and acceptor will dictate the efficiency of 
resonant energy transfer, and it must be empirically determined whether the fluorophores placed 
at the 5′ and 3′ end of the RNA are capable of FRET.  If this proves to be unfeasible, an 
alternative and potentially informative approach could be taken wherein either eIF-4E, and 
Pab1p, or eIF-4G and Pab1p would be labeled with donor and acceptor fluors through 
Chemoselective Ligation (CLick) chemistry.  Briefly, CLick chemistry has been applied in a 
variety of ways to specifically label a modified, unnatural amino acid, in this case L-
azidohomoalanine, which can be incorporated during translation.  After affinity purification, the 
protein will be modified with a Cy3 or Cy5 alkyne fluorescent molecule using commercially 
available sources.  Through this battery of conditions utilizing FRET moieties on a combination 
of both proteins and RNA we can begin to develop a more sophisticated view of the dynamics of 
mRNA regulation.   
 
 I have demonstrated a novel activity for an eIF-4E binding protein in the activation of 
mRNA decapping.  The results presented in Chapter Three (Blewett and Goldstrohm 2012) 
indicate that some 4EBPs are able to carry-out repressive mechanisms that diverge from the 
initial model of inhibition of translation initiation.  As indicated above, little is known about the 
function of the C-terminus of Eap1p due to lack of sequence conservation or functional analysis.  
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A Drosophila 4EBP, Cup, inhibits translation by activation of deadenylation and, surprisingly, 
stabilizes the silenced mRNA.  Yet when Cup was dissected into three functional domains, a mid 
and q-rich domain both activate deadenylation and decapping in S2 cells (Igreja and Izaurralde 
2011).  It appears that full-length Cup contains a domain that impairs the activation of decapping 
via the mid, and Q-rich domain.  Perhaps there are stimulus-dependent, or cell-type specific 
conditions where Cup does promote decapping and decay, very little is known about potential 
regulatory mechanisms that modulate Cup repression and/or activity.   
 
 Another example of a 4EBP activating mRNA decay comes from the human eIF-4E 
Transporter (4E-T).  Knock-down of 4E-T results in stabilization of an AU-Rich Element (ARE) 
mRNA (Ferraiuolo, Basak et al. 2005), suggesting that an ARE-binding protein may recruit 4E-T 
to activate mRNA decay on targeted messages.  It is not clear what role nucleo-cytoplasmic 
shuttling of eIF-4E by 4E-T (Dostie, Ferraiuolo et al. 2000) plays in activation of mRNA decay, 
but 4E-T and eIF-4E co-localize in P-bodies (Ferraiuolo, Basak et al. 2005), which are known to 
be sites of mRNA decay and translational repression.  The examples above demonstrate that 
post-transcriptional regulation by 4EBPs is exerted through a variety of mechanisms that are 
likely dictated by regions outside of the eIF-4E binding motif, probably through specific protein 
associations.   
 
 It is not clear at present how responsive Eap1p and Cup are to inhibition of the Target of 
Rapamycin (TOR) Pathway.  4E-BP1 and 4E-BP2 both inhibit the translation of specific mRNAs 
upon TOR inhibition in mammalian cells (Dowling, Topisirovic et al. 2010).  Another 
Drosophila 4EBP, Thor, plays an integral role in the metabolism and mainentance of adipose 
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tissue.  Thor mutant flies expend their fat stores more quickly than wild-type flies under 
starvation conditions, and the Thor mutants also die more quickly when starved (Teleman, Chen 
et al. 2005).  It will be beneficial to our understanding of 4EBP regulation to carry-out 
mechanistic analysis of 4EBP function in yeast and Drosophila S2 cells with and without TOR 
inhibition.  Another relevant question is: what effect does recruitment by an RNA-binding 
protein have on 4EBP activity?  We know that 4EBPs are capable of carrying-out repression 
independently, however specific association with RNA-binding proteins may add to 4EBP 
regulation in a combinatorial fashion.  Puf5p activates deadenylation in addition to recruiting 
Eap1p to HO mRNA.  Therefore, RNA-binding proteins have the potential to impact the activity 
of 4EBPs through nucleation of a complex that contains multiple repressive activities. 
 
 Mechanisms of mRNA Regulation via the Conserved PUM RNA Binding Domain 
(RBD) in D. melanogaster.  In Chapter Three I investigated what factors contribute to repression 
by the PUM RBD, and what functional effects are exerted on the mRNA itself.  These 
experiments were designed to test a very recent model for PUM RBD repression; this model 
proposed that the RBD associates with Elongation Factor 1A (eEF1A) and (Argonaute) Ago to 
repress translation elongation for PUM targets.  The Goldstrohm lab has developed a functional 
assay for PUM regulation in Drosophila S2 cells, in which multiple components can be 
perturbed to ask mechanistic questions about the nature of PUM RBD-mediated mRNA 
regulation in vivo, which enabled the relevance of the PUM-Ago model to be functionally tested.  
Collectively our data strongly suggest that the PUM RBD does not require interaction with Ago 
or eEF1A to inhibit expression of a targeted reporter mRNA.  We found that the PUM RBD 
activates mRNA degradation on the reporter mRNA through conserved mechanisms involving 
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acceleration of deadenylation, and promotion of mRNA decay through decapping.  Dcp1 is not 
absolutely required for decapping, but does activate catalysis by Dcp2, and couples decapping to 
5′ -3′ decay by Xrn1/Pacman (Braun, Truffault et al. 2012).  Because Dcp1 knock-down is not 
100% effective, and the decapping enzyme was not targeted, it is unclear what the absolute 
contribution of decapping is to repression via the RBD. 
  
 One approach to complement our data that dcp1 knock-down impairs PUF RBD 
repression is to express a catalytically inactive decapping enzyme in addition to Dcp2 knock-
down.  Previous work has shown that expression of the inactive mutant Dcp2 strongly impairs 
decapping (Igreja and Izaurralde 2011).  To ask if the RBD is utilizing decapping for repression, 
the PUM RBD or R7mut would be transfected along with the reporter and dominant negative 
Dcp2 expression construct.  Repression of reporter protein output would be monitored relative to 
R7mut expression to first ask if dominant negative Dcp2 expression results in reduced repression 
via the RBD.  Reporter mRNA levels would be quantitated to ask if the RBD is still able to 
reduce mRNA abundance.  If decapping plays a significant role in RBD repression, expression of 
the dominant negative Dcp2 should result in impaired repression, at both the mRNA and protein 
levels. In a related approach to ask if cap removal is important for PUM repression and 
degradation promotion, a synthetic PBE mRNA encoding Renilla Luciferase will be capped with 
either m
7
G or a non-hydrolyzable cap analog (Rydzik, Lukaszewicz et al. 2009).  Each RNA 
would be transfected along with a control Firefly Luciferase, and either wild-type RBD, or 
mutant RBD which cannot bind the PBE.  If decapping is targeted by the PUM RBD we would 
expect repression to be dramatically decreased for the non-hydrolyzable capped RNA.  However, 
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if the PUM RBD is targeting translation initiation, the non-hydrolyzable capped RNA should be 
repressed as well as the m
7
G capped RNA.   
  
 Thus far, we have taken a candidate approach to identifying the pathway(s) required for 
RBD-activated mRNA decay.  To identify and characterize factors that co-operate with the PUM 
RBD to activate mRNA decay, I propose the following RNA pull-down, mass spectrometry 
experiment.  The intent of this experiment is to isolate a functionally repressed reporter mRNA 
that is bound by the PUM RBD as well as yet to be identified repressive co-factors.  The 
difference between this experiment and traditional co-immunoprecipitation, mass-spectrometry 
is that the protein complexes will be isolated from a functionally repressed mRNA; this may lead 
to identification of associations that have direct functional relevance to PUM mRNA regulation.   
  
 To accomplish this goal, MS2 binding-site, stem loop sequences were cloned into the 
3’UTR of Renilla Luciferase 3X-PBE reporter construct used in Chapter Three.  Because the 
MS2 stem loops were inserted in relatively close proximity to the 3X-PBE, I asked if PUM is 
still able to repress the modified reporter mRNA.  Full-length, or R7mut PUM were transfected 
along with the RnLuc-3XPBE-MS2 reporter and the un-regulated Firefly control reporter.  The 
Dual-Glo™ assay was performed on four replicates, Renilla-MS2-PBE luminescence was 
normalized to Firefly, and then repression was quantified relative to R7mut repression.  Full-
length Pumilio repressed the modified MS2 reporter by 40% relative to the R7mut.  Therefore, 
Pumilio is able to repress the modified PBE-MS2 reporter, albeit with reduced efficiency.  The 
MS2 coat protein was then fused to the HaloTag™ (Promega) affinity handle (MS2-HT), and 
this construct was expressed and translated in E. coli cells using a rhamnose T7 induction 
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system.   MS2-HT was purified and covalently immobilized on HaloLink™ (Promega) resin to 
produce an affinity support for isolation of the RnLuc-3X-PBE-MS2 reporter mRNA.   
  
 To confirm that PUM is specifically associated with the reporter mRNA, V5-tagged wild-
type RBD or R7mut, would be expressed, and the reporter purified via MS2 RNA pull-down. 
Western analysis of eluates will be performed to determine if wild-type, but not R7mut come 
down with the reporter.  Also, silver stain of the same pull-down will be performed to ask if the 
proteins which come down with wild-type PUM display differences from the R7mut.  Another 
important optimization will be to confirm that the reporter mRNA is being effectively isolated 
via the MS2 purification. RNA will be extracted from the pull-down with the HT-MS2 beads and 
the 3XPBE reporter with, or without MS2 stem loops; this experiment will demonstrate 
specificity for MS2 pull-down in order to move forward with confidence.  Once the pull-down 
has been optimized and specificity shown, R7mut and wild-type PUM will be transfected along 
with the PBE-MS2 reporter, the MS2 affinity pull-down will be performed under stringent 
conditions empirically determined through the above experiments, the resulting isolated peptides 
will be identified via liquid chromatography tandem mass-spectrometry. 
  
 PUM reduces reporter mRNA levels significantly, therefore, it may be useful to knock-
down ccr4/pop2 to increase the overall mRNA levels and obtain more robust pull-down.  Aside 
from the issue of mRNA abundance, PUM causes a reduction in mRNA levels that does not rely 
on deadenylation.  Therefore, to increase the odds of identifying a novel repressive co-factor, and 
improve mRNA pull-down, it may in fact be beneficial to impair deadenylation.   
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Because a functionally repressed mRNA is the bait for pull-down, this should increase the 
likelihood that proteins found associated with PUM on the targeted mRNA will be of importance 
to PUMs repressive activity.  The use of the mutant PBE reporter and subsequent identification 
of the resident proteins in a well-translated mRNA will then be cross-referenced against the 
proteins identified on the PUM-targeted mRNA.  This approach has the potential to provide 
more nuanced protein association data than a traditional co-immunoprecipitation mass-
spectrometry experiment, as the proteins found through the traditional method are not necessarily 
involved in the particular activity being studied, in this case repression of a targeted mRNA.   
  
 The PUM RBD is clearly activating degradation of the targeted reporter mRNA, 
however, this activity does account for the full-repressive activity of the RBD.  The RBD has a 
versatile toolkit to repress mRNA expression, aside from activation of mRNA decay, the RBD 
targets Pabp to cause translational inhibition.  Because PUF5 in yeast is known to utilize PAB1 
for optimal repression (Chritton and Wickens 2011), we asked if this might be the case for the 
Drosophila PUM RBD.  We found that Pabp knock-down resulted in an inability of the RBD to 
accelerate deadenylation relative to the R7 mutant, and importantly, impaired repression by 50%.  
This data suggests a model in which the PUM RBD targets Pabp to inhibit translation, which 
then acts as a signal to promote deadenylation at a step immediately after inhibition of 
translation.  Therefore, while we can impair deadenylation by knocking-down the enzymes, the 
PUM RBD still utilizes Pabp to repress the mRNA through a translational mechanism.   
  
 Drosphila PUM is not the only post-transcriptional repressor to target Pabp for 
translational repression.  One of the earliest descriptions of translation inhibition through a Pabp-
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mediated mechanism comes from Paip2.  Poly(A) Interacting Proteins play positive and negative 
roles with regard to translation, where Paip1 binds Pabp and activates translation (Craig, 
Haghighat et al. 1998).  In contrast, Paip2 binds Pabp and inhibits translation.  Paip2 represses 
cap-dependent translation, which requires eIF-4G, but not cap-independent translation.  Also, 
Paip2 binding to Papb results in a decrease in the affinity of Pabp for the poly(A) tail 
(Khaleghpour, Svitkin et al. 2001).  In addition to decreasing affinity for the poly(A) tail, Paip2 
competes with eIF-4G for Pabp-binding, via what is called a PAM2 motif (Roy, De Crescenzo et 
al. 2002; Karim, Svitkin et al. 2006).  However, competition with eIF-4G through a PAM2 motif 
is not the only mechanism a repressor uses to target Pabp.  Another case involving translational 
repression exerted through an RNA-binding protein is the female-specific Sex Lethal (Sxl) 
protein.  Sxl binds to the 3′ and 5′ UTR of Male-Specific Lethal 2 (Msl-2), and recuits the UNR 
co-repressor which inhibits translation of the mRNA: repression is important for sex-specific 
dosage compensation (Bashaw and Baker 1997; Duncan, Grskovic et al. 2006).   Interestingly, 
repression by Sxl represses both cap-dependent and independent translation, suggesting a 
mechanism other than blocking eIF-4G binding to Pabp (Gebauer, Grskovic et al. 2003).  In fact, 
Sxl bound to the 3'UTR of Msl-2, recruits the UNR co-repressor which binds to Pabp, then 
blocks 40s ribosomal subunit recruitment, but leaves the eIF-4G-Pabp interaction unperturbed.   
 
Yet another example of Pabp-mediated repression comes from the post-transcriptional 
repressor, GW182.  GW182 associates with the miRNA RISC complex, and is thought to recruit 
deadenylase and decapping enzymes, and also inhibit translation translation (Chen, Zheng et al. 
2009; Fabian, Mathonnet et al. 2009).  It is thought that GW182 is able to repress translation 
through a mechanism that results in dissociation of Pabp from the poly(A) tail, and this involves 
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interactions between GW182 and the deadenylase complex.  Surprisingly, deadenylation is not 
required for GW182-mediated Pabp dissociation (Zekri, Kuzuoglu-Ozturk et al. 2013).  
Additionally, GW182 contains PAM2 motifs similar to Paip2, which enable GW182 to bind 
Pabp, therefore GW182 may act similarly to Paip2 in decreasing the affinity of Pabp for the 
poly(A) tail (Huntzinger, Braun et al. 2010). 
 
 Our unpublished results indicate that the PUM RBD binds to Pabp in RNase-treated 
extracts, yet, the RBD contains no apparent PAM2 motifs.  Also, PUM activated deadenylation 
requires Pabp, but deadenylation is not required for repression, however, a poly(A) tail is 
required.  Therefore, if a poly(A) tail is required, and deadenylation occurs after the Pabp-
promoted step, it seems unlikely that PUM is causing Papb to dissociate from the tail as GW182 
and Paip2 do.  It is possible that PUM association with Pabp forms a complex on the targeted 
mRNA that blocks ribosome recruitment.  However, it will be important to functionally test if 
Pabp dissociates from the poly(A) tail in a PUM-dependent manner.  It is remarkable that many 
RNA binding proteins that post-transcriptionally regulate target mRNAs do so in a manner that 
targets either eIF-4E or Pabp function.  And while the same translational components are 
targeted, the mechanisms used and the outcomes of repression differ significantly.  We have 
shown that the PUM RBD accelerates deadenylation, activates mRNA decay possibly through 
activation of decapping, and also exerts translational repression through a Pabp-mediated 
mechanism.  However, it must be stressed that repression elicited by the RBD is relatively minor 
in comparison to full-length PUM.  Within the N-terminus, three domains have been functionally 
identified that are capable of carrying out repression individually (Weidmann and Goldstrohm 
2012).  Also, while our data concerning the RBD suggest that a translational mechanism is 
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exerted through targeting of Pabp, the N-terminus reduces mRNA levels much more effectively 
than the RBD is capable of; this suggests that individual domains within PUM are capable of 
directing more robust mRNA decay activities.  There is little known about the function of the N-
terminus of both fly and human PUFs.  Future PUF research will benefit from focused efforts to 
dissect the multiple activities, as well as potential regulation mediated via the N-terminus of PUF 
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